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1 MOTIVATION 
"His lungs were so bad they couldn't supply the oxygen his body needed. A respiratory thera-
pist told us his lungs were so hard and infected that it was like trying to pump air into a brick."  
Scott Smith. 
 
Our lungs are essential organs for life. We never fully appreciate this being healthy, but as 
soon as respiratory function is impaired, nothing else but our breathing really matters. Nowadays 
respiratory tract infections (RTIs) constitute a large and growing public health problem. They are 
one of the most common cases of primary care visits and account for major antibiotic prescrip-
tions. [1-3] In 2016 RTIs killed approximately 3 million people worldwide, which makes them the 
leading infectious cause of death and the fourth-leading cause of death overall. [4] 
Like other infectious diseases, the outcome of RTIs is a complex interplay between the ability 
of the pathogen to infect, colonize and damage tissues, and the capacity of the host to mount an 
effective immune response. The average human inhales approximately 23,000 breaths of air each 
day along with any contaminating bacteria, virus and fungal particles present in the environment. 
Fortunately, the respiratory tract has evolved to withstand this invasion of potential pathogens by 
building a variety of innate and acquired immune defenses. For example, mechanical barriers limit 
the upper respitatory tract’s exposure to potential pathogens, while the mucociliary apparatus and 
cough reflexes work to expel any microorganisms that may bypass the initial defenses. If infectious 
agents manage to sneak into the lower respiratory tract, the alveolar macrophage and recruited 
phagocytes significantly decrease their chances of establishing infection. [5] However, if the de-
fense mechanisms are not working properly, pathogens have a higher likelihood of occupying the 
organism. This is the case, for instance, for immunocompromised patients. Potent immunosuppres-
sive therapies used for transplantations, the broad use of corticosteroids and immunosuppressant 
drugs for cancer, the lymphoproliferative and systemic diseases, tumour necrosis factor alpha in-
hibitors, monoclonal antibodies, and the pandemic of HIV/AIDS have created a favorable envi-
ronment for the emergence of various infections. [6, 7] Pulmonary complications appear in 60 % of 
such patients and are associated with high mortality rates, especially in patients with mechanical 
ventilation. [8, 9] 
Also susceptible are people suffering from chronic respiratory diseases such as asthma or ob-
structive pulmonary disease (COPD) as well as those who have genetic disorders affecting the 
lungs, like cystic fibrosis (CF). [10] In the case of chronic respiratory diseases, RTIs are the most 
common causal factors that disturb airway stability and lead to life-threating acute exacerbation of 
the main disease. [11, 12] CF is a disease characterized by the buildup of thick, sticky mucus, 
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which inhibit the clearance of microorganisms from the lungs. Thus, lower respiratory tract of CF 
patients is often colonized by pathogens. Ultimately, 80 to 95 % of patients with CF succumb to 
respiratory failure caused by chronic bacterial infection and concomitant airway inflammation. 
During infancy and early childhood, the main colonizing bacterium is the Gram-positive Staphylo-
coccus aureus, which is later replaced by Gram-negative Pseudomonas aeruginosa. [13] 
The last group of people at increased risk involves children, especially in low-income coun-
tries, and older adults. RTIs, predominantly pneumonia and bronchiolitis, are a major cause of 
death for children under 5 years of age. [14] Moreover, acute lower RTIs in childhood predispose 
individuals for chronic respiratory diseases later in life. [15] Considering older individuals 
(>65 years old) the morbidity rates of RTIs are similar as by younger people, but mortality rates are 
significantly higher. Reasons for this include: delayed diagnosis due to a frequent absence of typi-
cal signs and symptoms such as fever or leukocytosis; complications because of another chronic 
diseases, like diabetes; and often no response to the therapy. [16] 
Taking into account the gradually ageing and constantly growing number of immunocompro-
mised patients and individuals with chronic respiratory diseases, the growing mortality rates of 
RTIs are not surprising. Managing RTIs in susceptible patients is difficult: they often present atypi-
cally, progress rapidly and their identification and differentiation from noninfectious causes of 
fever and pulmonary infiltrates is far from simple. The development of prevention techniques as 
well as the improvement of diagnostic and treatment methods is essential to decreasing the fatal 
outcome of RTIs, especially in the susceptible groups mentioned above. 
Strategies for preventing RTIs consider enhancing lung defenses and avoiding aspiration. Ef-
fective prevention against specific organisms can be provided by immunization. For example, in-
fluenza vaccination reduces the risk of medically attended influenza virus infection by approxi-
mately 50 %, though there is considerable heterogeneity by season, setting, and population sub-
group. [17-19] Vaccination for preventing pneumococcal infection has also shown to be effective 
in healthy adults, but might not provide as much protection in individuals with chronic condi-
tions. [20] Despite the moderate success, the biggest drawback of the immunization approach is the 
selective spectrum of protection and the time required for the development of the protective anti-
body. Avoiding the aspiration of pathogens is barely possible because no environment is totally 
sterile. However, by being aware of the exact composition of the microorganisms in the air, suscep-
tible individuals could avoid being in the places with more dangerous pathogens. For instance, 
some susceptible individuals can have hypersensitivity to Aspergillus species, which can lead to 
allergic bronchopulmonary aspergillosis (ABPA) or other complications. [21] People with immu-
nosuppression due to B-cell abnormalities are predisposed to infection with encapsulated bacteria 
such as Streptococcus pneumoniae. [22, 9] Individuals with CF should particularly avoid coloniza-
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tion of P. aeruginosa. [23] Thus, the development of techniques for fast and automated identifica-
tion of the microorganisms in the air could be beneficial for the prevention of RTIs. 
The crucial requirement for decreasing mortality rates is an early and accurate diagnosis of the 
infections, which leads to appropriate treatment. Chest radiography (CXR) continues to be the pre-
ferred initial diagnostic imaging test for detecting suspected RTI. However, some researches have 
suggested that CXR may lack sensitivity for diagnosing, especially at early stages of infection [24, 
25] and computed tomography (CT) may be diagnostically superior [26]. Regardless, both CXR 
and CT are associated with a dose of ionizing radiation, which limits frequency of imaging and 
thereby hinders the use of those techniques for tracking the disease’s progres and treatment. Thus, 
it would be advantageous to develop other screening methods, which would enable easy, non-
invasive and rapid detection of the infection at an early stage and would provide information about 
the severity of the disease.  
Unfortunately, just the diagnosis of a RTI in the organism is not enough to establish correct 
treatment. Here, the detection of the exact infectious agent is highly important. [27] In current clin-
ical practice, identification of the pathogens is based on cultures from sputum and bronchoalveolar 
lavage fluid (BAL). However, depending on the microorganism species culturing can take several 
days. Moreover, some species are not cultivable or contamination by organisms unrelated to the 
cause of infection may occur. As an alternative, nucleic acid-based and immunological techniques 
were developed. Nucleic acid-based detection methods usually rely on the amplification of DNA or 
RNA via polymerase chain reaction (PCR). They provide a high level sensitivity and specificity 
and are also very rapid. However, PCR methods require expensive reagents and the design of tar-
get-specific primers. Moreover, if the sample matrix contains substances inhibiting the PCR reac-
tion, more or less complicated procedures will be necessary for the extraction of the target DNA. 
The method is also sensitive to contamination and experimental conditions. Immunological meth-
ods rely on antibodies’ binding to specific antigens of target microorganisms. Commonly used 
techniques include enzyme-linked immunosorbent assay (ELISA) and serological assays. These 
methods improved the microbial diagnosis because of their high-throughput capacity and time- and 
cost-efficiency along with ease-of-use. However, for ELISA both specificity and sensitivity are 
reduced due to the difficulty in generating selective antibodies and the need for large amounts of 
antigens for quantification. Serological assays are usually limited due to their long time the anti-
bodies need to be produced within the human body. [28, 29] 
Given limitations of all introduced methods increase attention to the one more alternative ap-
proach, namely, the indirect identification of the infectious agent by detection of metabolites re-
leased to body-fluids either by pathogen or reflecting the host response. 
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To sum up, there are three strategies, which should be considered for reducing mortality from 
RTIs in susceptible individuals: 
1) Prevention – fast and automatic monitoring of the composition of microorganisms in the 
air so that people could avoid being in places with potential pathogens. 
2) Screening – periodic checking of susceptible individuals to diagnose the disease at an 
early stage. 
3) Exact diagnosis of infectious agent directly from respiratory body-fluids. 
The continuous effort should be devoted to developing new and improving already existing 
methods of addressing these clinical tasks. Moreover, apects such as rapidness, reliability, cost-
effectiveness and simplicity should be considered. Simultaneously to fulfill all of these require-
ments is not easy, but one of the techniques which holds such promises is Raman spectroscopy 
(RS). RS is a vibrational spectroscopic method based on the inelastic scattering of light. This tech-
nique is able to non-invasively and rapidly provide the molecular information about the chemical 
composition of the sample, which could be used for certain medical needs. [30-33] Depending on 
the task, simple conventional RS can be used, or the techniques providing enhanced Raman signal, 
namely Resonance Raman Spectroscopy (RRS) and Surface-enhanced Raman Spectroscopy 
(SERS), can be applied. 
The aim of this thesis is to assess the potential and limitations of these Raman spectroscopic 
techniques (RST) for the prevention, screening and diagnosis of RTIs. In the following section, the 
theoretical basics of three RST will be briefly introduced. Subsequently, keeping the three men-
tioned clinical tasks in focus, the current state of the application of RST in the medical field will be 
critically reviewed and summarized. In the last section of the thesis, the results published in four 
different manuscripts will be discussed, highlighting the potential and challenges of the applied 
methods. Here, firstly, the UV-RRS for the identification of fungal spores dangerous to susceptible 
individuals will be demonstrated. Next, utilizing mouse model of aspergillosis, conventional RS of 
urine will be introduced as an easy tool for screening the RTI and its diagnostic performance will 
be compared to that for other diseases. Lastly, the SERS detection of the metabolite of 
P. aeruginosa bacterium directly in complex matrixes of saliva and artificial sputum using easily 
prepared SERS substrates will be introduced and discussed.  
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2 THEORETICAL FUNDAMENTALS 
2.1 Raman Spectroscopy 
When light interacts with matter, most photons are elastically scattered. This effect is called 
Rayleigh scattering and means that the energy of the incident photon is equal to that of the scat-
tered photon. However, one photon out of 107 is scattered inelastically, meaning that the energy 
between incoming and scattered photons differs. This effect was first experimentally observed by 
C.V. Raman in 1928 and was named in his honor. [34]
During the Raman effect, an initial photon with energy 0ω  is annihilated and the molecule is
excited from its initial vibrational energy state i〉  to a virtual state m〉 (this virtual state is neither a 
stationary state nor a solution of time-independent Schrödinger equation and it does not correspond 
to a well-defined value of energy). Next, the molecule relaxes to its final state f 〉  and a new pho-
ton with lower (Stokes Raman scattering) or higher (anti-Stokes Raman scattering) energy than the 
initial one is created. Stokes Raman scattering takes place when the scattering process starts from 
the vibrational ground state and ends up in a vibrational excited state via a transition into the virtual 
state. For the anti-Stokes Raman scattering the molecule is initially already in an excited vibration-
al state and by the scattering process is transferred into the vibrational ground state. [35, 36] As the 
majority of the molecules at room temperature are in the vibrational ground state, the Stokes Ra-
man scattering is more dominant. 
According to the classical description of light scattering, the intensity ( )i fI →  of the Raman scat-
tered light depends on the number of Raman active molecules (N), on the intensity of the incoming 
light ( )0I , the frequency of the incident laser radiation ( )0ω  as well as the frequency for a Raman 
transition from state i〉 to state f 〉 ( )fiω , and on a sum over the polarizability tensor compo-
nents ( )ρσα : 
24
0 0
,
( )i f fiI const N I ρσ
ρ σ
ω ω α→ = ⋅ ⋅ ⋅ ± ⋅∑ . (1) 
In 1990, the first Raman spectroscopic investigations on biological cells were performed by 
Puppels et al. [37] Later on, the interest of applying RS in biomedicine related studies steadily in-
creased. [38-41] The reason for this upswing in interest is the label-free, non-invasive and non-
destructive nature of the technique together with the ability to instantly provide information about 
the molecular composition of the sample. Additionally, it requires simple to no sample preparation 
I I 
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and only a small sample amount. However, although RS is characterized by high molecular speci-
ficity, its scattering efficiency is rather poor, especially for the molecules with small Raman cross-
sections. In addition to it, investigating biological samples using excitation wavelengths in the VIS 
or near infrared region, Raman scattering is very often interfered with the more intense fluores-
cence emission. To overcome these disadvantages of weak signal and overwhelming fluorescence 
background, special Raman signal-enhancing approaches, such as resonance Raman spectroscopy 
[42, 36] or surface enhanced Raman spectroscopy [43, 44] can be applied.  
2.2 Resonance Raman spectroscopy 
In resonance Raman spectroscopy, the dispersion relation of the polarizability α (i.e., its fre-
quency dependence) is utilized to enhance the Raman scattering intensity. Using second-order per-
turbation theory Kramers, Heisenberg, and Dirac derived an expression for the transition polariza-
bility tensor for a transition i f→ [45]: 
 ( )
r
f r r i
rf o r
f r r i
fi
ri o r ii
σ ρ
ρσ
ρ σ
ψ
ψ µ ψ ψ µ ψ
α
ω ω
ψ µ ψ ψ µ ψ
ω ω
〈 〉〈 〉
=
+ − Γ
〈 〉〈 〉
+
− − Γ∑     (2) 
with ρµ and σµ being the transition dipole moments, oω and riω being the angular frequency of the 
incident and of the i r→  radiation, respectively, and rΓ  is a damping factor which can be related 
to the life time of the excited vibronic state rψ 〉 . 
This equation describes Raman scattering as a two-photon process with a transition from the ini-
tial state with the vibronic wave function iψ 〉  to the entire manifold of eigenstates with the wave 
function rψ 〉  of the unperturbed molecule, followed by a transition to the final state with the wave 
Figure 1. Energy level diagram illustrating the sum-over states description of the Raman transition polar-
izability tensor. (a) Nonresonant Raman scattering; (b) resonance Raman scattering, where the Raman exci-
tation frequency matches the electronic transition of the molecule: o riω ω≈ . 
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function fψ 〉  as depicted in Figure 1. 
For normal Raman scattering ( ri oω ω , Figure 1a) the weighted summation over all possible 
states results in no information about the eigenstates rψ 〉 . The initial iψ 〉  and final state fψ 〉 play 
the determining role. That changes, however, when the incident laser frequency oω  matches the 
energy gap riω  to an electronically excited eigenstate rψ 〉  (Figure 1b). This electronic eigenstate 
will dominate the whole sum, because the denominator of the first term in the sum in Equation 2 
becomes really small, causing the first term to become very large, while the second term becomes 
negligible. This explains the signal enhancement up to six to eight orders of magnitude that is ob-
served in resonance Raman compared to normal Raman scattering.  
As resonance Raman scattering occurs involving an excited electronic state, the technique can 
be used to gain information about the molecular structure and dynamic of the excited electronic 
state. However, in this work RRS is not used because of its high power for photochemical analysis, 
but rather because of its high sensitivity and selectivity. By choosing an appropriate wavelength, 
excitation of specific macromolecular biomarkers can be achieved, which allows for the detection 
of low concentrations in a complex biological environment. For instance, using excitation wave-
length in the deep ultraviolet (UV) region, macromolecules such as proteins or DNA in the pres-
ence of other molecules, for instance, in whole cells, can be studied. [46] However, if the Stokes 
shift between the absorption and fluorescence of the molecule is not large enough, Raman bands 
can overlap with the fluorescence emission. The good way to avoid it is to use excitation wave-
lengths bellow 260 nm. Using such energy-rich UV-light, higher electronic excited states are in-
corporated. While Raman scattering occurs within the first few femtoseconds (10-15 s) directly from 
the high electronic state, fluorescence process occurs only on a time scale of nanoseconds (10-9 s) 
in most cases from the vibrational ground state of the first excited electronic state (Kasha’s rule). 
Therefore, the Raman and fluorescence signals are well separated on the energy 
scale. [36] However, due to high power excitation light, photodegradation of the sample can occur, 
which is a primary drawback of this technique. 
2.3 Surface enhanced Raman spectroscopy 
The weak Raman signal can be greatly enhanced by the introduction of SERS. Historically, the 
SERS effect was first observed and reported by Martin Fleischmann and co-workers for pyridine 
adsorbed onto the surface of roughened silver electrodes. [47] After decades of debate, it is now 
generally agreed that there are two primary enhancement mechanisms: electromagnetic and chemi-
cal enhancement.  
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The electromagnetic (EM) enhancement results from the amplification of the light by the exci-
tation of localized surface plasmon resonances (LSPRs). Surface plasmons are collective charge 
density fluctuations at metal/dielectric (or metal/vacuum) interface. If the metal surface is rough-
ened, the plasmons are no longer confined and the electric field can radiate both in parallel and 
perpendicular directions to the surface. Because of its resonant character, the oscillation may result 
in a polarization and induction of a strong electromagnetic field on the metallic nanostructure. This 
light concentration occurs preferentially in the gaps, crevices, or sharp features of plasmonic mate-
rials, which are traditionally noble and coinage metals (e.g., silver, gold, and copper) with na-
noscale features. As a result, the Raman modes of a molecule located in close vicinity to the 
nanostructure are enhanced because the Raman intensity is proportional to the squared incident 
electromagnetic field intensity (Equation 1). The EM enhancement mechanism was proved to ac-
count for signal enhancements of up to 1011. [48-50] The particle size and shape were found to 
have a strong influence on the resonance frequency. It is also known that the electromagnetic field 
of the excited surface plasmons has evanescent character and quickly decreases with the distance d 
from the surface. By McCall derived dipolar plasmon approximation for silver spherical metal par-
ticle with radius r resulted in such dependency: 
 
12
enhance
rEM
r d
 ∝  + 
. (3) 
The other mechanism involved in signal enhancement is chemical enhancement, which com-
bines three different processes: (1) chemical interaction of the nanoparticle and molecule in the 
electronic ground state; (2) resonant excitation of the charge-transfer process between the molecule 
and the nanoparticle; and (3) the resonance Raman enhancement appearing when the energy of the 
incident radiation matches the energy needed for an electronic dipole transition within the mole-
cule. The magnitude of contribution from the chemical enhancement is highly variable with report-
ed estimates ranging from 101 to as high as 106. [51-53]  
Comparing the SERS spectra to the normal Raman spectra the shift in vibrational bands and 
changed intensity pattern might be observed. Shift in the bands could be explained by redistribution 
of electron density inside the molecule caused by analyte-metal interaction and resulting in the 
change in bond lengths and molecular polarizability. [43, 54] The change in intensity pattern of the 
SERS spectrum is associated with the orientation of the molecule to the metallic surface. Accord-
ing to the surface selection rules, only vibrational modes which have a nonvanishing component of 
the transition dipole moment normal to the metallic surface will be enhanced. [55] Moreover, due 
to evanescent nature of the EM field, modes being closer to the surface will exhibit greatly higher 
enhancement (Equation 3).  
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The application of SERS in the biomedical field requires SERS substrates to allow reproducible 
and quantitative SERS measurements, to be non-toxic for the biological system under investigation 
and to have a good lifetime. Aiming to fulfill these requirements, different designs and fabrication 
processes of the SERS-active substrates have been investigated. [56-58] The most common SERS 
substrates can be classified as colloidal nanoparticles (NPs) and planar nanostructures. However, to 
this point there is no ‘best SERS substrate’, as the performance of each substrate strongly depends 
on the desired application and analyte molecule. More specifically, on the Raman scattering 
cross-section of the molecule, its affinity towards metallic surface and the orientation on the sur-
face.  
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3 STATE OF THE ART - MEDICAL APPLICATIONS OF RAMAN SPECTROSCOPIC 
TECHNIQUES 
3.1 Identification of microorganisms 
Rapid and reliable methods that enable the detection and identification of microorganisms are of 
great importance in medicine, food safety, and environmental or agricultural purposes. The early 
detection and subsequent elimination of highly pathogenic agents in the air or in food could prevent 
cases of a variety of diseases. For already established infections, the early identification of causa-
tive pathogens in the organism could significantly improve the outcome of the treatment and de-
crease overall health care costs. [59] Nowadays, the gold standard for the identification of microor-
ganisms is cultivation followed by an investigation of the morphological and metabolic characteris-
tics of grown cultures. Even though this technique is well established and reliable, it nonetheless 
entails two significant disadvantages. Firstly, depending on the bacterial species, culturing can take 
several days; moreover, some species are not cultivable or require a specific environment. Second-
ly, as the identification is based on careful observation and measurement of morphological charac-
teristics of the organism, it requires highly trained and experienced personnel. Therefore, in recent 
decades many new methods have emerged for microorganism identification. [60-62] The most 
widespread ones are immunoassays and PCR. However, these methods also suffer from certain 
limitations such as an inability to detect organisms not represented in an immunoassay or PCR 
panel, or to discriminate between living and dead organisms in a sample. [63-65] 
Among other alternatives, RS is a valuable and attractive tool in pathogen diagnostics because it 
provides information about the molecular structure and the chemical composition of the investigat-
ed samples. Different microbes vary, for example, in the composition of the proteome or the cell 
wall and accordingly exhibit a slightly different Raman spectrum. The first attempt to identify bac-
teria with RST was reported in 1987 by employing UV-RRS. [66] Relying on visual inspection of 
acquired spectra, authors confirmed spectroscopic differences between five different bacteria types 
and assigned them mostly to cellular RNA, DNA and the amino acids tyrosine and tryptophan. 
More recently, visual analysis of spectra has been replaced by more objective, powerful and auto-
matic chemometric approaches, which capture even slight differences between the samples and use 
them for the subsequent identification. Such symbiosis of RS and chemometrics significantly raised 
the potential of different RST for the fast differentiation and identification of microbial species and 
even strains. [67-70] 
Independent of the statistical algorithm used, all Raman-based pathogen classification methods 
require an extensive database of reference spectra of relevant microorganisms. With an established 
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database and well-trained statistical analysis algorithms [71], a broad range of pathogens could be 
identified with high accuracy. For instance, Hamasha et al. reported a differentiation of pathogenic 
and non-pathogenic Escherichia coli strains using conventional RS combined independently with 
principal component-discriminant function analysis or partial least squares-discriminant analysis 
(PLS-DA). For both multivariate chemometric techniques, the sensitivity and specificity exceeded 
95 %. [72] Rebrošová et al. performed a RS study with 277 staphylococcal strains belonging to 16 
species and, based on their Raman spectra, they were able to achieve the successful identification 
rate of more than 99 % for individual spectra on the species level. [73] This result is even more 
impressive knowing that bacterial colonies were investigated directly on solid medium after 24-
hour culturing. A few more studies showed that the successful identification of bacteria can be still 
achieved if culturing time is decreased to 6 [74] or even 3 hours [75]. This indicates the potential of 
RS to exclude the human factor from the identification process and speed up the clinical routine of 
the pathogen identification. Some studies showed that the cultivation step can, in general, be ex-
cluded and single bacteria can be detected and identified with conventional RS directly from 
body-fluids. [76-78] However, in this case some bacteria isolation and enrichment strategies should 
be used. [79] 
The main requirement for the RS-based identification of pathogens is providing for statistical 
analysis spectra with high signal to noise ratio. For some pigmented species of microorganisms, 
that could be a challenging task. For instance, Ghosal et al. performing a visible range RS study on 
several different microfungi spores relevant to indoor contamination pointed out that registration of 
a good spectrum was difficult due to combined fluorescence background and induced photodegra-
dation. [80] Similar difficulties were reported by Verwer et al. when trying to discriminate Asper-
gillus lentulus from Aspergillus fumigatus. The good quality spectra and classification accuracy of 
78 % were achieved only after whitening conidia. [81] One of the technical ways to minimize fluo-
rescence background from pigmented species is to use UV-RRS with excitation wavelength lower 
than 260 nm, as, in this case, fluorescence and Raman signal are energetically separated. Moreover, 
with this technique the selective information about taxonomically important cellular components 
such as DNA/RNA bases and aromatic amino acids can be collected and utilized for the identifica-
tion of microorganisms. Recently, UV-RRS was used to differentiate between 22 Candida strains 
of 12 clinically relevant species. Principal Component Analysis (PCA) combined with a Supporting 
Vector Machine (SVM) was used to build the model, which was evaluated with leave-one-batch-
out cross-validation (LBOCV). Reliable identification results were observed with accuracies rang-
ing from 93 %, all the way up to 100 %. [82] UV-RRS was also performed for discriminating be-
tween the common causal agents of urinary tract infection, namely E. coli, Klebsiella spp., Entero-
coccus spp. and Proteus mirabilis. Cluster analysis performed on the acquired data, correctly 
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grouped the spectra according to the genus. [83] Lopez-Diez and coauthors achieved successful 
discrimination on the species level between endospore-forming bacteria belonging to the genera 
Bacillus and Brevibacillus. [84] Despite the good performance, the UV-RRS has the disadvantage 
of inducing a ‘burning effect’ due to the high photon energy used for the Raman scattering excita-
tion. To overcome this problem, microorganisms in the mentioned studies were analyzed on a rotat-
ing stage. However, this is suitable only for bulk samples requiring larger amount of biomass, thus 
the cultivation step cannot be omitted. 
In recent years, the potential of SERS to speed up the pathogen identification was also widely 
explored. To this point, most SERS studies on microorganisms are based on two principal ap-
proaches: label-based and label-free. [85] In the case of label-based detection, plasmonic NPs are 
modified with specific target antibody or oligonucleotide and with Raman reporter molecule having 
large Raman cross-section. [86] Here, measurements provide spectral information on the Raman 
label, not on the bacterial cell itself, thus losing intrinsic SERS spectral information on the identity 
of the bacterial cell. Identification of the microorganism is based on the prior expectation of anti-
body or oligonucleotide specificity. [87, 88] Therefore, the label-based SERS can be used only 
when the target microorganism is known, which is very rarely the case in a clinical practice. More-
over, the complicated design of the SERS tags is time consuming and increases the analysis costs.   
Label-free SERS tends to be a simpler alternative. Here, three strategies are possible. The pre-
dominant one is mixing of pre-prepared gold or silver nanoparticles of various shapes or aggregates 
with bacterial cell suspension. [89-92] Using such method, the limit of detection (LOD) of 103 
CFU/mL was achieved [93] and identification of different bacteria (even in a mixture) was report-
ed [94]. However, due to not uniform mixture of nanoparticles and bacterial cells, spectral repro-
ducibility is often poor. To overcome this drawback, the synthesis of the nanoparticles directly on 
the bacterial wall was introduced. [95] This in situ strategy ensures homogenous contact of constit-
uents of the bacterial cells to NPs and thus gives an intense spectrum with better 
reproducibility. [96-99] For instance, Dina et al. using in situ Ag NPs in less than 5 min successful-
ly grouped Gram-negative and Gram-positive bacteria [100] and identified three fungal 
species [101]. The third strategy entails placing microorganisms on the top of different SERS-
active planar substrates. [102, 103] For example, Henderson and coauthors introduced an Ag 
nanorrod array for the identification of Mycoplasma pneumonia from a panel of 12 other human 
commensal and pathogenic mycoplasma species with 100 % cross-validated statistical 
accuracy. [104]  
Despite some reported success and actively ongoing research in this area, there is one major 
concern about using the SERS technique for the identification of microorganisms. While the Ra-
man spectra include spectral information on the entire bacteria cell, the SERS spectra exhibit the 
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spectral information mostly just from the cell wall components, which are binding to the SERS-
active surfaces, such as adenine or xanthine. [105] Thus, it is questionable whether this information 
is really enough willing to discriminate taxonomically similar species, not even talking about dif-
ferent strains. There is no binary answer to this question. For example, some studies showed that 
SERS spectrum of Mycobacteria is dominated by the mycolic acid, which is the characteristic 
component of the mycobacteria cell membrane. [106] As it is known that the mycolic acid structure 
slightly varies between species, the SERS spectra provide enough input for successful identifica-
tion. Unfortunately, this is not the generally the case for all microorganisms. Muhamadali et al. 
compared conventional RS and SERS for the classification of a range of industrial, environmental 
or clinically relevant bacteria. Although SERS displayed unique clustering patterns which allowed 
for the perfect differentiation of Gram-positive and Gram-negative bacterial samples, the overall 
accuracy on species level using SERS spectral data was lower than when conventional RS was 
used (74.9 % vs 97.8 %). [107]  
To sum up, numerous studies have shown the ability to use RST for the identification of micro-
organisms at different taxonomic levels. Indeed, careful thought is required prior to selection of one 
or more of these techniques, especially regarding sample type, format, preparation, and the biologi-
cal questions being asked. Furthermore, some work should be performed on standardization of the 
sample preparation and measurement protocols, as well as on statistical evaluation processes, be-
cause a huge variety of applied methods makes the results comparability difficult and inhibits the 
transition to the clinics. 
3.2 Body-fluids based screening of the diseases 
The objective of medical screening is to detect disease in its early stages and thereby increase 
the chances for its successful treatment. Some criteria established by World Health Organization 
(WHO) underline that screening tests should be easy to perform and interpret, should be cost effec-
tive for the healthcare system and, of course, highly accurate. [108] Examples of current screening 
tests include the pap smear for cervical cancer, cholesterol level for heart disease and X-ray/CT for 
lung cancer. [109] The analysis of body-fluids is particularly attractive for screening purposes due 
to a minimal or non-invasive collection of samples and the possibility of performing multiple 
screening tests. Metabolomics studies already proved that in the presence of the different disease 
the biochemical profile of the body fluids changes. [110, 111] Thus, the development of an easy 
and cheap technique that is able to register those changes would be advantageous for clinical appli-
cations.  
In this scope, RS holds significant diagnostic promises, because it provides a snapshot of the bi-
omolecular composition of the sample and the variations therein. Moreover, it offers rapid and non-
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destructive analysis with less sample quantity required and minimal or no sample preparation. 
Within the last years, a combination of conventional RS or SERS with advanced multivariate data 
analysis was actively explored for a wide range of diseases using different bio-fluids. [112, 113] 
The general workflow for such studies includes the acquisition of spectral data from samples ob-
tained from control and atypical cohorts, preprocessing of spectra, building of a classification mod-
el and verification of the model on an independent data set or by using cross-validation 
methods. [114] 
Currently, the majority of the biofluid-based RS research has focused on serum and plasma, 
since those samples are rich in proteins and contain verified or proposed markers for a variety of 
diseases. For instance, Gonzales-Solis et al. analyzed serum samples with conventional RS and, 
with the help of PCA combined with Linear Discriminant Analysis (LDA), could not only correctly 
distinguish between healthy volunteers and patients with leukemia, but also accurately classify 
three leukemia types. [115] Other serum-based Raman studies demonstrated higher than 90 % ac-
curacies in differentiating normal subjects from patients with breast [116], ovarian [117] or naso-
pharyngeal [118] cancer. The applicability of the method was also explored for infectious diseases, 
such as Hepatitis B [119], Hepatitis C [120], or dengue infection [121].  
In general, the good performance of RS for differentiation between healthy individuals and sick 
ones is not so surprising. The appearance of the disease activates the immune and metabolic sys-
tems, leading to some changes in the biochemical composition of blood and other bio-fluids, which 
can be reflected in ‘biomolecular spectral fingerprint’. However, in clinical reality it is not enough 
to know that a person is sick, it is extremely important to identify the disease. Therefore, the ques-
tion is: how different are the biomolecular changes for different diseases and is RS powerful 
enough to differentiate between them? In the case of sepsis and non-infectious systemic inflamma-
tory response syndrome, Neugebauer et al. demonstrated that conventional RS has such potential. 
Measurements were performed on dry droplets of blood plasma and subsequent analysis of the 
spectral data with PCA-LDA algorithms resulted in sensitivity of 100 % and specificity of 
82 %. [122] Much lower efficiency of the method (65 %) was reported for differentiation between 
individuals with head and neck cancer and patients with respiratory illnesses. [123] But here, when 
building the classification model authors utilized Raman spectra without background correction, 
which could explain comparably worse results.  
Some studies demonstrated that conventional RS on blood serum extra to the diagnosis of the 
disease can provide information about its stage. [124, 125] For example, an assay carried out on 
serum samples from 44 asthma patients of different grades showed that changes in protein structure 
and an increase in DNA- and glycosaminoglycan-specific Raman bands were linked with an in-
crease in asthma severity. [126] 
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SERS analysis of serum or plasma for disease diagnosis was also actively explored during the 
last decade, motivating it with the fact that it can enhance weak Raman signal and provide infor-
mation about molecules, which were not visible on the Raman spectrum or were hindered by fluo-
rescence. So far, aqueous Ag or Au colloids have proven to be the most efficient substrates for 
label-free analysis of bio-fluids, possibly because of the facile synthesis of colloidal NPs and the 
simplicity of adsorbing biomolecules on metal surface by mixing. [127, 128] For instance, Ag NPs 
were used to perform SERS investigation of the serum from 304 normal individuals, 333 patients 
with hepatopathy, and 99 patients with esophageal cancer. Using orthogonal PLS-DA a discrimina-
tion accuracy of 95 % was reached. [129] SERS applicability to detect other oncological diseas-
es [130-132], chronic kidney disease [133], Hepatitis B virus infection [134] or diabetic complica-
tions [135] based on serum or plasma spectra was also reported. 
Despite these positive results, there is still some concern about the SERS technique for screen-
ing purposes. Bonifacio et al. reported that proteins of serum or plasma can inhibit the aggregation 
of nanoparticles leading to very little or no surface enhancement. Therefore, it is beneficial to per-
form filtration of the sample prior to the analysis and get rid of the proteins. [136] However, this 
can lead to the loss of some potentially important diagnostic information. Moreover, authors 
showed that filtrated serum and plasma exhibit SERS spectrum strongly dominated by the bands 
from only two metabolites, namely uric acid and hypoxanthine. Thus, the choice of SERS for 
screening should be performed with extreme care, and should be foremost considered for diseases 
which may have a correlation with blood levels of these two metabolites. Another concern of using 
SERS relates to its strong dependency on the interaction between biomolecules and SERS active 
surfaces. This often influences the reproducibility of the spectra and brings extra variations, which 
could hinder the subtle spectral differences between the healthy and pathological samples. To 
check if SERS, in general, provides diagnostic benefits compared to conventional RS, Par-
askevaidi et al. used both techniques to diagnose ovarian cancer based on blood plasma samples. 
Using the SVM algorithm, cancerous and healthy individuals were differentiated by RS with 94 % 
sensitivity and 96 % specificity and by SERS with 87 % sensitivity and 89 % specificity. [137] The 
outcome of the study leads to the conclusion that conventional RS may be advantageous for screen-
ing purposes using blood samples. Moreover, it is simpler than SERS and has lower costs. 
Urine samples for the RST-based screening were investigated to a lesser extent, but there are 
still some studies that considered this excreted biofluid. Despite the fact that urine consists primari-
ly of water, it possesses a huge amount of metabolic information for clinical usage. The pilot study 
of Bispo et al. showed that urine analysis with conventional RS leads to discrimination between 
normal subjects and diabetic/hypertensive patients with and without complications with overall 
70 % accuracy. [138] The potential of the technique was also reported for the detection of oral can-
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cer. [139] However, it is worth mentioning that reported Raman spectrum of urine is dominated by 
spectral signature of urea (peak at 1004 cm-1), while other compounds have relatively low intensi-
ties and their many bands are convoluted.  
In an attempt to receive some more information from other biomolecules found in urine, the 
SERS method was explored. Here, in contrast with serum and plasma (whose SERS spectra in lit-
erature have similar characteristics) urine spectra reported by different groups are more diverse. 
Some spectra are dominated by urea, other by creatinine or hypoxanthine. This can be explained by 
different experimental conditions or by high inter- and intra-individual variability of urine in terms 
of composition, concentration and pH, which is known to influence SERS signal. [140] Neverthe-
less, the application of SERS for urine screening resulted in accuracies between 80 and 95 % for 
prostate cancer [141], esophagus cancer [142], diabetes mellitus [143] and coronary heart dis-
ease [144]. 
Some research attention was also devoted for other bio-fluids, mostly evaluating their feasibility 
for the screening of the pathologies in a closer relation to the biofluid production. For instance, 
saliva samples were mostly considered for oral cavity and respiratory diseases. Gonchukov et al. 
performed RS of dry saliva for the early detection of periodontitis and showed that carotenoids 
contained in saliva correlate with the periodontitis level. [145] SERS was applied for the discrimi-
nation between saliva of healthy volunteers and patients with lung cancer [146, 147] or oral squa-
mous cell carcinoma [148, 149]. However, for all studies, high spectral variability of saliva from 
sample to sample can be noticed and attributed to factors such as individuals’ genetics, hydration 
frequency, smoking, etc.  
Magee and coauthors analyzed induced sputum samples aiming to diagnose lung cancer cases 
and disease free patients with risk factor from healthy individuals. Conventional RS managed to 
identify people ‘at risk’ from healthy ones with a sensitivity of 90 % and specificity of 93 %. How-
ever, a lot of people ‘at risk’ were later misclassified as having cancer, resulting in 62 % specifici-
ty. [150] While, for screening test higher sensitivity is more desirable for not missing disease cases, 
low specificity rates are also a concern, because they lead to extra stress for individuals and higher 
costs. Spectral analysis of sputum samples combined with PCA appeared to be powerful for the 
distinguishing CF patients infected by P. aeruginosa and S. aureus. However, to achieve this result, 
authors had to perform a 30 min photobleaching of sputum samples to minimize huge fluorescence 
background hindering Raman signal. [151] The diagnostic use of SERS for sputum samples was 
not reported. This can be attributed to the highly viscous and inhomogeneous matrix of the sputum, 
which makes the use of SERS substrates challenging.  
In conclusion, all of the mentioned studies confirm that the use of RST for disease screening is 
possible for a wide range of pathological conditions. However, most of them used relatively small 
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(less than 40) sample numbers. Therefore, additional research using much larger cohorts is certain-
ly required for the transfer of the method to clinics. Moreover, studies including more groups of 
diseases are necessary in order to assess how specific a screening test can be. Finally, the practical 
benefits of using SERS for this clinical task are questionable, because it provides diagnostic value 
in the same range (or even lower) than conventional RS, but increases costs and analysis time, and 
brings some extra variations due to the interaction of biofluid components with metallic substrates. 
3.3 Detection of biomarkers in body-fluids 
The term biomarker could be generally described as “a characteristic, that is objectively meas-
ured and evaluated as an indicator of normal biological processes, pathogenic processes, or 
pharmacologic responses to a therapeutic intervention”. [152] With the rise of genomics, metabo-
lomics and other advances in molecular biology and biochemistry, biomarker studies have entered 
a whole new area and hold promise for early diagnosis and effective treatment of many diseases. 
Usually biomarkers are small molecules including metabolites, antigens, DNA, mRNA or enzymes, 
which are present at a low concentration in the complex mixture with different biomolecules. Thus, 
their detection and quantification, especially directly in body-fluids, is an analytical challenge. In 
the past few decades, significant progress has been made in this field and various promising detec-
tion methods have been developed, including ELISA, electrochemical immunoassay, fluorescence 
or surface plasmon resonance-based systems. [153-156] Although those and other methods are 
continuously improved, they still suffer from the lack of sensitivity and specificity required for 
clinical diagnostic applications. Thus, research for better alternatives is actively ongoing. 
From the three RST discussed along this thesis, SERS, due to its ability to detect molecules of 
interest at trace levels, is the best candidate for this clinical task. The available literature provides a 
substantial number of examples confirming the potential of SERS for biomarker detection, espe-
cially in the field of cancer diagnostics. [157, 158, 128] However, in the frame of this thesis the 
focus is set to infectious diseases. 
When it comes to infections, two diagnostic tasks are highly important: rapidly distinguishing 
between viral and non-viral infection cases and identification of the exact infectious agent. In the 
interplay between the host and the pathogen, a large number of molecules are released. From the 
initial interaction onwards, the majority of biomolecules available to measure are derived from the 
host, as pathogen numbers are very low. In a serious infection, when pathogens are able to over-
come the early host response, their numbers increase at an exponential rate and the concentration of 
secreted biomolecules increases. However, the usefulness of many of them as biomarkers for diag-
nosis is predominantly in the validation process.  
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Some studies showed that increased levels of bacterial-induced host proteins like C-reactive 
protein (CRP) or procalcitonin (PCT) in the blood are a sign of bacterial infection. [159-161] For 
instance, CRP values in patients with an influenza-like illness varied between 12.97 and 
32.41 mg/L for viral infections and exceeded 99.38 mg/L for bacterial infections, while in healthy 
individuals levels are considered to be less than 0.5 mg/L. [162] Diagnostically relevant levels of 
serum PCT begin from 0.1 ng/mL. [163] 
SERS studies investigating the detection of those two proteins mainly utilized a label-based ap-
proach. For instance, Liu et al. proposed an ultrasensitive biosensor, in a sandwich immunoassay 
format, consisting of Au@Ag core−shell SERS nanotags as labels and photonic crystal beads as 
carriers. This biosensor was successfully used for CRP detection in real serum samples with 
achieved LOD of 70.2 pg/mL, which is many orders below the clinically relevant range. [164] As 
multiplex detection of few biomarkers can provide better diagnostic information, Nguyen et al. 
developed a mesoporous SERS substrate based on display of cysteine-rich peptide on M13 phages 
for the triplex detection of CRP, PCT and soluble triggering receptor expressed on myeloid cells-1 
(sTREM-1). Substrates were functionalized with magnetic immune colloids gold-coated magnetic 
nanoparticles and specific antibodies to capture the biomarkers in the spiked serum samples. This 
method allowed detection till 27 pM (0.675 ng/mL), 103 pM (1.493 ng/mL), and 78 pM 
(2.34 ng/mL) for CRP, PCT and sTREM-1, respectively. [165]  
The methods mentioned above have many advantages, such as ultralow LODs and versatility. 
However, their simplicity of use is limited by several drawbacks, including the necessity to synthe-
size two sets of nanoparticles with limited stability, usually complicated experimental design, high 
risk of nonspecific interactions between particles and non-targeted compounds attracted from a 
matrix, and an inability to monitor the direct bonding of target to a specific antibody. Therefore, the 
movement in the direction of label-free SERS approach should be considered. Kim et al. proposed 
performing label-free detection of CRP via monitoring of CRP-specific ligand-protein interactions 
using SERS chip with concentration-induced Ag nanoparticle aggregates. Here, the vibrational 
C-H stretching at 2930 cm-1 was an indicator of the interaction. More intense signal corresponded 
to higher concentration of CRP with minimum detection amount of 0.01 ng/mL in buffer and 
0.1 ng/mL in 1 % serum. [166] 
Van de Veeronk and colleagues, investigating serum samples from patients with Epstein-Bar vi-
rus, found that, for them, Interleukin (IL)-18 concentration was much higher than for healthy indi-
viduals (1018 pg/mL vs 200 pg/mL). Therefore, authors concluded that serum IL-18 may function 
as a marker of viral infection, similar to CRP and PCT for bacterial ones. [167] A few years later, 
Kaminska et al. demonstrated that a SERS-based immunoassay combined with a microfluidic de-
vice can simultaneously detect interleukins: IL-6, IL-8, IL-18 levels in blood plasma. For this, Au 
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NPs coated with different Raman reporter molecules and specific antibodies served as SERS tags, 
while Ag-Au bimetallic substrates functionalized with specific antigens performed the function of 
capturing substrates. Later, PCA was applied for segregation of the signal from three complexes 
and quantification of the interleukins in blood plasma. The reported method allowed for the 
achievement of LODs of 3.8 pg/mL, 7.5 pg/mL, and 5.2 pg/mL for IL-6, IL-8, and IL-18, respec-
tively, which are lower than results using standard ELISA methods. [168] 
Considering fungal infections, the sputum galactomannan is accepted as a biomarker for the in-
vasive aspergillosis. [169] However, no SERS studies of this Aspergillus antigen could be found. 
As mentioned before, the detection of biomarkers in the body-fluids can be helpful not only to 
determine the type of the infection in the organism but also to provide some information about the 
infectious agent. Therefore, extensive efforts of researchers are directed to identify biomarkers 
specific for certain pathogen. However, the number of SERS studies in this field is limited. One of 
a bit more with SERS investigated biomarkers is dipicolinic acid (DPA), which is attributed to the 
bacterial Bacillus spores. Yao et al. measured a different number of B. subtilis cells using 3D plas-
monic trap array with the flower-like Ag microstructures and could see the Raman signature of 
secreted DPA, even when studying only one cell. [170] Another study reported the detection of 
DPA down to 5 ppb (29.9 nM) in aqueous solution using conventional Ag colloids. Moreover, ap-
plying multivariate data analysis allowed for the detection of DPA in complex extracts from viable 
spores. [171] 
Another bacterial biomarker found in the literature is pyocyanin (PYO). PYO is a specific me-
tabolite released by gram-negative bacteria P. aeruginosa, which is associated with persistent and 
chronic RTIs in patients with CF or weakend immune system. [172, 173] For CF patients, PYO 
concentration in the sputum samples varies between 7.7 µM and 76 µM. [174, 175] Although a few 
SERS studies on PYO are published, direct detection of PYO in sputum was still not reported. The 
study of Wu and collaborators considered clinical sputum samples, but direct detection was not 
possible due to high background signal from sputum matrix. Therefore, authors first extracted PYO 
by chloroform and then successfully measured it by employing silver nanorod arrays. [176] SERS 
detection of PYO was also performed in a medium from a bacterial culture, using surfaces with 
controlled nanometer gap spacing between plasmonic Au nanospheres. [177] For better quantifica-
tion of PYO in this more complex matrix, machine-learning algorithms were applied and concen-
trations down to 1 ng/mL were detected. Moreover, it was concluded that SERS detection of PYO, 
besides potential diagnostic application, can also be used for the imaging of quorum sensing in 
P. aeruginosa biofilm communities. [178, 177] 
To conclude, despite some progress in the field of infectious biomarkers, most of them are still 
not validated and only a limited number were successfully investigated with SERS. Label-based 
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SERS appeared to be a more explored and promising approach, as it allows overcoming problems 
connected with the complex composition of body-fluids. However, it has a complicated design with 
possible instability issues and risk of nonspecific interaction. Therefore, further improvements 
should be done in SERS-tags development. Moreover, studies often report very low LODs willing 
to demonstrate the power of their approach but forgetting to consider its clinically relevant range. 
Ultra-sensitivity is not always needed and simplicity of the test along with lower costs is more im-
portant. Thus, the applicability of label-free SERS in the biomarker detection should still be ex-
plored. 
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4 OWN RESEARCH RESULTS 
As described in the previous section, RST have already been broadly investigated for various 
clinical applications. However, while a plethora of information can be found about application of 
RST for oncological diseases, infections (especially the ones of respiratoty tract) have thus far at-
tracted significantly less attention. Moreover, often in the studies, in pursuit of high accuracies or 
low detection limits, some other important factors, such as simplicity or cost-effectiveness, were 
put aside. Therefore, in this thesis, the main focus was set for developing RST-based sensitive, 
reliable, but simultaneously simple and inexpensive solutions for better management of RTIs. 
In the following section, the research results achieved within the framework of this thesis will 
be presented and discussed. A schematic overview of the included studies is presented in Figure 2. 
Firstly, UV-RRS technique will be suggested as a tool for improving prevention methods for RTIs 
by demonstrating the analysis and identification of fungal spores [OZ1]. Afterwards, urine-based 
screening of respiratory tract and other diseases using conventional RS will be presented [OZ2]. In 
the final part, indirect identification of the infectious agent by detecting bacterial metabolite in 
complex body fluids will be described [OZ3-OZ4]. 
Figure 2. Schematic overview of the studies presented in the thesis. 
PREVENTION
SCREENING
DIAGNOSIS OF THE EXACT PATHOGEN 
UV-resonance Raman spectroscopy [OZ1]
Conventional Raman spectroscopy [OZ2]
SERS [OZ3-OZ4]
O
N
N
O
N
N
ON
N
O
N
N
Mr. PATIENT
PATHOGEN:
P. aeruginosa
Pneumonia
PYOCYANIN:
Infection with P. aeruginosa
YES NO
Pyocyanin
(metabolite of P. aeruginosa) SERS substrate
Respiratory sample
Fungal spores
Chemometric
analysis A. fumigatus
Mouse model of RTI
(Aspergillosis)
Chemometric
analysis
Aspergillosis
Urine
Healthy
O
N
N
4 OWN RESEARCH RESULTS 
22 
4.1 UV Raman spectroscopy for identification of highly pigmented fungal spores in 
the air [OZ1] 
Fungal spores were found to be one of the most common classes of airborne biological aero-
sols. [179, 180] Accordingly, humans inhale substantial numbers of fungal spores from outdoor and 
indoor air. Health risks of such fungal exposure strongly depend on the inhaled species, as different 
fungi produce different allergens and mycotoxins. [181, 182] Another important factor is sensitivity 
of the person. For instance, asthmatic individuals and people with CF are most commonly sensitive 
to Aspergillus species, which could lead to their symptoms worsening or developing of 
ABPA. [183, 184] Thus, avoidance of the aspiration of dangerous species is an important compo-
nent of preventing infection. In order to do so, individuals need to be aware of the composition of 
fungal spores in the air. In the previous section mentioned limitations of currently used identifica-
tion methods (culturing together with microscopical analysis, PCR, immunoassay) arise the need 
for the development of alternative techniques. The potential of RST for identification of microor-
ganisms was already presented in the section 3.1 of this thesis and the need for careful choice of the 
technique was underlined.  
Within the publication [OZ1] spores from eight different filamentous fungal species, implicated 
to a varied extent in respiratory diseases worldwide: Aspergillus fumigatus, Aspergillus niger, As-
pergillus nidulans, Aspergillus calidoustus, Cladosporium herbarum, Alternaria alternata, Penicil-
lium rubens, and Lichtheimia corymbifera were investigated. For this, fungi were grown for 7 days 
at room temperature; next, the spores were collected and inactivated with formaldehyde. Fungal 
spores of all the investigated species were highly pigmented, having dark brown, grey or green 
color, which makes achieving a high quality Raman spectra challenging. It has been previously 
reported that using visible excitation wavelengths for RS measurements of pigmented samples 
leads to high fluorescence background, which can partially or totally overwhelm the Raman sig-
nal. [185, 81] Therefore, for the spectroscopic examination the excitation wavelength in the UV 
region, namely 244 nm, was chosen, since at this wavelength fluorescence and Raman scattering 
are spectrally well separated. [186] Moreover, most taxonomic markers of microorganisms absorb 
in the UV region, leading to selective resonant enhancement of the Raman signals of taxonomical-
ly-important macromolecules (e.g. DNA/RNA bases and aromatic amino acids, which can be bene-
ficial for the identification). [187-189] Unfortunately, these advantages of the UV-RRS come along 
with the risk of sample photodegradation due to the high photon energy of the UV radiation. To 
minimize the ‘burning effect’, samples were continuously rotated during the measurements with a 
speed 60 rotations/min and moved in the x, y direction after each rotation. This also allowed obtain-
ing an average spectrum over a large amount of spores, which means that one spectrum already 
comprises metabolic and developmental diversity within the spore population. 
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To evaluate whether UV-RRS was a good method of choice for obtaining high quality spectra 
from deeply colored and highly absorbing samples, firstly, A. fumigatus spores were compared to 
non-pigmented spores of a same strain with a mutation in the pksP gene. [190] Mean Raman spec-
tra of both samples is demonstrated in Figure 3 (a). It can be seen that, despite the rotation of the 
samples, both experienced ‘burning effect’, which manifests itself by two broad carbon bands 
around 1360 and 1610 cm-1 [191]. However, spore-related spectral features, necessary for the spore 
identification process, are still clearly distinguishable for both samples. The primary bands ob-
served in fingerprint region in the UV-RRS are typically associated with different nucleic acids and 
protein subunits. More specifically, the signal at 1648 cm-1 can be assigned to thymine, and the one 
at 1612 cm-1 to the aromatic amino acids tyrosine and tryptophan. Guanine and adenine exhibit 
peaks at 1574 and 1479 cm-1, and together with tyrosine contribute to the signal at 1335 cm-1. 
The Raman mode at 1526 cm-1 originates from cytosine. Thymine and adenine have a band at 
1365 cm-1. The peak at 1171 cm-1 can be assigned to tyrosine and the ones at 758 and 1008 cm-1 
come from tryptophan. [187, 84, 192] Although the mentioned bands are more prominent for non-
pigmented strain, it still can be concluded that UV-RRS can be used for investigating highly pig-
mented spores as well. 
As a next step, Raman spectra from all fungal spores were obtained and their mean spectra are 
plotted in Figure 3 (b). The differences between the spectra can be noticed by the naked eye. Addi-
tionally, to different carbonization background, relative intensity of the main bands varies among 
the fungal species. This provides insight into the different compositions of the DNA/RNA and pro-
tein subunits. During the study, three different batches of each strain were measured and the stand-
ard deviation (SD), illustrated as grey shade around each spectrum, displays the good reproducibil-
ity of the method. The higher deviation appeared for the A. fumigatus species but only because 
three different strains of it were included in this study. Moreover, for the growth of A. fumigatus 
and P. rubens, two different culturing media were used. Although, after collecting, fungal spores 
were washed several times, the influence of different growing conditions was observable when 
comparing spectra of the same species grown on different media (for the details see Figure S-2 in 
Supporting Information (SI) for [OZ1]). Despite this, it was decided to include all strains grown 
on different agars for building classification models in order to check if the differences from culti-
vation conditions are smaller than the differences due to species affiliation. 
Keeping clinical needs in mind, three different models were established. As health hazards 
strongly vary between different genera, first of all, the statistical model was built to differentiate 
between species of Penicilium, Cladosporium, Aspergillus, Alternaria and Lichtemnia. To achieve 
this, firstly, PCA was performed to reduce the dimensionality of the Raman data and keep only the 
most significant information for classification. Generally, the choice of the number of principal 
components (PCs) is crucial, because, selecting too low risks missing some important information, 
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while taking too high number can result in overfitting of the model. Unfortunately, there is no 
common algorithm to determine the optimal number of the PCs, and different approaches can be 
found in the literature. [193, 194] In the presented study, the optimal number of PCs was chosen by 
finding a saturation point of the accuracy as a function of the number of PCs (for the details see 
Figures S-3, S-4, S-6 in SI for [OZ1]). For the classification on a genus level, 6 PCs were selected 
as optimal input for the following LDA. The performance of the created LDA model was estimated 
with LBOCV. During this process, each batch was used once as the secondary dataset and 
predicted by the model built with the remaining two batches. Achieved results showed not only 
high accuracy of 97.50 % in classification, but also reflected the phylogenetic relationship between 
the different genera. From the LDA score plot of the classification model, which is depicted in 
Figure 3 (c), it can be seen that A. alternata and C. herbarium belonging to the same class of 
Dothideomycetes were nicely separated from Penicillium and Aspergillus spores - affiliated to the 
class of Eurotiomycetes, and from L. corymbifera spores belonging to a lower group of fungi, the 
phylum Zygomycota. The most often misclassification occurred for the Aspergillus species. Here, 
22 spectra out of 629 were assigned to P. rubens. The reason for it could be their taxonomic 
relation within the same class or the fact that spores grown on different media were included in 
both groups, which led to more variations. However, despite these mistakes the sensitivity for 
identifying of Aspergillus spores was still high (95.87 %). This is very promising, because 
Aspergillus fungi are often of special danger for immunocompromised patients and people with 
chronic respiratory diseases. [183, 184, 195, 196] But it should be noted that, out of hundreds of 
Figure 3. (a) Mean UV-Raman spectra of the pigmented A. fumigatus ATCC 46645 strain and the non-
pigmented pksP mutant strain. (b) Mean UV-Raman spectra of the all batches from different fungal spores 
plotted together with their SD (grey area). For the A. fumigatus the mean spectrum represents all investigated 
strains. (c) LDA score plots for the classification model on the genus level. (d) LDA score plots for the clas-
sification model on the species level. Adapted from [OZ1]. 
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Aspergillus species, only tens of them are known to cause infections. Therefore, to assess the health 
risks from fungal exposure, in addition to genus level, the identification on a species level should 
be performed.  
In this study, four different Aspergillus species with different levels of danger were consid-
ered. Among them, A. fumigatus is the most common fungal pathogen, followed by A. niger. [197] 
A. calidoustus and A. nidulans are also classified as opportunistic pathogens, but cause infections 
relatively rarely. [198] To perform discrimination between these four species a LDA model with 7 
PCs was created. Validation of this model with LBOCV resulted in the correct assignment of all 
spectra, which means 100 % accuracy. Figure 3 (d) demonstrates LDA score plot of the classifica-
tion model. To the best of my knowledge, identification of fungal spores on a species level with RS 
was demonstrated before only once, where Aspergillus lentulus was differentiated from 
A. fumigatus with 78 % accuracy. [81] Our achieved accuracy is noticeably higher, suggesting that 
information provided by UV-RRS about DNA/RNA bases and aromatic amino acids may be bene-
ficial for the classification of microorganisms. 
To investigate the power of the technique more precisely, fungal spore identification at the 
strain level was also performed. For this purpose, three strains of A. fumigatus were considered. To 
know the exact strain of this fungus is useful, as the difference in virulence among strains was also 
reported. [199] The visual differentiation between the spectra from three strains was already not 
possible (see Figure 5 [OZ1]), due to their close phylogenetic relationship. For building the LDA 
model, the number of PCs was set to 10. The classification resulted in an overall accuracy of 
89.42 % and 321 spectra out of 359 were assigned to correct strain. RS-based identification of the 
fungal spores at a strain level was not found in the literature before. 
To conclude, in the focus of this study, it was shown that UV-RRS is a suitable method for the 
analysis of the highly pigmented fungal spores. Combining this technique with chemometrical 
methods, the highly accurate identification of the spores on genus (97.50 %), species (100 %) and 
strain levels (89.42 %) was achieved. Such results indicate undeniable potential of the UV-RRS for 
microorganism identification, however, it should be noted that the usage of the technique is limited 
to the biomass of the samples. At this point in time, measurements of few spores with the used 
Raman setup are challenging, because the device is not combined with microscope and finding the 
small spores on the slide would not be possible, nor would avoiding photodamage by the sample 
rotation. Therefore, currently, UV-RRS will not exclude the culturing step, but will provide an 
alternative for the conventional methods of fungal spore identification based on microscopic obser-
vation and morphological characterization of reference spores. Implementing UV-RRS in clinical 
routine would exclude human factor from the identification and make process more automated and 
objective.  
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4.2 Raman spectroscopy of urine for screening of respiratory tract diseases [OZ2] 
The diagnosis of RTIs in patients with another underlying illness is challenging, as usual symp-
toms of RTIs, like fever or cough, can overlap with symptoms of the main disease or can be simply 
absent. Thus, the diagnosis of the infection often happens after it reaches a more acute stage. Such 
diagnostic delay complicates the treatment and causes higher mortality rates. Therefore, an effort 
should be devoted to the exploration of new screening technologies that can detect early signs of 
RTI, preferably in an easy and non-invasive manner. In this context, analysis of body fluids is par-
ticularly attractive because, along with a relatively easy collection procedure, they are rich in bio-
chemical information of certain diagnostic value. 
Among different body-fluids, the attention in the publication [OZ2] was directed towards urine 
samples due to the simple and completely non-invasive collection in people of all ages, possibility 
of multiple sampling, and low cells and protein content with a high number of metabolites [200]. 
Aiming to develop an easy and cheap screening test, urine analysis was performed with conven-
tional RS. The main goal of the study was to evaluate whether RS of urine can provide enough 
information for the diagnosis of respiratory tract diseases and to compare its diagnostic ability with 
the one for kidney diseases. Respiratory tract diseases included aspergillosis infection and asthma. 
Asthma is a chronic inflammatory disorder, while aspergillosis is a fungal RTI associated with 
increased danger for immunocompromised patients and possible lethal outcomes, especially for late 
diagnosis cases [201, 202]. Although these diseases do not directly influence urine formation, some 
changes in the metabolic profile of urine are still expected as a response of the organism to the 
infection or external trigger. [203-205] On the other hand, to have more comprehensive study, dis-
eases known to be in direct connection with urine generation were also included. This involved 
nephrogenic diabetes insipidus (NDI), characterized by inability to concentrate the urine and distal 
renal tubular acidosis (dRTA) which leads to more acidic urine. [206, 207] 
To have more defined parameters and better comparison, it was decided to investigate mice 
models of all mentioned diseases before starting with a clinical study with the patients. After col-
lection, urine samples were frozen and stored at -80 °C untill Raman measurements. To decrease 
the fluorescence contribution in the Raman spectrum, it was decided to use an excitation wave-
length of 785 nm and to measure the samples as dried droplets. Schematic representation of the 
measurement workflow is depicted in Figure 4 (a). Here, mapping of three different areas was 
performed, aiming to include the intrinsic heterogeneity of the sample and collect a big amount of 
data for each mouse. Figure 4 (b) demonstrates mean spectra for the different groups included in 
different disease models together with their SD (presented as a shaded area). It can be seen that, for 
all groups, Raman spectrum has the same shape with the most intensive peak at 1004 cm-1. This 
band together with the smaller ones at 589, 1162, 1605 cm-1 can be assigned to urea, which is the 
most prominent component of the urine. The peaks at 839 and 1046 cm–1 are originating from cre-
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atinine, while the Raman bands at 872 and 1076 cm-1 may be attributed to nitrogenous com-
pounds. [208, 209] SDs for the mean spectra indicate that there is the intra- and inter-sample heter-
ogeneity inside the groups. The lowest calculated SD was for the healthy mice, which were consid-
ered as a control for the kidney diseases. The control mice for asthma, to be a proper control, un-
derwent a treatment with PBS, while control mice for the aspergillosis model were immunosup-
pressed with cortisone acetate. Moreover, in all models different type of mice were used. There-
fore, the first step in the study [OZ2] was to clarify how different control mice of the included 
models are and whether all models can be analyzed together. For this, difference spectra between 
control groups were calculated and depicted in Figure 4 (c) together with SD for each group. Clear 
differences can be observed between all of the control mice, being higher than SDs of appropriate 
groups. This means that control mice are already so different that it is incorrect to combine all of 
the diseases in one model, as doing so can lead to the classification based not on the disease but on 
other factors. Thus, different disease models should be considered individually. 
Firstly, the potential of urine-based RS was examined for kidney diseases. Since kidneys are the 
organs responsible for urine generation, it is expected that urine composition correlates with their 
health and RS has a high chance to monitor it. To prove this hypothesis, Raman spectra from urine 
samples from four mice with NDI, ten mice with dRTA and four healthy mice were obtained 
(Figure 4 (b)). To highlight the differences between these groups, the difference spectra were cal-
culated and presented in Figure 5 (a). One can see that urine from the mice with kidney diseases 
had lower intensities of the band around 1004 cm-1, which can be correlated with the decreased 
Figure 4. (a) Schematic illustration of the workflow of the Raman measurements. (b) Mean Raman spectra 
of the urine samples obtained from different groups in all included models, plotted together with the SD 
(shaded area); (c) Difference spectra between the mean urine spectra of control mice for different disease 
models with SD of the groups. Adapted from [OZ2]. 
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concentrations of urea. It is known that NDI is characterized by a genetic loss of urea transporters 
or inability of nephrons to respond to adequate concentrations of vasopressin, which reduces the 
interstitial concentration of urea and the concentrating ability of urine. [210] However, in the case 
of dRTA, decrease in the urea concentration is unclear. Comparing urine spectra from both diseas-
es, NDI urine had higher intensities of peaks at 991 and 1013 cm-1, which tentatively can be as-
signed to higher uric acid concentrations, while dRTA had more prominent Raman bands at 837 
and 1407 cm-1. The last peaks could originate from protein compounds, as it was also found that 
urine from dRTA mice contains more proteins, especially albumin. [211] 
To support visual comparison, advanced multivariate data analysis was applied and discrimina-
tion between the diseases was performed. Like in the previous section, for this classification PCA-
LDA was applied and the number of PCs was chosen by the same principal of finding the maximal 
accuracy as a function of the number of PCs (for the details see Figures S1-S5 in SI for [OZ2]). 
Evaluation of the model was performed with leave-mouse-out cross-validation (LMOCV). For this, 
spectral data of one mouse was removed from the data set and the LDA model was built with the 
remaining data. This procedure was repeated for all of the mice and provided a reliable, unbiased 
classification model. Using 6 PCs, 50387 spectra out of 52567 were assigned correctly and the 
overall accuracy of 95.85 % on spectral level was achieved. However, for the clinical needs, classi-
fication on a patient level is required. Therefore, the percentage of correctly identified spectra for 
every mouse should be calculated and compared with the set threshold. In the present study, a 
threshold of 50 % was applied, which means that a mouse was diagnosed as healthy or sick if more 
than half of her spectra were assigned to that group. In this manner obtained classification results 
on mouse level are presented in Figure 5 (b). It can be seen that all of the mice were correctly clas-
sified. This not only confirms the starting hypothesis that urine-based RS is very informative for 
detecting disorder in kidney function but also shows that presented approach has a high potential 
for the identification of the exact disease.  
After successful diagnosis of diseases directly influencing urine composition, respiratory tract 
diseases, which are not connected with urine production, were investigated. Here, the main goal 
was to evaluate the potential of Raman spectroscopic profiling of urine for the detection of respira-
tory tract infection, namely, aspergillosis. For this, 14 mice were immunosuppressed and 10 of 
them were exposed to A. fumigatus conidia, while four were kept as a control. Mean Raman spectra 
for both groups are presented in Figure 4 (b), while difference spectrum between the groups is 
shown in Figure 5 (c). Differences here are already not as obvious as for the kidney diseases. 
Moreover, spectral variability inside the groups is much higher than between them. Thus, there is 
an extreme need to apply chemometrics. To build the classification model, 11 PCs were used. 
Achieved results on mouse level are summarized in Figure 5 (d). Two healthy mice were misclas-
sified as sick and one sick mouse was assigned as healthy, that resulted in the model sensitivity of 
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50 % and specificity of 90 %. In general, for the screening tests specificity is of higher priority, as 
false negative results can cost human life. Nevertheless, sensitivity should also be high to avoid 
expenses on further, in fact unnecessary, diagnostic tests and minimize stress for the individuals. 
To investigate appeared misclassification more precisely, the clinical data of the false negative 
mouse was checked in more details. It appeared that this mouse, together with one other, did not 
show any signs of the infection, which was proved by a pathological check of their lungs. Howev-
er, the second mouse was still assigned to aspergillosis group. Furthermore, one extra mouse in the 
infected group developed only mild aspergillosis. All these facts may lead to the assumption that 
false positive results of the model appeared due to an incorrectly defined sick group. To check this, 
the aforementioned mice were excluded and the classification was repeated using the four control 
mice and seven mice with developed severe aspergillosis. To build the LDA model, 7 PCs were 
selected. Subsequent LMOCV resulted in 100 % accuracy on the mouse level. Such a result sug-
gests that urine based RS holds the promise to be used as a diagnostic tool for the RTIs, however, 
train data set should be defined with special care. 
Finally, the asthma model was considered. Here, asthma was chosen to check if urine reflects 
only the response of the organism to acute RTI or if inflammation of the airways also results in a 
change of metabolic and, consequently, in spectroscopic profile of urine. This model included 11 
control and 11 mice with Ovalbumin-induced allergic asthma. For the second group, urine was 
collected 1, 5 and 9 days after exposure to the allergen. Mean spectra for the both groups can be 
Figure 5. (a) Difference spectra between the mean urine spectra of mice with kidney disorders and control 
ones with SD of the groups. (b) Results of the mouse level classification model for kidney disorders evaluat-
ed with LMOCV. (c) Difference spectrum between the mean urine spectra of mice with aspergillosis and 
control ones, plotted together with SD of both groups. (d) Results of the mouse level classification model for 
aspergillosis infection evaluated with LMOCV. (e) Difference spectrum between the mean urine spectra of 
mice with asthma and control ones plotted together with SD of the both groups. (f) Results of the spectral 
level classification model for Aspergillosis infection evaluated with LMOCV. Adapted from [OZ2]. 
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seen in Figure 4 (b) and the difference spectrum in Figure 5 (e). Variations in the both groups 
were higher than the difference between them, thus, for the discrimination, the application of PCA-
LDA model was required. As an input for LDA, 7 PCs were selected. The results of the classifica-
tion on a mouse level are summarized in Figure 5 (f). Misclassification occurred for three control 
and two asthmatic mice. This resulted in an overall accuracy of 77.27 %. The false negative results 
appeared for the urine samples collected on the fifth and ninth days after exposure to the Ovalbu-
min aerosol. Theoretically, it could be that the organism of these mice, after few first days, started 
to recover from the allergenic reaction. However, no clinical data was provided to check this hy-
pothesis.  
The present study reveals that RS generally has a great potential to monitor the changes appear-
ing in urine due to pathological conditions. However, the performance of the method is diverse and 
depends significantly on the level of disease caused alterations in the urine samples. As kidney 
diseases directly influence the composition of the urine, the changes in urine are more obvious and 
RS, combined with PCA-LDA, can with 100 % accuracy discriminate not only between healthy 
and sick mice, but also between different kidney diseases. In the case of aspergillosis infection and 
asthma, the changes in urine reflect the overall organism response to the established infection or 
external trigger, thus variations are relatively small and their detection with RS becomes more chal-
lenging. Nevertheless, promising results for diagnosing these diseases were achieved. Asthmatic 
mice were discriminated from the control group with 77.27 % accuracy, while mice infected with 
A. fumigatus could be differentiated from the control ones with 78.57 % accuracy. Moreover, con-
sidering only mice with severe aspergillosis, accuracy is increasing untill 100 %. Such results show 
that urine based RS holds some promises for detection of the diseases not directly influencing urine 
composition and it could be useful for the screening of the RTIs. Ideally, spectroscopic analysis of 
urine could be performed periodically for susceptible individuals to monitor any deviations from 
‘normality’. However, to come to this point, firstly, more detailed clinical studies including much 
larger data sets should be performed. Moreover, to understand the molecular mechanism of altered 
spectral signature and to find the biochemical reasons, systemic studies combining RS with mass 
spectrometry or nuclear magnetic resonance spectrometry are required. 
4.3 Fast and sensitive SERS detection of bacterial biomarker directly in complex 
matrices [OZ3-OZ4] 
In the current clinical practice, treatment of the patients diagnosed with RTIs is initiated rather 
empirically without an accurate diagnosis of the infectious agent. This leads to the overuse of anti-
biotics, higher medical costs, prolonged hospital stays and increased mortality. The development of 
rapid, accurate and specific point-of care diagnostic tests able to screen for major pathogen groups, 
to enable identification of the causative organisms, and to define their antibiotic resistance profiles 
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would significantly improve the situation. [212] Within this scope, direct detection of the bi-
omarkers, specific for the pathogen or reflecting the response of the host, may be a good approach. 
Thus, in the studies [OZ3] and [OZ4], the SERS detection of the bacterial biomarker pyocyanin 
directly in body-fluids was investigated.  
PYO is a specific metabolite of P. aeruginosa, which is a Gram-negative, opportunistic patho-
gen causing acute and chronic infections, particularly in patients with CF or compromised host 
defense. [172, 173] The chemical structure of the PYO molecule is depicted in Figure 6 (a). Previ-
ous studies reported that concentration of PYO in the sputum samples can vary between 7.7 µM 
and 76 µM for CF patients and can reach up to 130 µM for patients with bronchiectasis. [174, 175] 
There is no universal ‘best’ SERS platform, so the careful consideration of the analytical problem 
is required before choosing or designing a SERS sensor. [213]  
One of the objectives of the thesis was to assess the capabilities and limitations of the SERS 
technique using conventional and easy-to-prepare SERS active surfaces. Therefore, in the study 
[OZ3], the preference was given to Ag colloids prepared by the easy and fast protocol of Leopold 
and Lendl. [214] Moreover, colloidal solution allows direct SERS analysis within the analyte natu-
ral solution medium. Before moving to the detection of PYO in complex matrices, the nature of the 
SERS spectrum of the molecule was investigated in 10 % ethanol solution due to its low solubility 
in purified water. All measurements were performed using 514 nm excitation wavelength, as it 
matches with the absorption region of Ag colloids (see Figure S1 in SI for [OZ3]). To achieve 
automated measurements and to obtain reproducible SERS spectra of different PYO concentra-
tions, the droplet-based microfluidic setup presented in Figure 6 (b) was employed. A more de-
tailed discussion about the combination of SERS with microfluidics and an overview of the recent 
developments and advancements in this field can be found in the review paper [OZ5-Review] pre-
pared in the frame of this thesis. During the presented study, to create a segmented continuous 
flow, mineral oil was pumped to one of the inlets with a flow rate of 9 nl/s, while Ag colloids and 
analyte solution were pumped to other inlets with a flow rate of 7 nl/s. No aggregation agent was 
required, because PYO exhibit the ability to induce the aggregation by itself (see Figure S3 in SI 
for [OZ3]). In this manner, PYO concentrations between 0.5 µM and 85 µM were measured. The 
mean Raman spectra for every concentration, as well as for the blank water-ethanol solution are 
presented in Figure 6 (c). It can be seen that the SERS spectra of PYO had a rich fingerprint in the 
200-1800 cm-1 spectral range with the most prominent bands at 547, 676, 1353, 1564 and 
1594 cm-1. According to the literature, the peak at 547 cm-1 originates from ring-breathing and C-N 
torsion, the Raman mode at 676 cm-1 corresponds to the ring-deformation, the band at 1353 cm-1 is 
assigned to the combined C-C stretching, C-N stretching and C-H in-plane bending modes of the 
aromatic ring and, finally, the double peak at 1564 and 1594 cm-1 is ascribed to the ring defor-
mation and the C-C stretch vibration. [178, 176] 
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Measuring PYO concentrations untill 10 µM ethanol Raman bands at 880, 1047 and 1087 cm-1 
can be detected. With the further increase of PYO concentration, they became less prominent and 
more convoluted with PYO bands. Additionally, the Raman peaks at 221 and 240 cm-1 could be 
observed and assigned to the Ag-N and Ag-O stretching vibrations, respectively. [215] This con-
firms the hypothesis that interaction with the silver surface is achieved via the oxygen and nitrogen 
atoms of the PYO molecule. With the increase of PYO concentration, the Ag-O band becomes 
dominant, which suggests that, due to the steric hindering, PYO might adopt an upright orientation 
and interact with the metallic surface only via the O atom.  
To assess the LOD and capability of SERS for quantitative analysis, the integrated peak area of 
the Raman bands at 240 and 667 cm-1 were plotted as a function of the in-droplet concentration (see 
Figure 3 in [OZ3]). The concentration curves for both peaks present an exponential increase until 
the concentration of 55 µM. However, the underlying mechanism is different. The Raman mode at 
240 cm-1 is due to the PYO molecules in the first layer on the surface of the metallic nanoparticles, 
whereas the intensity of the 676 cm-1 band also increases due to the molecules present in the upper 
layers, but still located in the ‘hot-spots’. As a result, the Raman band ascribed to the Ag-O vibra-
tion was implemented as internal standard and its use resulted in a linear response over the 
Figure 6. (a) Chemical structure of the PYO molecule (C13H10N2O). (b) Scheme of the droplet based micro-
fluidic chip used for LoC-SERS measurements. (c) Mean SERS spectra of PYO with concentrations between 
0.5 and 85 µM in aqueous solution measured in the microfluidic platform. The mean spectrum of the blank 
(when only water-ethanol solution is pumped through at the first dosing unit) is also presented. (d) The peak 
area ratio of the 676 cm-1 and 240 cm-1 Raman modes as a function of PYO concentration in aqueous solution 
in the range between 0.5 and 15 µM with linear fitting. The red line indicates the calculated LOD. 
(e) Zoomed regions of mean SERS spectra of the different concentrations of PYO in the saliva samples from 
three volunteers. Adapted from [OZ3].
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0.5-15 µM concentration range, which is demonstrated in Figure 6 (d). The calculated LOD was 
below the lowest measured concentration of 0.5 µM, which is ~10 times lower than minimal con-
centration found in clinical sputum samples (7.7 µM). Measurements were repeated with another 
microfluidic chip and demonstrated a good reproducibility of the method (see Figure S6-S7 in the 
SI for [OZ3]). 
However, the SERS detection in more complex matrixes is much more challenging due to the 
competition between matrix components and the target analyte for metallic sides of the SERS ac-
tive surface. This is especially important if the SERS surfaces are not functionalized to capture one 
specific molecule, which was the case for the studies dicussed within this thesis. As a first step 
towards increasing the complexity of the matrix and switching to real world respiratory samples, 
saliva was chosen. Despite the fact that saliva is composed mainly of water, it contains a variety of 
electrolytes and enzymes, immunoglobulins and other antimicrobial factors, expectorated bronchial 
and nasal secretions, microorganisms and their products. [216] In the [OZ3] study, for the proof of 
concept, saliva from three healthy volunteers was spiked with the appropriate amount of PYO in 
ethanol solution to achieve the final concentrations of 10, 25, 50, 75 and 100 µM. As a negative 
control, saliva samples were spiked only with ethanol. Next, filtration was performed to remove the 
oral epithelial cells and food debris. SERS spectra were recorded in plastic cuvettes with the addi-
tion of silver colloids and KCl for the aggregation of nanoparticles. Here, the addition of the aggre-
gation agent was beneficial, because saliva components reduced PYO ability to aggregate the Ag 
colloids.  
SERS spectrum of pure saliva in the fingerprint area contained many small, convoluted peaks, 
which are difficult to interpret due to the unknown exact composition of the samples (see Fig-
ure S8 in SI for [OZ3]). By adding PYO to the matrix, new bands at 676, 1353 and 1594 cm-1 
(which were previously assigned to PYO molecule) appeared. The zoomed spectral regions for 
every volunteer are shown in Figure 6 (e). For the first and second volunteer, spectral changes 
were already seen at the lowest investigated PYO concentration of 10 µM, while for the third vol-
unteer changes noticeable by eye appeared at a concentration of 25 µM. Compared to the aqueous 
solution, the sensitivity of the method decreased by two orders of magnitude. Despite the fact that it 
remained on the border of the clinically relevant range, it was clear that for a more complex and 
viscous matrix like sputum, the described method would not be sensitive enough and other strate-
gies should be considered. Functionalization of Ag colloids with capture molecule specific for PYO 
might be a possible option. However, design of the capture scheme as well as modification of the 
nanoparticles surface is a complicated task and the focus of this thesis was set on researching a fast 
and easy detection scheme.  
Therefore, in the [OZ4] study, development of the planar substrates for SERS detection of PYO 
in more complex respiratory samples was performed. The main advantage of the planar substrates 
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over colloidal NPs is that, beside the chemical affinity of the target molecule towards metallic sur-
face, the simple static physical attachment also plays a role. During this study, as a complex matrix, 
artificial sputum was investigated, not only because it closely simulates clinical samples but also 
due to its known composition it also offers the possibility to study the interaction of the matrix 
components and target analyte with plasmonic nanostructures. Prepared artificial sputum included 
DNA, mucin, bovine serum albumin (BSA), egg yolk, NaCl, KCl, diethylenetriaminepentaactetic 
acid and tris(hydroxymethyl)aminomethane hydrochloride. [77] For the SERS investigations, 
900 µL of artificial sputum were spiked with 100 µL of 1 mM PYO ethanol solution to achieve a 
concentration of 100 µM of PYO in the sputum. After this, serial dilutions were performed to get 
the final concentrations of 100, 75, 50, 25, 12.5 and 6.25 µM of the analyte in the sputum samples. 
As negative control sputum was spiked only with ethanol.  
For the SERS measurements, silicon nanowires (SiNWs) based substrates were considered. The 
attention was drawn to SiNWs due to their low-cost and relatively easy fabrication. Moreover, they 
have a very high surface area, which allows packing of high number of the NPs, leading to higher 
enhancement factors. [217] In the context of the study, four different designs of the substrates, 
which are schematically represented in Figure 7 (a), were fabricated. For this, SiNWs were pre-
pared by metal-assisted chemical etching (MACE) in hydrofluoric acid (HF) solution using Ag 
NPs. [218] Next, for two substrates the Ag NPs on the bottom of the SiNWs were left and for two 
they were removed. This was followed by Ag NPs deposition on the top of the SiNWs for one of 
each substrate type. Finally, on all substrates the reduction of gold(III) chloride in 5 M hydrofluoric 
acid was performed [219], which resulted in the formation of Au NPs on the SiNWs or around the 
previously deposited Ag NPs on the top. In this way, at the end four SERS substrates were pre-
pared: (1) Ag*Au*SiNWs – SiNWs with native layer of Ag NPs at the bottom and deposited 
Au NPs on the top; (2) * **Ag Au SiNWs  – SiNWs with native Ag NPs at the bottom and bimetallic 
Ag/Au NPs on the top; (3) Ag*Au*SiNWs – SiNWs with bimetallic Ag/Au NPs on the top; (4) 
Au*SiNWs – SiNWs with Au NPs deposited on the top. Investigation of substrates’ morphology 
with SEM showed that for all of the substrates SiNWs acquired a conical shape, which can be 
caused by simultaneous etching in HF during the deposition of Ag NPs and the gold reduction pro-
cess (see Figure 1 in [OZ4]). Native Ag NPs on the bottom of the substrate were sized around 100 
nm and the ones on the top around 50 nm. For all of the substrates, gold formed fine-grained struc-
tures consisting of NPs with sizes between 10-20 nm.  
To compare the SERS ability between the different designs of the substrates, artificial sputum 
with PYO concentration of 50 µM was selected as a sample. All substrates were incubated for 30 
min in PYO-artificial sputum solution, which was previously diluted 5 times with deionized water. 
Here, dilution was performed to reduce the matrix effects and optimize the SERS signal. [220, 221] 
As negative control, substrates were incubated in pure artificial sputum. After incubation substrates 
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were air-dried and subjected to Raman measurements performed with 785 nm excitation wave-
length. Investigation of the substrates under the microscope revealed that during the drying process 
‘coffee-ring effect’ appears and the sample is concentrated around the edge of the substrate. Thus, 
the scanning areas were selected closer to the edges of substrates. For every substrate ten areas with 
100 point were measured. Obtained mean SERS spectra are depicted in Figure 7 (b). First of all, it 
can be seen that the blank sputum by itself has intensive bands at 732, 960 and 1327 cm-1. Based on 
the SERS measurements of all the sputum components and on the literature, these bands were as-
signed to the DNA base adenine. [222] 
Despite this contribution of the matrix, the peaks of PYO at 597, 676, 1353, 1600 and 1615 cm-1 
also can be observed for all the investigated substrates. For a better comparison, the ring defor-
mation vibrational mode of PYO at 676 cm-1 was integrated and plotted in Figure 7 (c) together 
with the SD. More intensive signal was received from the substrates with the native Ag NPs on the 
bottom. This can be explained by the fact that some analyte molecules diffuse to the bottom of the 
substrate and their signal can be still enhanced by Ag NPs lying on the bottom. In the case of other 
two substrates with removed Ag NPs, Raman signal of those molecules is not enhanced, as they are 
too far away from the metal NPs on the top. The highest signal of PYO was achieved for the
* *
*Ag Au SiNWs  substrate. Moreover, it also demonstrated the smallest relative standard deviation 
(RSD), which is highly important for the SERS studies. Therefore, only this substrate was consid-
ered for further investigation. 
To estimate the detection sensitivity of the * **Ag Au SiNWs  substrate, the PYO concentrations of 
100, 75, 50, 25, 12.5 and 6.25 µM in artificial sputum were measured and the resulting mean 
Figure 7. (a) Schematic representation of the fabricated SERS substrates. (b) Mean SERS spectra of 50 µM 
PYO in artificial sputum measured on four different types of SiNWs substrates and the mean SERS spectra 
of artificial sputum. (c) Normalized peak area for the peak at 676 cm-1 for four different types of SiNWs 
substrates. Adapted from [OZ4]. 
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spectra are plotted in Figure 8 (a). Despite some background from the artificial sputum 
components, the characteristic peaks of PYO already appear for the 6.25 µM concentration. For a 
better visualization, the integrated peak area of the PYO band at 1353 cm-1 (zoomed region is 
depicted in Figure 8 (b)) was calculated and plotted against the concentration of PYO. Figure 8 (c) 
shows the linear response in the concentration range from 6.25 µM to 100 µM.  
Parallel to the detection in artificial sputum, PYO detection in aqueous solution was also per-
formed aiming to evaluate the effects brought by complex matrix. Analyzing aqueous solutions 
PYO signal was clearly visible down to concentration of 1 nM (see Figure S8 in SI for [OZ4]). 
This proves that, in the case of artificial sputum, the competition for the free binding sites on the 
metallic surface occurs, and leads to decrease in SERS signal of PYO. Nevertheless, achieved de-
tection of PYO in artificial sputum down to 6.25 µM perfectly fits the clinically relevant limit. This 
indicates the high potential of using the described substrates for the direct detection and quantifica-
tion of PYO in artificial sputum, which, to the best of my knowledge, has not been reported before. 
However, even though SERS offers a great potential for bioanalytical applications, often plas-
monic substrates have been hindered by poor reproducibility. Therefore, the SERS signal reproduc-
ibility of the * **Ag Au SiNWs  substrate was studied more precisely. For this, 50 µM concentration 
of PYO in artificial sputum was used and the signal variations from point-to-point were checked. 
Measuring 100 spectra with 5 µm step, SERS signal of PYO appeared to be quite stable demon-
strating RSD around 11.6 %. Considering ten different areas within the substrate, deviation became 
higher and reached 22.7 % (see Figure 3 [OZ4]). This can be in the main explained by inhomoge-
neous drying of the sputum. Additionally to the point-to-point, SERS substrates should have very 
good batch-to-batch reproducibility, which ensures that all new substrates made with the same pro-
Figure 8. (a) Vector normalized mean SERS spectra of artificial sputum spiked with different PYO concen-
trations. (b) Zoomed mean spectra for different PYO concentrations. (c) The peak area of the band at 
1353 cm-1 as a function of the PYO concentration in the range between 6.25 and 100 µM. Adapted from 
[OZ4]. 
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cedure will provide the same results. During the study, four different batches of the * **Ag Au SiNWs  
substrates were prepared by two different researchers. All batches were similarly SERS active ex-
hibiting RSD of the SERS signal around 12 %. Such variations suggest that there is still some room 
for the optimization of the substrates. MACE protocol used for production of SiNWs involves very 
short (15 s, 30 s) incubation steps in etching solutions and manual performing of them can lead to 
shorter or longer incubation, which result in small morphological variations between the substrates. 
Therefore, automation of the fabrication process would be beneficial. 
To conclude, the presented studies show the high potential of the label-free SERS for the detec-
tion of the bacterial biomarker PYO directly in the body-fluids. Moreover, proposed SERS detec-
tion platforms with Ag colloids or SiNWs-based planar substrates are easy to prepare within a few 
minutes and require no special equipment. Although, in comparison to aqueous solution, the pres-
ence of interfering components of saliva or artificial sputum increased PYO detection limits, SERS 
signal of PYO in those complex fluids could still be clearly visible in the micromolar concentration 
range. This indicates that SERS, in prospect, can be implemented in real clinical setting because 
clinically relevant PYO concentrations in sputum lie between 7 and 130 μM. Furthermore, the 
achieved linear responses raise the question of a potential use of SERS not only for detection but 
also for quantification of this biomarker in body fluids. Clinical sputum samples should be consid-
ered in order to further explore the capabilities of this method. 
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5 SUMMARY AND OUTLOOK 
The burden of respiratory tract infections (RTIs) is a substantial public health concern. High 
mortality rates worldwide highlight the extreme need for improving management of this type of 
infections. In particular, intense focus should be set on the individuals with higher susceptibility to 
RTIs, as they make up a significant part of the infection cases and are at higher risk of lethal out-
come. To this group can be assigned people with any type of immunosuppression, individuals suf-
fering from chronic respiratory tract diseases, persons with some genetic disorders affecting the 
respiratory organs, children till the age of five and elderly generation. To decrease the mortality of 
RTIs, especially among these people, improvement of prevention techniques as well as searching 
for faster and more accurate diagnostic methods leading to a more effective treatment, should be 
performed. The aim of this thesis was to investigate the potential and limitations of Raman spectro-
scopic techniques (RST) for these clinical tasks.  
First of all, the role of RST for prevention purposes was demonstrated. Since currently availa-
ble vaccinations for the prevention of infections provide selective spectrum of protection and have 
controversial effectiveness for susceptible individuals, some other actions should be considered. 
Taking into account that humans are constantly breathing and no environment is totally sterile, 
avoiding the aspiration of potential pathogens seems to be impossible. However, if they are aware 
of the exact composition of the microorganisms in the air, susceptible individuals could avoid be-
ing in the places with pathogens of high danger. To do so, a fast identification of the microorgan-
isms found in the air should be performed. That is there RST enters the battlefield as an alternative 
to the time consuming and personnel-dependent culturing methods or to nucleic acid-based and 
immunological techniques requiring the complicated generation of selective antibody and large 
amount of antigens. RST were already broadly investigated for identification of microorganisms, 
however the application of it was mainly limited to not colored samples. In the frame of this thesis, 
it is demonstrated that highly pigmented and darkly colored fungal spores can also be identified 
based on their ‘spectral fingerprint’. Fungal spores are often found in the air, and depending on the 
species, can cause the RTIs, especially in susceptible individuals, or trigger the exacerbation of an 
already developed respiratory disease. Raman measurements were carried out using UV-RRS, due 
to possibility of avoiding the fluorescence and obtaining the enhanced signal from taxonomically 
important biomolecules such as DNA/RNA. Subsequent spectral classification performed with 
PCA-LDA and evaluated with leave-batch-out cross-validation (LBOCV) demonstrated accuracies 
higher than 97 % not only in discrimination between spores of five different genera, but also for 
identification of four different Aspergillus species. This is highly relevant because out of hundreds 
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of Aspergillus species, only tens are known as opportunistic pathogens. The power of the technique 
was also assessed on the never before reported strain level and the accuracy of 89.42 % in differen-
tiating between three strains of A. fumigatus was achieved. Since the usage of the Raman setup was 
limited to the biomass of the sample, the omission of the cultivation step was not possible at this 
point in time. However, combining of UV-RRS with chemometrical methods completely excludes 
the human factor from the identification process and makes it more automated. To make a full use 
of the potential of the technique, further studies should be directed towards technical improvements 
of the setup enabling measurements of spores directly from collection filters. This would allow for 
the susceptible individuals to perform online monitoring of the microorganisms’ composition in the 
air and to take appropriate preventitive steps.  
Another crucial point in managing RTIs is their rapid diagnosis, which allows earlier interven-
tion and results in more effective treatment. However, for susceptible individuals it is often a chal-
lenging task, as usual symptoms of RTIs, like fever or cough, can overlap with symptoms of the 
main disease or can be simply absent. Therefore, a periodically performed easy and non-invasive 
screening test could be extremely beneficial. Nowadays there is no real screening program for the 
RTIs and detection of suspected infections is initially performed with chest radiography. However, 
frequent use of this imaging test is limited by the accompanied dose of ionizing radiation. In the 
scope of this thesis, conventional RS of urine was investigated as a possible screening technique for 
RTIs, which were represented by the mice model of aspergillosis infection. Here, urine attracted 
the interest due to simple and completely non-invasive collection in people of all ages, possibility 
of multiple sampling and possessing large amount of metabolites, which could reflect the develop-
ing infection. To assess more precisely the diagnostic value of urine and ability of RS to monitor 
changes in its composition, along with aspergillosis infection, the mice model of allergic asthma 
was included together with two kidney diseases known to have a direct influence on urine for-
mation. Comparison of spectral data from control mice for all of the models revealed significant 
differences between them, which forced separated investigation of each model. Discrimination 
between sick and healthy mice was done using PCA-LDA and resultant model was evaluated with 
leave-mouse-out cross-validation (LMOCV). The classification accuracy of 100 % was achieved 
for the kidney disease model, which supported the starting hypothesis that urine is very informative 
for the diseases with direct connection to its formation and RS is able to read out this information. 
Considering respiratory tract diseases, which have no direct influence on urine composition, much 
smaller differences between control and sick mice were registered, but RS still showed promise for 
diagnosis. For detecting the allergic asthma, the accuracy of 77.27 % was achieved; however, it is 
worth noticing that occurred false negative results could have been caused by organism's capacity 
for self-regeneration, as the included urine samples were collected on different days after exposure 
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to allergens. Analyzing the aspergillosis model, firstly the sensitivity of 50 % and specificity of 
90 % were achieved, but more detailed clinical data revealed that some of the infected mice did not 
develop the infection, which could lead to misclassifications. Rebuilding the model only with mice 
diagnosed with acute aspergillosis, the identification accuracy reached 100 %. This shows that 
urine-based RS holds some promises for the screening of RTIs but further clinical studies including 
significantly larger cohorts should be conducted for more precise validation of the method. 
Finally, to increase the chances for the successful treatment of the RTIs, fast identification of 
the exact infectious agent is required. Within this scope, indirect detection of the pathogens by 
identifying the biomarkers released to body fluids by the microorganism or reflecting the host re-
sponse may be a good alternative approach to the routine time consuming bacteriological culture. 
In the framework of the thesis, a highly sensitive SERS technique is suggested for this purpose by 
demonstrating, as an example, the detection of P. aeruginosa biomarker – pyocyanin (PYO) direct-
ly in respiratory body-fluids. With the focus on the clinical application, the main goal was to pro-
vide a cost-effective, sensitive, rapid and easy-to-use detection platform, which is able to detect 
clinically relevant PYO concentrations (7 – 130 µM in sputum samples). Initially, as SERS active 
agent easy-to-prepare Ag NPs were considered. To achieve more automated and reproducible 
measurements, SERS was combined with a microfluidic platform. To assess the suitability of the 
method, firstly, detection of PYO in aqueous solution was performed and the linear response of the 
SERS intensity in the concentration range of 0.5 – 15 µM was achieved with calculated limit of 
detection being lower than 0.5 µM. As a next step towards matrix complexity, spiked saliva sam-
ples from the volunteers were considered. Despite the more compounded solution, signatures of 
PYO were still visible for two volunteers down to 10 µM and for one down to 25 µM. Although 
these values are still in the clinically relevant range, such a drop of the detection sensitivity, com-
pared to aqueous solution, provided insight that using the same strategy, PYO detection in a more 
complex biofluid such as sputum would be already challenging.  Therefore, for the next measure-
ments SERS performance of planar substrates was considered. Keeping in mind the requirement of 
simple and cost-effective detection platform, chemically within 20 min produced SiNWs variously 
decorated with Ag and/or Au NPs were introduced as SERS substrates. Investigating different de-
signs was concluded that, for the SERS signal, it is beneficial to have the Ag NPs on the bottom of 
the NWs, because the Raman signal from the analyte molecules diffused to the bottom can be also 
enhanced. Moreover, placing on the top of SiNWs bimetallic Ag/Au NPs rather than only Au NPs 
improved the stability of the signal. Using such substrate the detection of PYO in artificial sputum, 
which mimics clinical samples, was performed. To decrease the influence of the matrix, dilution of 
the samples was suggested and PYO signal down to 6.25 µM concentration could be observed by 
the eye. Moreover, the linear response of SERS intensity in the concentration range of 
 41 
6.25 - 100 µM was achieved. These results indicate that label-free SERS is suitable candidate for 
the PYO detection in respiratory bio-fluids and this technique holds significant promise for the 
quantitative analysis. Future studies should be focused on the optimization of the fabrication pro-
cess of introduced SERS substrates and on the investigation of real sputum samples. 
In conclusion, within the framework of this thesis, the potential role of RST for improving 
prevention and diagnostic strategies of RTIs in susceptible individuals was assessed, highlighting 
the need of careful choice of the technique according to the desired clinical task. To do so, 
UV-RRS spectroscopy was successfully applied for the identification of highly pigmented fungal 
spores samples, conventional RS of urine was investigated for the fast screening of the RTIs and 
SERS was used for the detection of a bacterial metabolite in complex matrixes for the rapid and 
more precise diagnosis. Along with the promising results, the challenging aspects such as (i) laser 
induced photodegradation and the need of spore’ biomass for obtaining the good quality spectra for 
identification; (ii) decreased diagnostic value of urine for the diseases not directly connected with 
urine formation and (iii) interfering contribution of the complex matrix components to the SERS 
signal of target analyte, were discussed. Therefore, there remains a need for further investigations 
with clinical samples before RST can be accepted as an effective tool in clinical applications. How-
ever, the results achieved in the frame of this thesis represent a significant step forward toward this 
direction. 
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6 ZUSAMMENFASSUNG UND AUSBLICK 
Infektionen der Atemwege (engl. respiratory tract infection, RTI) haben nicht nur einen sehr 
negativen Einfluss auf die Gesundheit der gesamten Weltbevölkerung, sondern auch erhebliche 
finanzielle und humanitäre Auswirkungen. Weltweit hohe Sterblichkeitsraten weisen auf die drin-
gende Notwendigkeit eines verbesserten Managements bei dieser Art von Infektionen hin. Hierbei 
sollte der Fokus auf Personen mit einer erhöhten Anfälligkeit für RTI gelegt werden, da sie einen 
erheblichen Teil der Gesamtheit derartiger Infektionen ausmachen und ein besonders hohes Sterb-
lichkeitsrisiko aufweisen. Zu dieser Gruppe zählen Personen mit jeder Art von Immunsuppression, 
wie auch Menschen, welche an chronischen Erkrankungen der Atemwege leiden oder die bestimm-
te genetische Störungen der Atmungsorgane aufweisen, aber auch Kinder bis zu einem Alter von 
fünf Jahren sowie alte Menschen. Um die Mortalität bei RTI, speziell bei diesen Personen, zu sen-
ken, sollten die Bemühungen zur Verbesserung der Präventionstechniken sowie die Erforschung 
von schnelleren und genaueren Diagnoseverfahren intensiviert werden, damit schließlich eine ef-
fektivere Behandlung erfolgen kann.  
Ziel dieser Arbeit war es, das Potential und die Grenzen Raman-spektroskopischer Verfahren 
(RSV) für die Prävention und Diagnostik von RTI zu untersuchen. 
Zunächst wurden die Möglichkeiten von RSV für Präventionszwecke erforscht. Da derzeit 
verfügbare Impfungen zur Verhinderung von Infektionen nur einen unvollständigen Schutz bieten 
und die Wirksamkeit bei anfälligen Personen umstrittenen ist, sollten auch andere Maßnahmen in 
Betracht gezogen werden. Weil der Mensch ständig atmen muss und praktisch keine Umgebung 
vollkommen steril ist, scheint es unmöglich, den Kontakt mit potentiellen Krankheitserregern gänz-
lich zu vermeiden. Wäre jedoch die genaue Zusammensetzung der Mikroorganismen in der Atem-
luft bekannt, könnten anfällige Personen sich gezielt von Orten mit hochgefährlichen Krankheitser-
regern fernhalten. Dazu ist eine schnelle Identifizierung der in der Luft vorkommenden Mikroorga-
nismen erforderlich. Für diese Aufgabe sind RSV eine attraktive Alternative zu Kultivierungsme-
thoden, die sehr zeitaufwendig sind und deren Resultate von der durchführenden Person abhängig 
sind. Nukleinsäure-basierte und immunologische Techniken sind zwar ebenfalls schneller als kulti-
vierungsbasierte Ansätze, erfordern aber eine komplizierte und kostspielige Erzeugung von selek-
tiven Antikörpern und eine große Menge an Antigenen oder sehr teure Spezialreagenzien. Die Nut-
zung von RST zur Identifizierung von Mikroorganismen wurde bereits umfassend untersucht, je-
doch war die Anwendung hauptsächlich auf Proben, welche keine Farbpigmente enthielten, be-
schränkt. Im Rahmen dieser Arbeit wird gezeigt, dass hochpigmentierte und dunkel gefärbte Pilz-
sporen auch anhand ihres „spektralen Fingerabdrucks“ identifiziert werden können. Pilzsporen sind 
häufig in der Luft zu finden und können, abhängig von ihrer Spezies, RTI insbesondere bei anfälli-
gen Individuen verursachen oder bereits bestehende Atemwegserkrankungen verschlimmern. Um 
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diese zu charakterisieren wurde die Methode der Ultraviolett-Resonanz-Raman-Spektroskopie 
(UV-RRS) angewandt. Dabei wird das störende Fluoreszenzsignal der Probe vermieden, während 
die Raman-Banden von taxonomisch wichtigen Biomolekülen wie DNA / RNA verstärkt werden. 
Die nachfolgende spektrale Klassifizierung, die mit der Hauptkomponentenanalyse (engl. Principal 
Component Analysis, PCA) und der lineare Diskriminanzanalyse (engl. Linear Discriminant Analy-
sis, LDA) durchgeführt und mit der „Leave-One-Batch-Out“-Kreuzvalidierung (engl. leave-one-
batch-out cross validation, LBOCV) ausgewertet wurde, zeigte Genauigkeiten von mehr als 97 %. 
So wurde nicht nur die Unterscheidung von Sporen fünf verschiedener Gattungen, sondern auch die 
Identifizierung von vier verschiedenen Aspergillus-Arten ermöglicht. Dies ist äußerst relevant, da 
von Hunderten von Aspergillus-Arten nur zehn als opportunistische Erreger bekannt sind. Die Leis-
tungsfähigkeit dieser Technik konnte ebenfalls anhand eines noch nie zuvor erreichten Spezifizie-
rungslevels untermauert werden, wobei eine Genauigkeit von 89% bei der Differenzierung zwi-
schen drei Stämmen von A. fumigatus erreicht wurde. Da der verwendete Raman-Messaufbau eine 
gewisse Menge an Biomasse der Probe erforderte, war der Verzicht auf einen Kultivierungsschritt 
zu diesem Zeitpunkt noch nicht möglich. Die Kombination von UV-RRS mit chemometrischen 
Methoden schließt jedoch den Faktor Mensch vollständig aus dem Identifizierungsprozess aus und 
macht ihn automatisierbar. Um das Potential dieses Ansatzes voll ausnutzen zu können, sollten 
weitere Anstrengungen im Hinblick auf die technische Verbesserung des Aufbaus ausgerichtet 
sein, sodass eine direkte Messung von Sporen aus Luftfiltern möglich ist. Dies würde es dem ge-
fährdeten Personenkreis ermöglichen, eine Online-Überwachung der aktuell in der Luft vorhande-
nen Mikroorganismen durchzuführen und gegebenenfalls geeignete Präventionsmaßnahmen zu 
ergreifen. 
Weitere entscheidende Punkte bei der Bekämpfung von RTI sind die schnelle Diagnose und 
die genaue Identifizierung der Erreger, wodurch ein früheres Eingreifen und eine wirksamere Be-
handlung möglich wird. Für die Patienten selbst sowie für die behandelnden Ärzte ist beides jedoch 
häufig schwer realisierbar, da die üblichen Symptome von RTI, wie Fieber oder Husten, von den 
Symptomen der Haupterkrankung überlagert werden können oder ganz fehlen. Ein regelmäßig 
durchgeführter einfacher und nichtinvasiver Screening-Test wäre hier von großem Nutzen. Bislang 
gibt es jedoch kein echtes Screening-Programm für die RTI. Die Erkennung von vermuteten Infek-
tionen wird zunächst mit der Thorax-Radiographie durchgeführt. Die regelmäßige Verwendung 
dieses bildgebenden Tests ist aber durch die damit verbundene Dosis ionisierender Strahlung be-
grenzt. Im Rahmen dieser Arbeit wurde die konventionelle Raman-Spektroskopie (RS) von Urin 
als mögliches Screening-Verfahren für RTI, repräsentativ am Mausmodell der Aspergillo-
se-Infektion, untersucht. Urin wurde deswegen als Probenmatrix gewählt, weil er einfach und 
nicht-invasiv bei Menschen jeden Alters entnommen werden kann, die Möglichkeit der Mehrfa-
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chentnahme besteht und eine große Menge an Metaboliten aufweist, welche ihre Zusammensetzung 
ändern können, wenn sich eine Infektion entwickelt. Um den diagnostischen Wert des Urins und 
die Fähigkeit von RS zur Überwachung von Änderungen in seiner Zusammensetzung genauer zu 
erforschen, wurde neben einer Aspergillose-Infektion am Mausmodell auch allergisches Asthma 
zusammen mit zwei Nierenerkrankungen eingeschlossen, von denen bekannt ist, dass sie einen 
direkten Einfluss auf die Urinbildung haben. Ein Vergleich der Spektraldaten von Kontrollmäusen 
für alle Modelle ergab signifikante Unterschiede zwischen ihnen, was eine getrennte Untersuchung 
jedes Modells notwendig machte. Die Diskriminierung zwischen kranken und gesunden Mäusen 
wurde unter Verwendung von PCA-LDA durchgeführt und das resultierende Modell mit einer 
„Leave-One-Mouse-Out“-Kreuzvalidierung (engl. leave-one-mouse-out cross validation, LMOCV) 
bewertet. Eine Klassifizierungsgenauigkeit von 100 % wurde für das Nierenkrankheitsmodell er-
reicht, welche die Ausgangshypothese unterstützte, dass Urin bei Krankheiten, welche in direktem 
Zusammenhang mit seiner Produktion stehen, einen hohen Informationsgehalt besitzt, der mit RS 
ausgelesen werden kann. Im Hinblick auf Atemwegserkrankungen, die keinen direkten Einfluss auf 
die Zusammensetzung des Harns haben, wurden geringere Unterschiede zwischen Kontrollmäusen 
und erkrankten Mäusen festgestellt, jedoch zeigte die RS immer noch vielversprechende Ergebnis-
se in Bezug auf eine Diagnose. Beim Nachweis des allergischen Asthmas wurde eine Genauigkeit 
von 77 % erreicht. Zu berücksichtigen ist hierbei jedoch, dass aufgetretene falsch-negative Ergeb-
nisse durch die Fähigkeit des Organismus zur Selbstregeneration verursacht werden könnten, da die 
verwendeten Urinproben an verschiedenen Tagen nach der Allergenexposition entnommen wurden. 
Bei der Analyse des Aspergillosemodells wurden zunächst eine Sensitivität von 50 % und eine 
Spezifität von 90 % erreicht. Eine detailliertere Analyse der klinischen Daten zeigte aber, dass bei 
einigen der infizierten Mäuse keine Symptome auftraten bzw. keine Infektion nachweisbar war, 
was vermutlich zu Fehlklassifizierungen führte. Bei der erneuten Generierung eines Modells nur 
mit den Mäusen, bei denen eine akute Aspergillose diagnostiziert wurde, erreichte die Erkennungs-
genauigkeit 100 %. Dies zeigt, wie vielversprechend RS auf Urinbasis für das Screening von RTI 
ist. Für eine genauere Validierung der Methode sollten jedoch weitere klinische Studien mit deut-
lich größeren Kohorten durchgeführt werden. 
Um die Chancen für eine erfolgreiche Behandlung der RTI zu erhöhen, ist eine schnelle Iden-
tifizierung des genauen Infektionserregers erforderlich. Dazu ist zum Beispiel ein indirekter Nach-
weis der Erreger durch charakteristische Biomarker, die durch den Mikroorganismus abgegeben 
werden, oder vom Wirt als Reaktion auf die Infektion gebildet werden, eine geeignete Alternative 
zu zeitraubenden Kultivierungsverfahren. Im Rahmen der Dissertation wurde für diesen Ansatz die 
hochsensitive oberflächenverstärkte Raman‐Spektroskopie (engl. Surface enhanced Raman 
spectroscopy, SERS) gewählt und exemplarisch der Nachweis des von P. aeruginosa gebildeten 
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Biomarkers - Pyocyanin (PYO) direkt in der Atemwegsflüssigkeit realisiert. Mit dem Fokus auf die 
diagnostische Anwendung bestand das Hauptziel darin, eine kostengünstige, empfindliche, schnelle 
und benutzerfreundliche Erkennungsplattform bereitzustellen, mit der klinisch relevante PYO-
Konzentrationen (7 – 130 µM in Sputumproben) nachgewiesen werden können. Als SERS-Substrat 
wurden zunächst einfach herzustellende Silber-Nanopartikel (Ag-NPs) verwendet. Um automati-
sierte und reproduzierbare Messungen durchführen zu können, wurde SERS mit einem Mikroflu-
idik-System kombiniert. Zur Beurteilung der generellen Eignung des Verfahrens, wurde zunächst 
der Nachweis von PYO in wässriger Lösung und die Korrelation der SERS-Intensität mit der Kon-
zentration im Bereich von 0,5 – 15 µM untersucht. Dabei wurde eine Nachweisgrenze von weniger 
als 0,5 µM berechnet. Für den nächsten Schritt in Richtung einer erhöhten Matrixkomplexität wur-
den mit PYO-versetzte Speichelproben von freiwilligen Probanden analysiert. Trotz der komplexe-
ren Zusammensetzung des Speichels waren die Signaturen von PYO bei zwei Probanden bis zu 
10 µM und bei einem bis zu 25 µM messbar. Obwohl diese Werte noch im klinisch relevanten 
Bereich liegen, war die Nachweisempfindlichkeit im Vergleich zu wässriger Lösung deutlich ver-
ringert. Um den PYO-Nachweis in komplexeren Biofluiden wie Sputum mit dieser Methode den-
noch durchführen zu können, wurden die nächsten Messungen mit einer planaren SERS-
Substratvariante durchgeführt. Unter Berücksichtigung der Forderung nach einer einfachen und 
kostengünstigen Nachweisplattform wurden chemisch hergestellte Silizium-Nanodrähte (engl. si-
licon nano wires, SiNWs), die mit Ag- und / oder Au-NPs versehen waren, als SERS-Substrate 
eingeführt. Bei der Untersuchung verschiedener Designs wurde schließlich festgestellt, dass es für 
die SERS-Signalintensität vorteilhaft ist, die Ag-NPs an der Unterseite der NWs zu platzieren, da 
auf diese Weise das Raman-Signal von den nach unten diffundierten Analytmolekülen ebenfalls 
verstärkt werden kann. Darüber hinaus verbesserte das Aufbringen von Bimetall-Ag / Au-NPs an-
stelle von Au-NPs auf die Spitze der SiNWs die Stabilität des Signals. Mit einem solchen Substrat 
wurde der Nachweis von PYO in künstlichem Sputum, welches klinische Proben nachahmt, durch-
geführt. Um den Einfluss der Matrix zu verringern, wurde eine Verdünnung der Proben vorge-
nommen. Das PYO-Signal konnte dabei bis zu einer Konzentration von 6,25 µM im Spektrum 
eindeutig mit bloßem Auge erkannt werden. Darüber hinaus wurde ein lineares Verhalten der 
SERS-Intensität im Konzentrationsbereich von 6,25 – 100 µM beobachtet. Diese Ergebnisse zei-
gen, dass markerfreies SERS für den PYO-Nachweis in Biofluiden der Atemwege gut geeignet und 
diese Technik zudem vielversprechend für die quantitative Analyse ist. Weiterführende Studien 
sollten sich somit auf die Optimierung des Herstellungsprozesses der eingeführten SERS-Substrate 
und auf die Untersuchung realer Sputumproben konzentrieren. 
Im Rahmen dieser Arbeit wurde insgesamt das Potential von RSV zur Verbesserung der Prä-
ventions- und Diagnosestrategien von RTI bei anfälligen Personen untersucht, wobei besonders 
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Wert darauf gelegt wurde, die zum Einsatz kommende Technik sorgfältig auf die jeweiligen klini-
schen Anforderungen abzustimmen. So wurde die UV-RRS-Spektroskopie erfolgreich zur Identifi-
zierung hochpigmentierter Pilzsporenproben eingesetzt und mittels konventioneller RS eine schnel-
le Screeningmethode für RTI an Urinproben realisiert. Darüber hinaus wurde demonstriert, dass 
SERS zum Nachweis eines bakteriellen Metaboliten in komplexen Proben geeignet ist und damit 
für eine schnelle und genauere Diagnose verwendet werden kann. Neben diesen vielversprechen-
den Ergebnissen wurden die herausfordernden Aspekte, wie (i) der laserinduzierte Photoabbau und 
der Bedarf an Sporenbiomasse, um Spektren mit guter Qualität für die Identifizierung zu erhalten; 
(ii) der verminderte diagnostische Wert des Urins für die Krankheiten, die nicht direkt mit der 
Urinbildung zusammenhängen, und (iii) der störende Beitrag der komplexen Matrixkomponenten 
zum SERS-Signal des Zielanalyten kritisch diskutiert. Demnach gibt es aktuell immer noch Bedarf 
an weiteren Untersuchungen und Studien mit klinischen Proben, bevor RSV als wirksames Instru-
ment in der klinischen Anwendung akzeptiert werden kann. Die in dieser Arbeit erzielten Ergebnis-
se sind jedoch ein großer Schritt in diese Richtung. 
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ABSTRACT: Fungal spores are one of several environmental 
factors responsible for causing respiratory diseases like asthma, 
chronic obstructive pulmonary disease ( COPD ), and aspergil-
losis. These spores also are able to trigger exacerbations during 
chronic forms of disease. Different fungal spores may contain 
different allergens and mycotoxins, therefore the health hazards 
are varying between the species. Thus, it is highly important 
quickly to identify the composition of fungal spores in the air. In 
this study, UV-Raman spectroscopy with an excitation wave-
length of 244 nm was applied to investigate eight different fungal 
species implicated in respiratory diseases worldwide. Here, we 
demonstrate that darkly colored spores can be directly 
I PCA/LOA I • I 
examined, and UV-Raman spectroscopy provides the information sufficient for classifying fungal spores. Classification models 
on the genus, species, and strain levels were built using a combination of principal component analysis and linear discriminant 
analysis followed by evaluation with leave-one-batch-out-cross-validation. At the genus level an accuracy of 97.5% was achieved, 
whereas on the species level four different Aspergillus species were classified with 100% accuracy. Finally, classifying three strains 
of Aspergillus fumigatus an accuracy of 89.4% was reached. These results demonstrate that UV-Raman spectroscopy in 
combination with innovative chemometrics allows for fast identification of fungal spores and can be a potential alternative to 
currently used time-consuming cultivation. 
H undreds of millions of people of all ages suffer every day 
from chronic respiratory diseases. According to the latest 
WHO estimates (2004), which are considered conservative, 
> 300 million people are afflicted with asthma, 210 million 
people suffer from chronic obstructive pulmonary disease 
(COPD), while >400 million suffer from some other form of 
respiratory disease. 1 These diseases all have a negative impact 
on the quality of life of those affected and in many instances 
can be life threatening, especially in cases of acute 
exacerbation. Exacerbations of allergic respiratory disease 
occur frequently in COPD and asthma patients, likely triggered 
by exposure to environmental stimuli. Although debated, these 
exacerbations are generally characterized by increased airway 
inflammation, mucus production, and impaired lung function. 
'V' ACS Publications © 2018 American Chemical Society 8912 
Outdoor fungal spores are one of several environmental 
factors responsible not only for causing respiratory diseases in 
humans, 2 - 4 but also for triggering exacerbations during 
chronic forms of lung diseases such as asthma and COPD. 
For example, it was reported that asthma hospitalization cases 
increase during thunderstorms due to the increased aerosoliza-
tion of fungal spores.5 Since different fungi may produce 
different allergens and mycotoxins, the severity of asthma 
exacerbation may vary between spores of different fungal taxa, 6 
e.g., some patients have hypersensitivity only to Aspergillus 
spec., which can lead to allergic bronchopulmonary aspergillosis 
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(ABPA) or other complications in patients suffering from 
asthma, cystic fibrosis, or COPD.7 Therefore, it would be 
beneficial to identify and eliminate fungal spores before they 
trigger respiratory disease or exacerbations in patients with 
chronic respiratory diseases. 
Currently the "gold standard" for fungal identification is the 
cultivation of sampled organisms coupled with careful 
observation and measurement of macroscopic and microscopic 
morphological characteristics of the organism of interest, 
including reproductive structures like spores. However, this 
method is laborious and requires highly trained and 
experienced personnel. Additional difficulties in fungal 
identification include the presence of a wide range of 
nonculturable organisms and/ or contamination of fungal 
cultures with fast-growing bacteria, as these factors make the 
analysis of morphological information complicated. 8 A fast, 
highly automated method, which can identify fungal spores via 
pattern recognition, would exclude the human factor from the 
identification process and would improve turn-around times 
for spore identification. As an alternative approach to the more 
classic culture methods, polymerase chain reaction (PCR)-
based detection methods for fungal spore identification have 
been reported.8- 11 PCR methods require expensive reagents 
and design of target-specific primers and tend to produce false-
positive results. Another possibility is offered by vibrational 
spectroscopy, a technique which utilizes molecular vibrations 
to provide information about the molecular composition, 
structure and behavior within a sample. 
Among the vibrational spectroscopic methods, Raman 
spectroscopy is a very promising tool for the characterization 
of microorganisms.12' 13 This method offers specific molecular 
information about the chemical species in the samples in a 
noninvasive and label-free manner. The abilities of Raman 
spectroscopy for investigation and characterization of airborne 
allergens, such as individual pollen grains, has been 
demonstrated by various groups.14- 16 The characterization of 
fungal spores using Raman spectroscopy with visible excitation 
wavelengths has been previously also reported. However, in 
these studies, the excitation wavelengths utilized could only be 
applied to white or light-colored spores.17' 18 Several different 
microfungi spores relevant to indoor contamination were 
successfully characterized and identified with Raman spectros-
copy, describing the biochemical composition of a single 
spore.19 A study of C. Wang et al. reported measurements of 
Raman spectra in 1600-3400 cm-1 spectral range from 
individual pollen particles and Bermuda grass smut spores held 
in a photophoretic trap. Due to the small size of spores the 
spectrum had high background and only three Raman bands 
were visible. 20 Raman spectroscopy with visible excitation 
wavelengths was also used to discriminate Aspergillus lentulus 
from Aspergillus fumigatus with an accuracy of only 78%.17 K 
De Gussem et al. combined Raman spectroscopy with linear 
discriminant analysis (LDA) and reached around 90% accuracy 
in assigning the spectra of spores to the correct genus, 18 while 
identification on the species level was not possible. Instead of 
applying visible Raman excitation wavelengths various studies 
on mammalian cells,21'22 bacteria,23- 25 and pollen26 showed 
that utilizing electronically resonant excitation wavelengths in 
the UV region can be beneficial for the identification of 
microorganisms due to a selective resonant enhancement of 
the Raman signals of taxonomically important macromolecules, 
e.g., DNA/RNA bases and aromatic amino acids. Furthermore, 
the fluorescence background in UV resonance Raman spectra 
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is negligible for excitation wavelengths below 260 nm, which 
lead to Raman spectra with high signal-to-noise ratio.27- 31 
In the present study, for the first time the UV-Raman 
spectroscopic identification of fungal spores is demonstrated. 
Eight different filamentous fungal species, implicated to a 
varied extent in respiratory diseases worldwide, were examined: 
Aspergillus f umigatus, Aspergillus niger, Aspergillus nidulans, 
Aspergillus calidoustus, Cladosporium herbarum, Alternaria 
alternata, Penicillium rubens, and Lichtheimia corymbifera. 
Except for the mucoralean fungus Lichtheimia corymbifera, a 
basal fungal lineage, all other species belong to the division 
Ascomycota. In contrast to previous studies/ 7' 18 highly 
pigmented spores were successfully investigated. The identi-
fication of spores was based on a combination of principal 
component analysis (PCA) and LDA of the UV resonance 
Raman spectral data and was applied at a genus, species, and 
strain level. The performance of the models was evaluated with 
leave-one batch-out cross-validation. The presented results 
highlight the possibility of UV-Raman spectroscopy as a 
promising method for the automated identification of fungal 
spores. 
MATERIALS AND METHODS 
Fungal Spores. For this study 11 fungal strains from 8 
different species were utilized, namely A f umigatus, P. rubens, 
A. niger, C. herbarum, A. alternata, A. nidulans, A. calidoustus, 
and L. corymbifera (Table S-1 of the Supporting Information, 
SI) . The A fumigatus pksP mutant has been described 
previously. 32' 33 The fungi were grown for 7 days, in the dark, 
on 10 cm agar plates at room temperature ( ~22 °C). Growth 
was conducted on Aspergillus minimal media (AMM; 6.0 g/L 
NaNO3, 0.52 g/L KC!, 1.52 g/L KH2PO4, 0.52 g/L MgSO4· 
7H2O, 1% (wt/vol) glucose, and 1 mL of trace element 
solution [l g/L FeSO4·7H2O, 8.8 g/L ZnSO4·7H2O, 0.4 g/L 
CuSO4·5H2O, 0.15 g/L MnSO4·4H2O, 0.1 g/L Na2B4O7• 
10H2O, 0.05 g/L (NH4)~o7O24·4H2O] per liter),34 malt agar 
(MA) (Sigma-Aldrich), or modified SUP agar plates (4.1 g/L 
KH2PO4, 1.1 g/L NH4Cl, 0.9 g/L K2HPO4, 0.1 g/L MgSO4, 
1 % ( wt/vol) glucose, and 0.5% ( wt/vol) yeast extract).35 
AMM was supplemented with 0.06 mg/L biotin and 5 mM 
arginine for growth of A nidulans A89. Conidia ( asexually 
produced spores) from each strain were collected in 10 mL of 
water and separated from hyphae through a 40 µm pore filter. 
After centrifugation for 10 min at 1800 X g, conidia were 
resuspended in 3% (v/v) formaldehyde and incubated for 1 h 
for inactivation. Following formaldehyde-inactivation, each 
conidial-mixture was washed with water to remove any 
contaminating formaldehyde. The inactivation of the spores 
was confirmed by the lack of growth on appropriate media. 
Each growth condition was tested in triplicate, on three 
separate days. For the UV-Raman measurements 10 µL of 
spore suspensions was spread on a fused-silica surface and 
allowed to dry at room temperature. 
Spectroscopic Instrumentation. Raman measurements 
were performed using a LabRam HR 800 spectrometer from 
Horiba Jobin-Yvon (Bensheim, Germany) with a 2400 lines/ 
mm grating. As excitation wavelength, a frequency doubled 
argon-ion laser ( Coherent Innova 300, MotoFReD, Coherent, 
Dieburg, Germany) operating at 244 nm was applied. The 
samples were illuminated via a microscope (Olympus BX 41) 
equipped with a 20X magnification antireflection coated UV 
objective (LMU UVB) with a numerical aperture of 0.4. The 
laser power at the laser head was ea. 10.5 mW and on the 
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sample ea. 0.8 mW at a spot diameter of~ 1 µm, corresponding 
to ~105 W/cm2 irradiance. The entrance slit was set to 300 
µm. The Raman scattered light was detected by a nitrogen-
cooled CCD camera with an integration time of 20 s with 2 
accumulations. The samples were rotated with a speed 60 
rotations/rnin and moved in the x,y direction after each 
rotation to obtain an average spectrum over a large sample area 
to minimize possible photodegradation by UV radiation. Ten 
spectra were collected per sample. Measurements were 
performed by two independent operators. 
Data Analysis. Data processing was performed using an in-
house developed script in the programming language R. 6 First, 
the spectra were wavenumber calibrated by using the Teflon 
Raman spectrum measured prior to each sample measurement 
as reference. Next, the Raman spectra were background 
corrected using the sensitive nonlinear iterative peak (SNIP) 
clipping algorithm37 with a second-order clipping filter. Finally, 
all spectra were vector normalized and used as input for PCA, 
which was performed to reduce the dimensionality of the data 
while retaining the most significant information for classi-
fication. PCA was followed by LDA The performance of the 
created LDA model for classification of fungal spores was 
estimated using the leave-one batch-out-cross-validation 
(LBOCV) approach.38 In this method, one batch was held 
out from the data set, and the LDA model was redeveloped 
using the remaining spectra. The resultant model was then 
used to classify the removed batch. This process was repeated 
with every batch until all spectra were classified. In this manner 
LBOCV of the PCA-LDA model was utilized for all number of 
principle components (PCs). Then, an optimal number of PCs 
was chosen by finding a saturation point of the accuracy as a 
function of the number of PCs. For spectral comparison across 
the groups, mean Raman spectra for each fungal species were 
calculated using preprocessed, vector-normalized spectra of all 
batches. 
RESULTS AND DISCUSSION 
The primary goal of this study was to determine the feasibility 
of UV-Raman spectroscopy for the identification of melanised 
fungal spores. The selected fungal spores were all highly 
pigmented: black for A. alternata and A. niger, dark green for A. 
f umigatus strains and P. rubens, brown for A. calidoustus and C. 
herbarum and light gray for L. corymbifera and A. nidulans 
(Figure S-1 ). The difficulties of recording Raman spectra using 
visible excitation wavelengths from such dark conidia were 
previously reported; the dark pigments result in a strong 
interferin? fluorescent signal, which masks the original 
spectrum. 7 Therefore, initially, the possibility of obtaining 
good quality spectra with UV-Raman from deeply colored, 
highly absorbing samples was investigated. For this purpose, 
wild-type A. fumigatus conidia were compared to non-
pigmented conidia of a strain with a mutation in the pksP 
gene, essential for the formation of the gray-green spores con-
taining dihydroxynaphthalene (DHN)-melanin.32 The UV-
Raman spectra of these samples are depicted in Figure 1. 
During the measurements, the samples were continuously 
rotated; however, this rotation was insufficient to completely 
eliminate the laser-induced degradation of spore proteins into 
polymeric hydrogenated amorphous carbon. Thus, a carbon 
background manifesting itself by the two broad bands at 
approximately 1360 and 1610 cm-1 is observed.39- 41 For the 
nonpigmented pksP mutant strain, the graphitization level was 
lower, and therefore the bands originating from the spores in 
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Figure 1. Mean UV-Raman spectra and their double standard 
deviation of the pigmented A. fumigatus ATCC 46645 strain and the 
nonpigmented pksP mutant strain. 
the region of 1500-1700 cm-1 are more prominent. However, 
the general shape of the spectra and the peak positions are the 
same for both samples. In the pigmented wild-type spores of A. 
fumigatus, the unique spore-related spectral features necessary 
for the spore identification process are still easily visible. 
Hence, it can be concluded that UV-Raman can be used for the 
measurement of highly pigmented spores. 
To compare a diverse range of allergenic fungi, we had to 
cultivate these organisms on several different media to 
promote sporulation due to different nutrient requirements. 
To test the variability induced by different culture media, we 
cultivated P. rubens strain ATCC 28089 and A. f umigatus strain 
ATCC 46645 on both MA and AMM medium for direct 
comparison. The mean UV-Raman spectra of the collected 
spores are presented in Figure S-2. The influence of the culture 
medium on the spectra was visible and can be best seen in the 
1250-1700 cm-1 wavenumber region. In the case of A. 
fumigatus grown on MA medium, the signal at 1365 cm-1 is 
more intense, whereas for P. rubens the peak at 1648 cm-1 is 
more prominent. Despite this observation, all strains grown on 
different agars were included into the classification model, 
proving that the differences from cultivation conditions are 
smaller than the differences due to species affiliation. 
The representative preprocessed mean Raman spectra of the 
studied fungal spores are depicted in Figure 2. 
For all species, primary bands were observed in the 
wavenumber region between 750 and 1700 cm-1, which is 
typically associated with various nucleic acids and protein 
subunits in UV-Raman spectroscopy. The band positions are in 
good agreement with previously published UV-Raman 
spectroscopic studies of microorganisms.24'23'42 The signal at 
1648 cm-1 can be assigned to thymine and the one at 1612 
cm-1 to the aromatic amino acids tyrosine and tryptophan. 
Guanine and adenine exhibit peaks at 1574 and 1479 cm-1; 
they also contribute to the signal at 1335 cm - 1• The latter band 
( at 1333 cm_,) also contains information from tyrosine. The 
signal at 1526 cm-1 can be assigned to cytosine. Thymine and 
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Figure 2. Mean UV-Raman spectra of the all batches from different 
fungal spores plotted together with donble standard deviation (gray 
area). For the A. fumigatus the mean spectrum represents all 
investigated strains. 
adenine exhibit a band at 1365 cm-1. The peak at 1171 cm-1 
can be assigned to tyrosine. Tryptophan exhibits characteristic 
bands at 758 and 1008 cm-1. In this study, measurements were 
performed on the bulk sample under continuous rotation; so 
several spores contribute to one spectrum. Therefore, one 
spectrum already comprises metabolic and developmental 
diversity within the spore population. The reproducibility of 
these spectra was tested by measuring the Raman spectra from 
three independent batches. 
It is evident from Figure 2 that the fungal spores belonging 
to different genera display distinct Raman spectral signatures 
and are easily distinguishable based on their spectra. The peak 
positions for all analyzed spores are the same, however the 
relative intensities for the bands in the region of 1250 and 
1750 cm-1 differ. For the C. herbarum and A. alternata 
measurements, three Raman modes at 1574, 1612, and 1648 
cm-1 are strongly convoluted due to a higher carbonization 
97.5% 
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JMRC:FSU:9682 SUP 
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background. In addition to a visual comparison, a PCA/LDA 
model was applied and verified using the leave-one batch-out-
cross-validation. Three different models on genus, species, and 
strain level were established (see Figure 3 ). Health hazards 
related to fungal spores may differ across genera and species 
due to the difference between allergenicity and types of 
mycotoxins produced. It is known for example that the severity 
of asthma exacerbation may vary between spores of different 
taxa. 6 To prevent exacerbations, it is important to define the 
composition of spores in the air on the genus level. Thus, the 
classification model was first trained to distinguish spores on 
the genus level. Prior to LDA, the data size was reduced by 
PCA The optimal number of PCs was chosen by finding a 
saturation point of the accuracy as a function of the number of 
PCs; in this case, 6 PCs were selected (Figure S-3). The LDA 
model was trained with 2 batches of spores and then tested 
with one independent batch of the same strain. This allowed 
for three different batch permutations for validation and gave a 
reliable unbiased classification model. The sensitivity, specific-
ity, and accuracy of the LDA model in each run were calculated 
and averaged. Table 1 shows the number of spectra that were 
classified correctly for each species of the fungi and also 
summarizes sensitivity and specificity. 
Out of 1079 spectra, 27 were misclassified; this resulted in 
97.5% accuracy. In Figure 4, the LDA score plot of the 
classification model is depicted, whereby each dot represents 
one spectrum and the ellipsoids correspond to confidence 
regions for the scores on a level of 95% of the spectral data for 
each class. The biggest amount of errors appeared to be due to 
the misclassification of Aspergillus species to the closely related 
genus Penicillium. The LDA score plot also nicely reflects the 
phylogenetic relationship between the different genera: A. 
alternata and C. herbarium belong to the same class of 
Dothideomycetes, while the closely related genera Penicillium 
and Aspergillus are grouped into the class Eurotiomycetes. The 
species L. corymbifera belongs to a lower group of fungi, the 
phylum Zy~omycota that diverged early in the evolution of 
true fungi. 4 
In the second step, the model distinguishes between four 
different Aspergillus species. Several Aspergillus species are able 
to cause infections like invasive pulmonary aspergillosis or 
allergic reactions like ABP A, while others are nearly non-
pathogenic.44 In addition, antifungal drug suscef tibility is 
wide-ranging among even quite similar organisms.4 Thus, the 
A.nidulans 
A89_AMM+Biotin 
A.niger CEAlO_AMM 
ATCC627S_AMM 
A.fumigatus ATCC4664S_AMM/MA 
A.ca/idoustus D141_AMM 
SF006S04_AMM 
Figure 3. 3-Level PCA/LDA classification model of fungal spores cultured in three independent batches ( the percentage represents the accuracies 
of the model achieved by LBOCV). 
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Table 1. Identification Results for Different Fungal Spores on the Genus Level 
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" "' ·= -~ :: .. :::: "' Predicted -~ " ., -§ 
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'I:' u 
Altenaria alternata 90 0 0 
Aspergillus species 0 603 0 
Cladosporium herbarwn 0 4 90 
Lichtheimia corymbifera 0 0 0 
Penicillium rubens 0 22 0 
Figure 4. LDA score plots for the classification model on the genus 
level. 
knowledge of the species identity may influence the choice of 
appropriate antifungal therapy. The visual differentiation of the 
spectra from A. f umigatus, A. nidulans, A. calidoustus, and A. 
niger is already not as obvious as it was for different genera 
(Figure 2 ). For building the identification model on the species 
level, the number of PCs was set to 7 (Figure S-4). All 629 
spectra were assigned correctly resulting in 100% accuracy. 
The differentiation was based mostly on the different amount 
of DNA in the spores, mainly resulting in the intensity 
differences for the peaks at 1365, 1479, and 1648 cm-1 (Figure 
S-5). The achieved accuracy was higher than the one reported 
by P.E.B. Verwer et al., where the discrimination of Aspergillus 
lentulus from Aspergillus fumigatus with VIS-Raman spectros-
copy was correct for 78% of spectra.17 
Finally, the model was trained to classify three different 
strains of A. f umigatus, since diversity in virulence among 
different A. fumigatus strains is also well-docurnented.46 The 
UV-Raman spectra of the three investigated A. fumigatus 
strains are presented in Figure 5. By comparing the spectra, it is 
clear that the main spectral characteristics of the investigated 
strains were the same, as a consequence of their close 
phylogenetic relationship. The LDA model was built with 10 
PCs (Figure S-6), and the classification was correct for 89.4% 
of spectra. The results of this classification model are 
summarized in Table 2. The misclassification occurred mostly 
between the ATCC 46445 and D 141 strains. The identification 
of fungal spores on the strain level using Raman spectroscopy 
was not previously reported. 
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Figure 5. Mean UV-Raman spectra of three A. fumigatus strains. 
Table 2. Results of the Identification of A. fumigatus Strains 
lfl .... 
"' "' .... Sensitivity, % Specificity,% u = u :;: :;;: f- Q d < u 
ATCC46645 151 I 8 83.89 94.97 
CEAJO 6 89 0 98.89 97.77 
D141 23 0 81 91.01 91.48 
CONCLUSIONS 
In the case of respiratory fungal infections, identification of the 
fungal agent is often incredibly challenging due to a diverse 
array of potential organisms and relatively poor diagnostic 
possibilities. Thus, the development of sensitive and automated 
methods for the identification of fungal spores is of particular 
medical interest. In this study, a combination of UV resonance 
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Raman spectroscopy and chemometrical methods allowed for a 
highly accurate identification of fungal spores on a genus, 
species, and even strain level. In all analyzed classification 
models, strains grown on different agars were included. The 
promising results presented here indicate that the differ-
entiation of spectra is not determined by the cultivation 
conditions, but instead based on the differences in the amounts 
of DNA, RNA, and protein aromatic amino acid units in spores 
of each species. Moreover, it has been demonstrated that 
darkly colored spores can be directly examined with UV-
Raman spectroscopy, and the contribution of amorphous 
carbon in the spectra does not inhibit the correct identification 
of the spores. The obtained classification ratios in the range 
between 89% and 100% demonstrate that UV resonance 
Raman spectroscopy represents a powerful tool for fungal 
spore identification and should be considered for further 
investigations. 
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Table S-1. Strains used in the study 
Organism Strain Growth Media 
Aspergillus fumigatus CEAIO AMM 
Aspergillus fumigatus ATCC 46645 MA/AMM 
Aspergillus fumigatus ATCC 46645 with pksP mutation AMM 
Aspergillus fumigatus D141 AMM 
Aspergillus calidoustus SF006504 AMM 
Aspergillus niger ATCC 6275 AMM 
Aspergillus nidulans A89 AMM1 
Cladosporium herbarum ATCC MYA-4682 MA/AMM 
Alternaria alternata ATCC 66981 AMM 
Penicillium rubens ATCC 28089 MA/AMM 
Lichtheimia corymbifera JMRC:FSU:9682 SUP 
* AMM = Aspergillus minimal media; AMM1= AMM +Biotin +Arginine; MA= Malt Agar; SUP= SUP-
modified Media 
P.rube11s 
ATCC 28089 
A.fumigatus 
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A.fumigatus 
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A.niger A.calido11st11s 
ATCC 6275 ATCC 6275 
C.llerbarum A.altemata L.corymbifera A.11id11la11s 
ATCC MYA-4682 ATCC 66981JMRC:FSU:9682 A89 
Figure S-1. Images of dried spore biomass from the studied fungal species on the fused silica substrate. 
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Figure S-3. Accuracy as a function of the number of PCs for the genus level. 
S-3 
7 PUBLICATIONS 
60 
100 
95 
90 
0 
iS 
85 
::l 
(.) 
(.) 
<( 80 
75 
70 
0 5 10 15 20 25 
PCs 
-- Leave-one spectrum out-C 
--+- Leave-one batch out-CV 
30 35 40 45 50 
Figure S-4. Accuracy as a function of the number of PCs for the species level. 
Cl) 
Q) 
:::::l 
ro 
> 
0) 
C 
i5 
ro 
0 
....J 
LD3 
LD2 
LD1 
500 750 1000 1250 1500 1750 
Wavenumber, cm-1 
Figure S-5. Loading vectors for the species level model. 
S-4 
 61 
7.1  UV-Raman spectroscopic identification of fungal spores important for respiratory diseases [OZ1] 
 
  
100 
95 
90 
85 
0 80 
1S 75 ro 
:i 
u 70 u 
<( 
65 
60 
55 
50 
0 5 10 15 20 25 
PCs 
--Leave-one spectrum out-C 
--Leave-one batch out-CV 
30 35 40 45 50 
Figure S-6. Accuracy as a function of the number of PCs for the strain level. 
S-5 
7 PUBLICATIONS 
62 
7.2 Towards Raman spectroscopy of urine as a screening tool [OZ2] 
Olga Žukovskaja, Oleg Ryabchykov, Maria Straßburger, Thorsten Heinekamp, Axel A. Brakhage, 
Christopher Hennings, Christian Hübner, Michael Wegmann, Dana Cialla-May, Thomas W. Bock-
litz, Karina Weber, Jürgen Popp 
 
Submitted to Journal of Biophotonics (16.04.2019). 
 
Declaration on authorship and copyright in a cumulative doctoral thesis 
1Olga Žukovskaja, 2Oleg Ryabchykov, 3Maria Straßburger, 4Thorsten Heinekamp, 5Axel A. 
Brakhage, 6Christopher Hennings, 7Christian Hübner, 8Michael Wegmann, 9Dana Cialla-May, 
10Thomas Bocklitz, 11Karina Weber, 12Jürgen Popp 
Involved in 
 1 2 3 4 5 6 7 8 9 10 11 12 
Conceptual research design X X       X X X X 
Planning of research activi-
ties 
X  X X X X X X X X X X 
Data collection X            
Data analyses and interpre-
tation 
X X        X   
Manuscript writing X X       X X X X 
Suggested publication 
equivalence value 
1.0 0.5           
 
 
  
 63 
7.2  Towards Raman spectroscopy of urine as a screening tool [OZ2] 
 
Author Contribution  
  
Olga Žukovskaja 
concept development  
Raman spectroscopic measurements 
data analysis and interpretation 
writing of manuscript  
Oleg Ryabchykov 
data analysis and interpretation  
proofreading of manuscript 
Maria Straßburger 
establishing of aspergillosis mouse model 
proofreading of manuscript 
Thorsten Heinekamp 
establishing of aspergillosis mouse model 
proofreading of manuscript 
Axel A. Brakhage 
establishing of aspergillosis mouse model 
proofreading of manuscript 
Christopher Hennings 
establishing of kidney disorders mouse model 
proofreading of manuscript 
Christian Hübner 
establishing of kidney disorders mouse model 
proofreading of manuscript 
Michael Wegmann 
establishing of asthma mouse model 
proofreading of manuscript 
Dana Cialla-May 
discussion of experimental concept and results  
proofreading of manuscript 
Thomas W. Bocklitz 
discussion of data analysis concepts and results  
proofreading of manuscript 
Karina Weber 
discussion of experimental concept and results  
proofreading of manuscript 
Jürgen Popp 
project management  
discussion of concepts and results  
discussion and proofreading of manuscript  
 
  
7 PUBLICATIONS 
64 
Towards Raman spectroscopy of urine as screening tool 
Olga Zukovskaja,a,b,c Oleg Ryabchykov, a,c Maria StraBburger,d Thorsten Heinekamp,d Axel A. 
Brakhage,ct,e J. Christopher Hennings,r Christian A. Hiibner,r Michael Wegmann,g,h Dana Cialla-
May, a,b,c Thomas W. Bocklitz,a,c Karina Weber *a,b,c and Jurgen Popp a,b,c 
• Institute of Physical Chemistry and Abbe Center of Photonics, Friedrich Schiller University Jena, Helrnholtzweg 4, 
07745 Jena, Germany; 
b Research Campus Infectognostic, Philosophenweg 7, 07743 Jena, Germany; 
0 Leibniz Institute of Photonic Technology Jena - Member of the research alliance "Leibniz Health Technologies", 
Albert-Einstein-Str. 9, 07745 Jena, Germany; 
d Leibniz Institute for Natural Product Research and Infection Biology, Hans-Knoll-Institute, Beutenbergstr. 1 la, 
07745 Jena, Germany; 
0 Institute of Microbiology, Friedrich Schiller University Jena, D-07743 Jena, Germany 
r Institut fiir Humangenetik, Universitatsklinikum Jena, Am Klinikum 1, 07747 Jena, Germany; 
g Division of Asthma Exacerbation & Regulation, Program Area Asthma & Allergy, Leibniz-Center for Medicine 
and Biosciences, - Member of the research alliance "Leibniz Health Technologies", Parkallee 1-40, 23845 Borstel, 
Germany; 
h Airway Research Center North (ARCN), Member of the German Center for Lung Research, Borstel, Germany 
* Corresponding author: karina.weber@leibniz-ipht.de 
Abstract 
For the screening purposes urine is an especially attractive biofluid, smce it offers easy and 
non-invasive sample collection and provides a snapshot of the whole metabolic status of the 
organism, which may change under different pathological conditions. Raman spectroscopy (RS) 
has the potential to monitor these changes and utilize them for disease diagnostics. The current 
study utilizes mouse models aiming to compare the feasibility of the urine based RS combined 
with chemometrics for diagnosing kidney diseases directly influencing urine composition and 
respiratory tract diseases having no direct connection to urine formation. The diagnostic models 
for included diseases were built using principal component analysis with linear discriminant 
analysis and validated with a leave-one-mouse-out cross-validation approach. Considering kidney 
disorders, the accuracy of 100 % was obtained in discrimination between sick and healthy mice, 
as well as between two different kidney diseases. For asthma and invasive pulmonary 
aspergillosis achieved accuracies were noticeably lower, being, respectively, 77.27 % and 
78.57 %. In conclusion, our results suggest that RS of urine samples not only provides a solution 
for a rapid, sensitive and non-invasive diagnosis of kidney disorders, but also holds some 
promises for the screening of non-urinary tract diseases. 
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Introduction 
Screening is the process by which unrecognized diseases or defects are identified, using 
tests, which can be applied rapidly for large numbers of people. In this context, the 
analysis of bio:fluids is particularly attractive, because they are rich in biochemical and 
biological information, offer minimal or non-invasive collection of samples and give a 
possibility to perform multiple screening tests. The rise in metabolomics demonstrated 
that metabolic profile of bio:fluids changes due to different pathological conditions and 
those changes can be utilized for diagnostic purposes.[1-3] Thus, there is a continuing 
effort devoted to the exploration of new technologies that can rapidly detect those 
changes. 
In this field, Raman spectroscopy (RS) is a promising technique, since it provides a 
spectral "fingerprint" of the sample under investigation, which represents a snapshot of 
the biomolecular composition of the sample. Combining RS with multivariate statistical 
analysis, even minimal spectral changes from the 'normality' can be detected and 
correlated with the certain disease.[4-6] Moreover, it offers rapid and non-destructive 
analysis with minimal or no sample preparation, which is highly beneficial for the 
screening test. The literature provides numbers of examples of the successful application 
of bio:fluid based RS for screening of various cancer types, some infections and 
neurological diseases. [7-11] Blood serum and plasma samples are the most often used 
ones, because they provide an overview of the whole organism health status. However, 
some researchers assure that other bio:fluids, like urine, saliva or sputum, also should not 
be neglected. Among them urine is of high interest, because it allows a complete non-
invasive sample collection procedure with no discomfort for the patient and it contains 
many metabolites, which physicochemical properties may vary due to some diseases.[12, 
13] 
RS of urine in terms of disease screening was rather slightly investigated and only few 
reports are available. Few studies performed RS analysis of urine aiming to assess the 
developing of kidney disease in patients with diabetes and hypertension. For this, 
quantitative information regarding important urine biomarkers (urea, creatinine, and 
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glucose) was obtained from Raman spectra and with a help of statistical models correlated 
with the renal impairment and other complications.[14-16] Except of this, RS based 
'metabolic fingerprinting' of urine was used only for the screening of oral and breast 
cancer.[17, 18] Therefore, to assess the potential of urine based RS as a screemng 
technique more precisely, a broader range of diseases should be investigated. 
In this study, urine samples were considered for the RS based diagnosis from two 
groups of pathological states established in animal models. The first group included 
diseases in direct connection to the urine formation, namely, distal renal tubular acidosis 
(dRTA) and reversible nephrogenic diabetes insipidus (NDI) elicited by pharmacological 
intervention with excessive Lithium intake. Both disease states relate directly to the urine 
composition. NDI is characterized by the inability to concentrate the urine efficiently, 
leading to polyuria (excessive urine production) and polydipsia (excessive thirst),[19] 
while dRTA is characterized by defective renal acid-base regulation and as a result less 
acidic urine.[20] The second group considered diseases which possess no direct 
connection to the urine formation, namely, asthma and infection with Aspergillus 
fumigatus causing invasive pulmonary aspergillosis. Asthma is a chronic inflammatory 
disorder, which affects 339 million people in all regions of the world[21] and aspergillosis 
is a life-threatening fungal infection predominantly affecting immunocompromised 
patients.[22, 23] For both diseases, the access to easy screening test could lead to early 
intervention and better disease management. 
The aim of this study is to investigate and compare the potential of urine based RS for 
the diagnosis of the mentioned diseases. Here, animal models were utilized, since they 
allow controlling the experiment parameters employing a defined model, before starting 
with a clinical study. Classification models were built using principal component analysis 
(PCA) followed by linear discriminant analysis (LDA) and evaluated with a leave-one 
mouse-out cross-validation (LOMOCV). The presented results identify that, although 
urine based RS are more suitable to diagnose diseases having direct and specific 
correlation with urine composition, spectroscopic screening of other diseases holds some 
potential as well. 
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Materials and methods 
Animals. The urine samples of mice used within this study were provided from three 
different laboratories. All animals were cared for in accordance with the European animal 
welfare regulation and all experiments were approved by the responsible local authorities 
of Thuringia or Schleswig-Holstein States of Germany. All mice, except of the ones with 
DRTA disease, were supplied by Charles River, Germany. A brief description about the 
animals and treatment protocols is provided in Table 1. 
T bi 1 D a e escnptlon o t emcu e fh. ldd mice mo d 1 e s. 
Model Groups Treatment Mice type Age 
Number 
of mice 
Control no C57BL/6J 3 months 4 ., 
;,-. .. 
Nephrogenic diabetes 1 week with 40 mM LiCl- and 3 weeks " .. = "Cl C57BL/6J 3 months 4 "Cl .. insipidus (ND I) with 60 mM Li Cl-supplemented diet ~i Distal renal tubular 0.14 M Sodium bicarbonate during the first 
Atp6v0a4-deficient 2.5 months 10 
acidosis (dRTA) 2 months of age 
·! Control Immunosuppression with cortisone acetate CD-1 mice 6-8 weeks 4 .s = .... 
" Immunosuppression with cortisone acetate i:,. Aspergillosis CD-1 mice 6-8 weeks 10 .,< + exposure to A. fumigatus conidia 
., Control Injection of PBS BALB/c 6-8 weeks 11 e 
! Asthma Injection of OVA BALB/c 6-8 weeks 11 
Exposure to 1 % OVA aerosol 
Kidney disorder models (NDI and dRT A). NDI in mice was induced according to Trepiccione 
et al.[24] Briefly, mice were fed a diet containing 40 mM/kg LiCl for one week and then 60 
mM/kg LiCl for three weeks. Control mice received a LiCl-free mouse chow with otherwise 
identical ingredients. Water was provided ad libitum. As model of dRTA Atp6v0a4-deficient 
mice were used. Generation of those mice is described in Hennings et al.[25] For all mice urine 
was collected during 24 h using metabolic cages, frozen immediately after collection and stored 
at -80°C. 
Invasive Pulmonary Aspergillosis model. Mice were immunosuppressed with two single doses 
of 1 g/kg body weight cortisone acetate (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany), 
which were injected intraperitoneally (i.p.) three days before and immediately prior to infection 
with A. fumigatus. Afterwards the mice were anesthetized intraperitoneally by an anesthetic 
combination of midazolam, fentanyl, and medetomidine. 2 x 105 conidia in 20 µl PBS were 
applied to the nares of the mice. Anesthesia was terminated by subcutaneous injection of 
flumazenil, naloxon and atipamezol. The infected animals were monitored at least twice a day 
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and humanely sacrificed if moribund ( defined by severe lethargy, severe dyspnea, or 
hypothermia). A group of PBS infected mice served as control. Pathological changes in the lungs 
were recorded during postmortem analysis. The spontaneous urine was collected in sterile Petri 
dishes during the handling or invasively after sacrification. The urine samples were frozen 
immediately after collection and stored at -80°C. 
Asthma mouse model. Mice were sensitized by i.p. injection of Ovalbumin (OVA) (Grade VI; 
Sigma-Aldrich Chemie GmbH, Munich, Germany) adsorbed to aluminium hydroxide (Imject 
Alum Adjuvant, Thermo Scientific Inc., Pierce Biotechnology, Rockford, IL, USA) in 200 µL 
sterile Dulbecco's phosphate-buffered saline (PBS) on days 1, 14, and 21 as described 
previoulsy.[26] The control group received sterile PBS via i.p. injection at the indicated time 
points. In order to induce allergic airway inflammation and formation of experimental allergic 
asthma, sensitized mice were subsequently exposed to a 1 % OVA-aerosol (1 % w/v in PBS) on 
days 26 to 28. The spontaneous urine was collected in sterile Petri dishes after one, five and nine 
days after exposure to 1 % OVA-aerosol, frozen and stored at -80°C. 
Spectral acquisition. After passive thawing, raw urine samples were subjected to Raman 
spectroscopy by analyzing two separated droplets of 2 µ1 of the sample deposited on a calcium 
fluoride slide and letting them dry at room temperature. Raman spectra were recorded using a 
Renishaw in Via Raman system equipped with 785 nm excitation laser and using a 1200 lines/mm 
grating. The samples were illuminated via a microscope equipped with a 50x magnification 
objective (Leica) with a numerical aperture of 0.75. The laser power at the laser head was ea. 
300 mW. For every sample 3 scans of different areas of the dried droplets were performed with a 
step size of 20 µm, resulting in ea. 1200 spectra per sample. The integration time for every 
spectrum was 2 s. 
Data Analysis. Prior to the statistical analysis, the spectra were preprocessed in order to improve 
the robustness and stability of the results.[27] The data processing was performed using an in-
house developed script in the programming language R.[28] First, we removed the most 
corrupted spectra which contained signal intensities larger than upper limit of the detector range. 
These removed spectra featured either extremely large fluorescence background or highly intense 
cosmic ray spikes. After removing the most corrupted spectra, the wavenumber axis was 
calibrated using the Raman spectrum of the standard 4-acetamidophenol, which were collected on 
each day of measurement.[29] The calibrated Raman spectra were background corrected using 
the sensitive nonlinear iterative peak (SNIP) clipping algorithm with a second-order clipping 
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filter.[30] Next, all spectra were vector normalized and used as input for a PCA, which was 
performed to reduce the dimensionality of the data while retaining the most significant 
information for classification. The PCA was followed by a LDA.[31] The performance of the 
created LDA model for the classification of healthy and disease samples was estimated using a 
leave-mouse-out-cross-validation (LMOCV) approach.[32] In this method, the spectra of a 
mouse were held out from the data set, and the LDA model was redeveloped using the remaining 
spectra. The resultant model was then used to predict the spectra of the removed mouse. This 
process was repeated with every mouse until all spectra were classified. A LMOCV of a PCA-
LDA model was performed for number of principle components (PCs) from 1 to 50. Then, an 
optimal number of PCs was chosen by finding a saturation point of the accuracy as a function of 
the PC number (see Figures S1, S2, S3, S4 in the supplementary material). For spectral 
comparison across the groups, mean Raman spectra for each group were calculated using 
preprocessed, normalized spectra of all samples. 
Results and discussion 
The urine of healthy individuals consists primarily of water (approximately 96 %) with 
high concentrations of urea (from amino acid metabolism), inorganic salts ( chloride, 
sodium, and potassium), creatinine, ammonia, organic acids, various water-soluble toxins 
and pigmented products of hemoglobin breakdown, including urobilin, which gives urine 
its characteristic color.[33] Since some variations in the urine composition can be brought 
by diet and hydration level of the individual, for this proof of concept study we utilized an 
animal model, which allows having more defined and controllable experimental 
parameters. The disease models presented here were established in different laboratories 
using different types of mice. Moreover, for asthma and aspergillosis models even not sick 
mice were somehow treated to be a proper control. Therefore, to evaluate if it is possible 
to analyze all models together, firstly, the urine samples from the control groups of the 
mice were compared. To collect a large amount of spectra from each sample, thereby 
characterizing their intrinsic heterogeneity, Raman spectral mapping was performed. 
Figure 1 (a) shows the mean Raman spectra obtained for each control group. For all mice 
the most prominent component in the urine Raman spectra is urea, which exhibits an 
intensive band around 1003 cm-1 and bands at 589, 1162, 1605 cm-1• The peaks at 839 and 
1046 cm-1 can be assigned to creatinine, while the Raman peaks at 872 and 1076 cm-1 may 
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be attributed to nitrogenous compounds.[34, 35] Comparing mean Raman spectra among 
the mice groups, one can notice that spectral variations for the control mice for kidney 
disorder model were much lower. For this, two reasons can be pointed out: firstly, those 
mice were healthy and had no treatment and, secondly, their urine was collected in 
metabolic cages during 24 h. Thus, variations in urine composition are balanced over the 
day. Control mice for asthma and aspergillosis models were somehow treated and mice 
included in those groups could react different to the treatment, which could affect the 
urine composition and subsequent spectral deviations. 
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Figure 1 (a) Mean Raman spectra of the urine samples obtained from control mice for different disease models 
together with the standard deviation (SD) (shaded area); (b) Difference spectra between the mean urine spectra of 
control mice for different disease models with SD of the groups. 
To better highlight differences between control mice of different models, difference 
spectra have been generated and are shown in Figure 1 (b).One can observe that there are 
clear differences between different models, particularly when it comes to peak intensities. 
To support visual comparison, advanced multivariate data analysis was applied. Here, 
firstly, the data was reduced by a PCA using 11 PCs ( Figure S1) and, next, LDA was 
performed. In order to evaluate the PCA-LDA model a leave-mouse-out-cross-validation 
(LMOCV) was applied. Thereby, the data from one mouse was removed from the data set 
and the LDA model was trained with the remaining data. The spectral data of the taken 
out mouse was subsequently predicted. This allowed for different mouse permutations for 
validation and gave a reliable unbiased classification model. Table S1 shows that perfect 
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classification accuracy for mice from different models was achieved. This leads to the 
conclusion that the control mice of the included models are very different and it is not 
correct to evaluate different disease models together, since the potential discrimination 
might be caused not by differences in diseases but by other factors. Therefore, three 
disease models were considered separately. 
The kidney disorder cohort included healthy mice and mice with two different kidney 
disease states. Four mice, due to nutrition with LiCl-supplemented diet, developed NDI 
and 10 other mice were Atp6v0a4 deficient, resulting in dRTA. Figure 2 (a) demonstrates 
the mean urine spectra for healthy mice and the ones having one of two kidney disease 
states, while in the Figure 2 (b) difference spectra among those groups are depicted. From 
the difference spectra it is obvious that urine from mice with induced kidney problem or 
dR TA have a lower urea concentration but higher concentration of other components. 
Urine from mice with Atp6v0a4 deficient mice was less acidic and contained more 
proteins, especially albumin.[25] Therefore, peaks around 835 and 1404 cm-1, which are 
clearly more intensive for the dR TA mice, can be tentatively assigned to protein 
compounds. 
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Figure 2 (a) Mean Raman spectra of the urine samples obtained from control mice and the ones having NDI or 
dRTA, plotted together with the standard deviation (SD) (shaded area); (b) Difference spectra between the mean 
urine spectra of mice with kidney disorders and control ones with SD of the groups. 
To get more objective and automatic differentiation of the discussed kidney disorders, 
the already introduced PCA-LDA model was used. Here, the number of PCs was set to 6 
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(Figure S2). Because the PCA/LDA model assigns the spectra individually, firstly, the 
classification on spectral level was performed and after evaluation of the model with 
LMOCV resulted in overall accuracy of 95.85 % (Table S2). However, ultimately, the 
goal of the study is to determine an individual health status of a mouse. Therefore, the 
initial results must be aggregated in order to predict the disease at the mouse level. Here, a 
procedure must be applied to combine the predictions on the spectra level to a mouse level 
prediction. Within this study a voting scheme was utilized, which uses a threshold on the 
relative frequency of predictions. We used 50 % as threshold; thus, a single mouse is 
classified as healthy or sick if at least 50 % of its spectra are assigned to that group. The 
results of such classification on mouse level are shown in Table 2 . Although the cohort 
size is limited, the classification accuracy is 100 % for differentiating between healthy and 
sick mice, as well as between NDI and dRTA mice. This indicates that urine based RS can 
not only successfully diagnose kidney disease states but also provide more exact diagnosis 
within the wide spectrum of them. 
Table 2 Results of the mouse level classification model for kidney disorders evaluated with LMOCV. 
True 
Control NDI dRTA Sensitivity Specificity 
"Cl Control 4 0 0 100% 100% .. .... 
:a NDI 0 4 0 100% 100% .. .. 
dRTA 0 0 10 100% 100% 
Such good results for the kidney disorder model were rather expectable, since it is 
known that those diseases directly influence the composition of urine and changes therein 
can be depicted with RS. More intriguing is the question whether RS of urine can provide 
enough information for the diagnosis of diseases with no direct connection to kidney 
function. To answer that question two mouse models of respiratory tract disorders were 
used. Firstly, aspergillosis infection was considered. Similar as before, the analysis started 
from having a look on the mean urine spectra from control and with A. fumigatus infected 
mice, which are depicted in Figure 3 (a), as well as on their difference spectrum shown in 
Figure 3 (b ). The mean spectra for those two groups are very similar in general spectral 
shape and peak positions. From Figure 3 (b) one can easily notice that the difference 
spectrum is less intense comparing with the ones for the kidney disorder model. 
Moreover, it is few times lower than spectral variations within the group, which are 
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demonstrated by the standard deviations (SD) and originate from the intra- and inter-
sample heterogeneity. Therefore, here more than ever, the application of multivariate 
statistical analysis for the classification is required. 
(a) 
I 0.025 
600 600 1000 1200 1400 1600 
b Wavenumber, cm·1 
( ) Difference spectra between mice in aspergillosis model: 
·f 0.06 SO for aspergillosis m· e 
c SO for control mice 
C 0-03 Aspergillosis 
J o.oo+-~---~~-~----1 i -0.0J Control 
j-0.06 
600 800 1000 1200 1400 1600 
Wavenumber, cm·1 
Figure 3 (a) Mean Raman spectra of the urine samples obtained from control and aspergillosis mice, plotted together 
with the standard deviation (SD) (shaded area); (b) Difference spectrum between the mean urine spectra of mice with 
aspergillosis and control ones (black solid line), plotted together with SD of both groups (shaded areas). 
To build a classification model 11 PCs were selected (Figure S3) and the final results 
on spectral level are shown in Table S3 and on mouse level in Table 3. It can be seen that 
for two mice false positive diagnosis took place, meanwhile one sick mouse was 
misclassified as healthy, which led to 50 % sensitivity and 90 % specificity of the model. 
Thought for the screening techniques higher specificity is in favour, since it guarantees 
that no disease cases will be missed, a sensitivity of 50 % is critical, because it leads to 
unnecessary stress for individuals and increased costs for subsequent more precise 
diagnostic tests. 
Table 3 Results of the mouse level classification model for aspergillosis infection evaluated with LMOCV. 
True 
Control ~perglllosh Sensitivity Specificity 
-0 Control 2 1 50.00 % 90.00 % ., .... ., 
:a ., 
"" Asperglllosls 2 9 90.00 % 50.00 % 
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Trying to find the reason for the false negative result for one mouse the medical 
information for the infected mice were rechecked and it appeared that this mouse, 
although it was infected with A. fumigatus conidia, did not show any signs of the 
infection, which was proved by pathological check of the lungs. The same happened with 
one more mouse but it still was classified correctly. Additionally one mouse developed 
only light infection. Knowing those facts could be presumed that built classification model 
got confused due to presence of not sick or lightly sick mice in the aspergillosis group. To 
check this hypothesis these three mice were excluded from the data set and the model was 
rebuilt for the remaining really sick mice. For building the LDA model 7 PCs were used 
(Figure S4) and after the evaluation with LMOCV the accuracy of 100 % on mouse level 
was reached (Table S4 ). 
Finally, the RS was utilized for the asthma model. The potential of RS to diagnose 
asthma was demonstrated for blood serum samples with achieved 80.6 % accuracy 
discriminating between healthy people and patients with mild asthma.[36] However, the 
use of urine would be even more beneficial, especially for children, due to easy collection 
and possibility for multiple testing. For this study mouse urine samples were collected 1, 5 
or 9 days after allergen exposure. The mean Raman spectra of control mice and the ones 
with induced asthma are demonstrated in Figure 4 (a), followed by the difference 
spectrum between the groups shown in Figure 4 (b ). Similarly as for the aspergillosis 
model, the difference spectrum is lower than the SD of the both groups and visual 
comparison of the spectra is not suitable for the discrimination of asthmatic mice. 
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Figure 4 (a) Mean Raman spectra of the urine samples obtained from control mice and mice with asthma, plotted 
together with the standard deviation (SD) (shaded area); (b) Difference spectrum between the mean urine spectra of 
mice with asthma and control ones (black solid line) plotted together with SD of the both groups ( shaded areas). 
A LDA classification model was created with 7 PCs ( Figure S5) and the results 
achieved after evaluation with LMOCV are summarized in Table S5 on spectral level and 
in Table 4 for each mouse. It can be seen that three control mice were classified as sick 
and two sick mice were assigned to the healthy ones. This resulted in sensitivity of 
72.73 %, specificity of 81.82 % and final model accuracy of77.27 %. 
Table 4 Results of the spectral level classification model for aspergillosis infection evaluated with LMOCV. 
True 
Control Asthma Sensitivity Specificity 
-0 Control 8 2 72.73 % 81.82% .. 
t: :a .. .. Asthma 3 9 81.82 % 72.73 % 
To check, which exactly mice were misclassified, the percentage of correctly classified 
spectra per mouse was calculated and presented in the Table S6. It can be seen that urine 
collected after the first day after exposure to the allergen, provided correct diagnosis for 
all mice, while one false negative classification appeared using urine of the fifth day and 
the second mistake using urine of the ninth day. This somehow correlates with medical 
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prognosis of asthma, which states that severe allergic reaction is most possible during first 
days after the contact with allergens and with the time organism starts to recover. 
However, to evaluate such correlation, a more detailed study is required involving much 
larger cohorts of subjects. 
Conclusions 
Within this study the applicability of urine based RS for diagnosis of kidney and 
respiratory tract diseases was investigated utilizing mouse models. Raman spectra were 
acquired from unprocessed dried urine samples and a PCA-LDA model was built. To 
ensure the reliability of the results the model was validated using a LMOCV approach. 
Considering kidney disorders perfect classification was achieved not only for 
distinguishing between healthy and sick mice but also for identifying the exact kidney 
disease from two included in the model. Such good results can be explained by the direct 
connection of kidney function to urine composition. For respiratory tract diseases, which 
included aspergillosis and asthma, already worse results were achieved reaching 78.57 % 
and 77.27 % accuracies, respectively. However, for both models occurred false negative 
results could be up to some level explained from medical data of mice, such as not 
developing of the infection in mice infected with A. fumigatus or possible recovery from 
the allergic asthma with time. Overall promising results were obtained, and more detailed 
clinical studies in this direction should be considered to develop urine based RS as a 
screening tool and path the way for further Raman based disease diagnostics. 
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Figure S1. PCA/LDA model accuracy as the function of PCs for control mice from different disease models.
Table S1. Results of the mouse (spectral) level classification model for control mice for different diseases evaluated with 
leave-one mouse-out-CV.
Figure S2. PCA/LDA model accuracy as the function of PCs for kidney disorder model. 
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Table S2. Results of the spectral level classification model for kidney disorders evaluated with LMOCV. 
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Figure S3. PCA/LDA model accuracy as the function of PCs for aspergillosis model. 
Table S3. Results of the spectral level classification model for aspergillosis evaluated with LMOCV. 
True 
Control AspergiUosis Sensitivity,% Specificity, % 
"C Control 10989 11119 47.95 71.76 ... ... 
"C 
lo. AspergiUosis 11930 28253 71.76 47.95 i=.. 
 83 
7.2  Towards Raman spectroscopy of urine as a screening tool [OZ2] 
100 
90 
80 
t!. 70 
>, 
'-' 60 
:::J 
'-' 50 '-' <( 
40 
30 
20 
0 
7 PCs 
Leave-one spectrum-out-CV 
- Leave-one mouse-out-CV 
5 10 15 20 25 30 35 40 45 50 
PCs 
Figure S4. PCA/LDA model accuracy as the function of PCs for aspergillosis model including only very sick mice. 
Table S4. Results of the mouse (spectral) level classification model for aspergillosis including only very sick mice 
evaluated with LMOCV. 
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Figure SS. PCA/LDA model accuracy as the function of PCs for asthma model. 
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Table S5. Results of the spectral level classification model for aspergillosis evaluated with LMOCV. 
True 
Control Asthma Sensitivity, % Specificity, % 
"Cl Control 18094 6228 73.39 74.42 -c.; ... 
"Cl - Asthma 6562 18118 74.42 73.39 =-
Table S6. Results of the classification for every mouse for the asthma model using leave-one mouse-out-CV. 
Percentage of correctly Mouse diagnosis 
Mouse classified spectra per mouse, according to the 
% RS 
Day 1 5077 95.76 Healthy 
Day 1 5078 42.04 Sick 
Day 1 5079 100 Healthy 
Day 1 5080 99.95 Healthy 
Day5 5141 99.40 Healthy 
Control Day5 5143 74.37 Healthy 
Day5 5144 66.6 Healthy 
Day9 5117 49.52 Sick 
Day9 5118 30.73 Sick 
Day9 5119 94.49 Healthy 
Day9 5120 67.89 Healthy 
Day 1 5081 77.78 Sick 
Day 1 5082 100 Sick 
Day 1 5083 100 Sick 
Day 1 5084 98.05 Sick 
Day5 5146 89.6 Sick 
Asthma Day5 5147 0.47 Healthy 
Day5 5148 69.49 Sick 
Day9 5121 99.44 Sick 
Day9 5122 71.24 Sick 
Day9 5123 8.74 Healthy 
Day9 5124 65.23 Sick 
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Abstract: Pyocyanin (PYO) is a metabolite specific for Pseudomonas aeruginosa. In the case of 
immunocompromised patients, it is currently considered a biomarker for life-threating Pseudomonas 
infections. In the frame of this study it is shown, that PYO can be detected in aqueous solution by 
employing surface-enhanced Raman spectroscopy (SERS) combined with a microfluidic platform. 
The achieved limit of detection is 0.5 µM. This is ~2 orders of magnitude below the concentration of 
PYO found in clinical samples. Furthermore, as proof of principle, the SERS detection of PYO in the 
saliva of three volunteers was also investigated. This body fluid can be collected in a non-invasive 
manner and is highly chemically complex, making the detection of the target molecule challenging. 
Nevertheless, PYO was successfully detected in two saliva samples down to 10 µMand in one sample 
at a concentration of 25 µM. This indicates that the molecules present in saliva do not inhibit the 
efficient adsorption of PYO on the surface of the employed SERS active substrates. 
Keywords: SERS; pyocyanin; microfluidics; diagnosis; artificial sputum 
1. Introduction 
Increasing antibiotic resistance impedes the successful treatment of infections, such as pneumonia 
or tuberculosis. This leads to longer hospital stays, higher medical costs and increased mortality [l ]. 
Therefore, it is essential to identify the exact pathogen prior to the antibiotic treatment. 
Pseudomonas aeruginosa is an important gram-negative bacterium and is the leading cause of 
respiratory tract infections in the case of patients with compromised host defense mechanisms. 
Therefore, this pathogen is responsible for the highest rates of acquired infections in intensive-care 
units [2]. Because of its intrinsic ability to develop antibiotic resistance, to form impenetrable biofilms 
and to release a large arsenal of virulence factors [3], P. aeruginosa is one of the greatest therapeutic 
challenges, and rapid detection, as well as the selection of the appropriate antibiotic to initiate the 
therapy, is critical to optimize the clinical outcome. 
Currently, the routine detection and identification of P. aeruginosa in respiratory samples is 
performed by bacteriological culture. The time to achieve reliable results is at least 24 h. An alternative 
approach is the indirect detection of the bacteria by identifying the biomarkers released by the 
organism. P. aeruginosa produces several toxic metabolites, the most predominant of them being the 
Sensors 2017, 17, 1704; doi:10.3390/s17081704 www.mdpi.com/journal/ sensors 
7 PUBLICATIONS 
88 
Sensors 2017, 17, 1704 2of 11 
redox-active phenazine compound pyocyanin (PYO). PYO is capable of destroying host cells by altering 
critical cellular processes, generating reactive oxygen species and inducing neutrophil apoptosis [4]. 
P. aeruginosa is the only microorganism known to produce PYO, and for this reason PYO can be used 
as a potential biomarker. It was found that in clinical sputum samples PYO can reach concentrations 
up to 16.5 µg/mL (~76 µM) for cystic fibrosis patients and up to 27.3 µg/mL (~130 µM) for patients 
with bronchiectasis [5]. Moreover, Hunter et al. concluded that levels of PYO and its biosynthetic 
precursor, phenazine-1-carboxylic acid, varying between 7.7 µM and 46.8 µM in expectorated cystic 
fibrosis sputum samples are negatively correlated with lung function [6]. The presence and the 
concentration of PYO in clinical samples is traditionally determined through extraction of the pigment 
with chloroform and by subsequently performing high performance liquid chromatography (HPLC). 
However, HPLC is available only in academic and clinical centers and it is time consuming, costly 
and laborious. 
Surface-enhanced Raman spectroscopy (SERS) was proven to be a molecular specific and highly 
sensitive analytical technique suitable for biological applications [7- 10]. SERS allows the sensitive 
identification of the molecular fingerprint of the analyte brought in the proximity of plasmonic 
nanostructures by enhancing its Raman signal by several orders of magnitude. For example, 
Polisetti et al. demonstrated that SERS can be used for investigating PYO produced by laboratory and 
cystic fibrosis lung isolate strains of P. aeruginosa for different growing conditions [11]. Additionally, 
Bodelon et al. developed different Au nanorod structures and performed SERS measurements for 
studying the intercellular communication of growing P. aeruginosa biofilms on the basis of secreted 
PYO [12]. Further on, the detection of PYO in clinical sputum samples was also successfully performed 
using silver nanorod array substrates [13]. However, due to the complex sputum matrix, PYO was 
outcompeted for available adsorption sites on the metallic surface by other species and its SERS 
detection became possible only after extracting it from sputum samples by the traditional chloroform 
procedure. Additionally, even though SERS is a highly specific and sensitive detection method, 
traditional SERS measurements still suffer from low reproducibility. This hinders a quantitative 
analysis. Combining SERS with microfluidics overcomes this limitation and enables the handling of 
small sample volumes [14- 16]. 
Within this study, SERS was first combined with a droplet-based microfluidic platform to obtain 
reproducible and automated measurement conditions for the detection of PYO in aqueous environment. 
This is essential because, as the majority of the already published SERS studies have demonstrated, 
for each targeted analyte, a smart experimental design is needed to obtain SERS spectra with an 
optimized signal-to-noise ratio [17- 19]. By taking into account the ability of the biomarker to induce 
the aggregation of the employed silver nanoparticles and by carefully choosing the measurement 
design, PYO levels down to concentrations of 0.5 µM were detected with the lab-on-a-chip SERS 
(LoC-SERS) platform. In the second part of the study, saliva was considered to be a clinically relevant 
sample matrix. This body fluid can be collected in a simple, non-invasive manner and offers high 
chemical complexity. Additionally, when collecting sputum, the clinical samples also contain saliva. 
This makes saliva an important and easy-to-access sample. Consequently, the interferences brought 
by this matrix in the SERS spectra have to be assessed. The results demonstrate that despite the high 
complexity of the matrix, PYO spiked in saliva collected from healthy volunteers can be successfully 
detected in the micromolar range. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Pyocyanin from P. aeruginosa, 2':98% (HPLC) in powder form, silver nitrate (ACS reagent, 99%), 
hydroxylamine hydrochloride (ReagentPlus, 99%) and mineral oil were purchased from Sigma Aldrich 
(St. Louis, MO, USA), whereas potassium chloride (KCl) (2':99.5% p.a. ACS, ISO) was acquired from 
Carl Roth (Karlsruhe, Germany). 
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2.2. Silver Nanoparticles (Ag NPs) Synthesis 
The silver colloidal solution was prepared through the chemical reduction of silver nitrate by 
hydroxylamine in the presence of sodium hydroxide at room temperature, as established in the 
standard Leopold and Lendl protocol [20]. The synthesized nanoparticles were characterized by 
UV-Vis spectroscopy (Figure Sl) and transmission electron microscopy (TEM) (Figure S2). 
2.3. Pyocyanin Solution 
Since PYO is sparingly soluble in water, first a stock solution of PYO at 1 mM concentration was 
prepared in ethanol by adding the appropriate amount of powder. Working solutions were obtained 
by diluting the stock solution with high-purity water, keeping a concentration of 10% of ethanol in the 
final solutions. 
2.4. Saliva Sample Preparation 
Saliva collected from the control group of the IDES (Innovative Diagnostik fur Infectionserregern 
bei Pneumonien, InfectoGnostics research campus (13GW0096F)) study (ethical approval 4672-01/16) 
were used. The samples were obtained from two female and one male volunteer at least 1 h after a 
meal. The samples were stored at 4 °C until analysis. None of the individuals had undergone medical 
treatment at the time of sample collection and they were also not in medical evidence for chronic 
diseases. Prior to the measurements, PYO solutions in ethanol with different concentrations were 
added to the saliva samples in a ratio of 1 to 9. The as obtained samples had the following biomarker 
concentration: 10, 25, 50, 75 and 100 µM. As negative control, a sample containing only ethanol and 
saliva was considered. To remove oral epithelial cells and food debris, the samples were filtrated using 
a cellulose acelate membrane with a pore size of 0.2 µm (VWR International, Radnor, PA, USA). 
2.5. Instrumentation 
Raman and SERS spectra were acquired with a commercially available WITec Raman microscope 
(WITec GmbH, Ulm, Germany) equipped with a diode laser (Fandango, Cobolt) that emits at 514 nm. 
During the measurements, a 600 lines per mm grating was used with a spectral resolution of ~5 cm-1 
and the same objective (Nikon 20 x 0.4 N.A., Tokyo, Japan) was employed for focusing the laser beam 
on the sample and for collecting the Raman backscattered light. For all measurements, a laser power 
of 38 mW and an integration time of 1 s were used. The reference Raman and SERS spectra of the 
water-ethanol, as well as of the PYO solution were measured in plastic cuvettes and each spectrum is 
the result of 50 accumulations. 
In order to determine the limit of detection of PYO in aqueous solution, a droplet-based glass 
microfluidic chip was employed (Scheme 1). 
Scheme 1. Schematic representation of the droplet based microfluidic chip used for 
LoC-SERS measurements. 
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A detailed description of the chip has been published elsewhere [21]. The glass syringes 
(ILS Germany GmbH, Stiltzerbach, Germany) were filled with different solutions and connected 
with the chip via Teflon capillaries, having an inner diameter of 0.5 mm (WICOM GmbH, Heppenheim, 
Germany). The solutions were pumped into the chip via a computer controlled pump system 
(neMESYS Cetoni GmbH, KorbuBen, Germany). To create a segmented continuous flow, mineral 
oil was pumped with a flow rate of 9 nL/ s, while the analyte and the Ag NPs were both injected 
with 7 nL/ s. All other ports were blocked. The SERS spectra were measured continuously with an 
integration time of 1 s. 
To assess the interferences brought by the molecules present in the saliva, the control samples and 
the ones spiked with PYO were mixed with the silver colloidal solution in a 1 to 1 ratio, followed by 
the addition of 1 M KCl (final mixing ratio 1:1:0.2). Here, KCl was added to induce the aggregation 
process. Three independent measurements were recorded for each sample with 1 s integration time 
and 20 accumulations. 
2.6. Data Processing 
The data processing was performed using an algorithm developed in-house in the programming 
language R [22]. In the case of the LoC-SERS measurements, Raman/SERS spectra were measured 
continuously during the flow. Accordingly, alternating SERS spectra of the analyte containing droplets, 
Raman spectra of the oil phase and mixed spectra of both phases were recorded. Therefore, during the 
data processing, the oil and mixed spectra were removed first. Afterwards, spectra were background 
corrected using the Statistics-sensitive Non-linear Iterative Peak-clipping (SNIP) algorithm with 80 
iterations and cut to the region of interest [23]. Univariate statistical analysis was performed by 
calculating the peak area of the band around 676 cm - 1. This Raman mode corresponds to the ring 
breathing mode of PYO. For peak integration, the Simpson's rule [24] was applied. The integrated 
peak area was plotted as function of the concentration. SERS spectra measured in plastic cuvettes 
were vector-normalized. The same background correction algorithm was also applied to the spectra 
recorded in cuvettes. 
3. Results and Discussion 
3.1. SERS Detection of Pyocyanin in Aqueous Solution 
PYO is a redox-active phenazine and its chemical structure is depicted in Scheme 2. It is a 
heterocyclic nitrogen containing compound, which exist as a zwitterion at the pH value of blood 
(7.35-7.45). PYO can accept a single electron, yielding a relatively stable anion radical, and readily 
undergoes a redox cycle [25]. 
Scheme 2. Chemical structure of the PYO molecule (C13H10N20). 
In Figure 1, the normalized Raman spectrum of PYO in a water-ethanol solution at a concentration 
of 0.5 mM and the normalized SERS spectrum of PYO at a concentration of 10 µM are plotted together 
with the Raman and the SERS spectra of the solvent without the analyte. Based on this, the normal 
Raman spectrum of the PYO solution is dominated by the Raman modes assigned to the molecular 
vibrations of ethanol at 880, 1047, 1087 and 1456 cm-1 (see Figure l a). Nevertheless, at 676, 1353 and 
1606 cm -l clearly distinguishable Raman bands ascribed to the presence of the PYO molecule can be 
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also noticed. A comprehensive band assignment of the Raman modes of the metabolite can be found in 
the literature [12,13]. Briefly, the band around 676 and 1606 cm-1 was assigned to the ring deformations, 
while the signal at 1354 cm-1 corresponds to the combined C-C stretching, C-N stretching and C-H 
in-plane bending modes of the aromatic ring. In the presence of the Ag nanoparticles, the already 
mentioned Raman marker bands are strongly enhanced and new ones appear. More exactly, the double 
band at 1564 cm-1 and 1594 cm-1, ascribed to the ring deformation and the C-C stretch vibration, 
the two bands at 423 and 547 cm-1, corresponding to the ring torsion and the ring breathing with 
C-N torsion, become prominent, whereas the Raman band at 1606 cm-1 is convoluted with the rest of 
the signal. 
200 400 600 800 1000 1200 1400 1600 1800 
Wavenumber [cm-'] 
Figure 1. Normalized Raman spectra of 10% ethanol solution (a) and PYO 500 µM solution (b), as well 
as normalized SERS spectra of the same ethanol solution (c) and PYO 10 µM solution (d). 
3.2. LoC-SERS Measurement of PYO in Aqueous Solution 
In order to achieve automated measurements and to obtain reproducible SERS spectra of PYO in 
aqueous solution at different concentrations, the microfluidic setup depicted in Scheme 1 was employed. 
Generally, to get strong Raman signal enhancements, the aggregation of spherical nanoparticles is 
required [26]. Usually the creation of "hot-spots" is achieved by the addition of an active (e.g., KCl) or 
a passive (e.g., KNO3) electrolyte to the colloid-analyte mixture. However, based on our performed 
experiments, PYO induces by itself the aggregation of the colloids and the addition of aggregation 
agents is not needed. This is demonstrated by recording the SERS spectra in the absence of salts as 
well as in the presence of KCl at different concentrations (Figure S3). For clarity, the integrated peak 
area of the Raman band located at -676 cm-1 is represented in the inset of Figure S3 for different 
measurement conditions. This band was chosen because its intensity is not influenced by surrounding 
bands. According to the results, the most intensive and stable signal is achieved when no salts are 
present. The decrease of the signal with KCl addition can be explained by the fact that the presence of 
KCl causes over-aggregation and creates large clusters, which cannot support high electromagnetic 
enhancements at the used excitation wavelength. Therefore, all following measurements were carried 
out in the absence of any additional aggregation agent. 
Another important factor for SERS measurements is the time elapsed between the induction of 
the aggregation and the measurements. Performing measurements in the microfluidic chip offers 
time-control by choosing the measurement position. For this purpose, during SERS measurements, the 
excitation laser was focused in the middle of each microfluidic channel. The results showed that the 
intensity of the signal was the same for different positions, but the lowest relative standard deviation 
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of the signal was achieved for the measurement done in the 3rd channel (Figure S4). Therefore, all 
subsequent measurements were performed with the laser beam fixed in the middle of the 3rd channel. 
By taking the clinically relevant range into account (7-130 µM) [5,6], PYO solutions with 
concentrations between 0.5 µMand 85 µM were measured employing our proposed LoC-SERS-based 
detection scheme. In Figure 2, the mean SERS spectra for all concentration steps are plotted together 
with the blank spectrum. It can be observed that for concentrations higher than 20 µM, the most 
prominent ethanol band at 880 cm-1 becomes convoluted with the intense PYO spectra. The spectral 
signature of PYO at 676 cm-1 and 1353 cm-1 is still present at a concentration of 0.5 µM. For better 
visualization, the integrated peak area of the ring deformation vibration band at 676 cm-1 was plotted 
against the concentration of PYO (Figure 3). The concentration curve has a sigmoidal form, reaching 
a plateau for concentrations higher than 55 µM. This is explained by a full occupation of the Ag 
nanoparticle's surface with PYO molecules. Thus, by further increasing the concentration of the PYO 
molecules, no significant increase of the band intensity was observed due to an increased distance of 
the analyte molecule toward the metallic surface. 
250 500 750 1000 1250 1500 1750 
Wavenumber [cm·'] 
Figure 2. Mean SERS spectra of PYO with concentrations between 0.5 and 85 µMin aqueous solution 
measured in the microfluidic platform. The mean spectrum of the blank (when only water-ethanol 
solution is pumped through at the first dosing unit) is also presented. 
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Figure 3. Integrated peak area of the PYO Raman mode at 676 cm-1 (black) and of the mode at 
240 cm-1 which corresponds to the Ag-(adsorbed atom) (red). 
It is known that usually the bonding of molecules to the silver surface takes place either through 
the lone pair electrons of the nitrogen or oxygen atoms or through the n electron system of the aromatic 
ring [27,28]. In the first two cases, Raman bands assigned to the vibrational modes of the Ag-adsorbed 
molecule (i.e., Ag-N, Ag-O) can appear in the low wavenumber region (200-260 cm-1) because of 
the molecule adsorption. Furthermore, when electrolytes containing c1- are used for inducing the 
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aggregation of the nanoparticles, a low wavenumber Raman band also appears due to the Ag-Cl 
vibration. Since PYO is causing the aggregation of the nanoparticles, no additional salts were added to 
the colloid-analyte mixture. Thus, the bands in the low wavenumber range in the recorded spectra 
cannot be assigned to this vibration. 
Based on the molecular structure of PYO (see Scheme 2), it is expected that oxygen and nitrogen 
atoms carry partial negative charges, thus, most probably an interaction with the silver surface is 
achieved via these heteroatoms. As a result of the interaction of PYO with Ag nanoparticles, Raman 
bands in the low wavenumber region, at 221 and 239 cm-1, can be observed and assigned to the Ag-N 
and Ag-0 stretching vibrations [29]. The increase of their intensity (see Figure SS) can be attributed to 
the increment of the number of adsorbed PYO molecules on the Ag surface. The change of the ratio of 
these two bands with increasing PYO concentration might be caused by a change in the orientation of 
the target molecule on the surface of Ag nanoparticles. Namely, at low concentrations, the molecule 
might interact with the metallic surface via the free electron pairs of both N and 0, while at high 
concentrations, due to the steric hindering, PYO might adopt an upright orientation and interact with 
the metallic surface only via the O atom. 
The integrated peak area of the two convoluted bands in the low wavenumber range is presented 
by red scatter plot in Figure 3. Comparing it with the integrated peak area of the 676 cm-1 band, 
a similar sigmoidal behavior with saturation after 55 µM was observed. However, the underlying 
mechanism behind the increment of the signal is different for the two Raman bands. The Raman mode 
at 240 cm-1 band is due to the PYO molecules in the first layer on the surface of the silver nanoparticles. 
Meanwhile, the intensity of the 676 cm-1 is increasing also because of the molecules present in the 
upper layers but still found in the 'hot-spot' between the nanoparticles. 
In the following, the Raman band centered at 240 cm-1 was used as an internal standard [30]. 
The normalized integrated peak area of the Raman marker band of the metabolite is plotted in 
Figure 4. After normalization, a linear response over the 0.5-15 µM concentration range is achieved. 
According to the IUPAC definition, the limit of detection is equal with the signal of the blank plus three 
times its standard deviation. The calculated limit of detection (LOD) is below the lowest measured 
concentration (0.5 µM) (the threshold is illustrated in Figure 4). Moreover, the normalization of the 
signal significantly improved the "chip-to-chip" reproducibility. As illustrated in the supporting 
information, the integrated peak area of the Raman mode at 676 cm-1 for two different microfluidic 
chips is difficult to compare (Figure S6); however, after normalization, the concentration curves gain 
the same profile (Figure S7). Therefore, the Ag-adsorbed atom mode can be considered to be an internal 
standard and it increases the comparability of different data sets. 
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Figure 4. The peak area ratio of the 676 cm-1 and 240 cm-1 Raman modes as a function of PYO 
concentration in aqueous solution in the range between 0.5 and 15 µM with linear fitting. The red line 
indicates the calculated LOD. 
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3.3. SERS Detection of PYO in Saliva 
In order to move toward clinical applications, the feasibility of SERS for PYO detection in saliva 
was investigated. The spectroscopic analysis of clinical samples is often challenging due to the complex 
and heterogeneous nature of biological fluids. In the case of SERS, different components can interact 
with the metallic structures and the detection of the Raman modes of the molecules of interest present 
in low concentrations can be inhibited. In the current study, saliva was chosen as the test sample 
matrix. This biological fluid will be present in the respiratory tract samples. Despite the fact that 
saliva is composed mainly of water, it has a multitude of dissolved components, for example minerals, 
electrolytes, hormones, mucins and enzymes. It also contains expectorated bronchial and nasal 
secretions, serum and blood derivatives from oral wounds, bacteria and bacterial products, viruses, 
fungi, desquamated epithelial cells and food debris [31]. Since the composition of saliva varies among 
individuals, for the proof of concept, saliva samples from three healthy volunteers were used for this 
study. Six different solutions with different PYO salivary concentrations (0 M, 10 µM, 25 µM, 50 µM, 
75 µM, 100 µM) were prepared for each sample by mixing 9 parts of human saliva with 1 part of 
ethanol solution containing the target molecule. To remove oral epithelial cells and food debris, the 
samples were filtrated prior to the measurement. The recorded mean SERS spectra of the samples 
originating from the three volunteers at different PYO concentrations are presented in Figure 5. Since 
the ethanol concentration in all samples was kept constant, for a better comparison, all spectra were 
normalized to the ethanol Raman mode at 880 cm-1. 
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Figure 5. Mean SERS spectra and their double standard deviation of the different concentrations of 
PYO in the saliva sample from volunteer number one (A), two (B) and three (C). 
The SERS signal of the pure saliva (Figure S8) is challenging to interpret because of the convolution 
of the Raman bands in the fingerprint region. However, the Raman modes around 1240, 1472, 1610 
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and 1653 cm-1 can be distinguished and tentatively assigned to proteins, amino acids, lipids and DNA 
and/ or RNA bases [32,33]. Because PYO stock solutions were prepared in ethanol, as negative control 
for the current study a mixture of saliva with ethanol was considered. The latter molecule gives rise 
to the intensive Raman bands at 880, 1047, 1087 and 1456 cm-1 observed in Figure 5 for the O µM 
samples. By spiking PYO to the complex matrix, a new band appears at 1353 cm-1, while the bands 
at 676 cm-1 and 1598 cm-1 gradually increase in intensity with the increment of PYO concentration. 
These three Raman modes are characteristic for the targeted molecule. In the case of the first and 
second volunteer, spectral changes can be seen already at the lowest investigated PYO concentration 
(10 µM) (Figure SA,B and Figure S9), while for the third volunteer changes can be noticed by eye at a 
concentration of 25 µM (Figure SC and Figure S9). In the case of the highest concentration, 100 µM, the 
increased standard deviation of the recorded spectra can be explained by the poisoning of the metallic 
surface by the high number of molecules present in the matrix. In comparison with the LOD previously 
obtained for PYO in water (below 0.5 µM), the complexity of the matrix affects the sensitivity of the 
method and the metabolite could be detected down to a 10 µM concentration. For these samples, the 
LOD was not calculated based on the IUPAC definition, but instead the lowest concentration causing 
observable changes in the SERS spectrum of the sample was considered. Nevertheless, by using easy to 
prepare silver nanoparticles, we showed that the detection of PYO in the clinical range can be achieved 
and the saliva collected from the three volunteers does not significantly affect the detection of the 
target molecule. 
4. Conclusions 
P. aeruginosa is an opportunistic human pathogen responsible for acute and chronic infections, 
particularly in individuals with compromised immune systems and host defenses. PYO is a virulence 
factor uniquely produced by this pathogen. Thus, its fast and selective detection can reveal the presence 
of P. aeruginosa in the organism, which can help with fast and successful antibiotic treatment. 
In this study, the detection of pyocyanin (PYO) was performed through surface-enhanced Raman 
spectroscopy (SERS) combined with a microfluidic platform. It was shown that the aggregation of the 
silver nanoparticles is induced by the presence of the analyte and no additional salts are necessary to 
achieve enhancement. PYO was successfully detected in aqueous solution in the clinically relevant 
range (7-130 µM) with the linearity in the 0.5 µM-15 µM region and a limit of detection <0.5 µM. This 
demonstrated that the described LoC-SERS approach is versatile and allows the detection of bacteria 
metabolites. In the second part of the paper, as proof of concept, saliva collected from three volunteers 
was considered as a matrix. As none of the individuals were under treatment for pneumonia, PYO 
was artificially added to the saliva and it was successfully detected in this chemical environment 
down to the 10 µM concentration for two of the investigated samples, while in the case of the third 
sample spectral changes were observed at 25 µM. The results establish the potential for the detection 
of PYO directly from complex matrixes. For further studies, other respiratory specimens will be also 
considered. Additionally, the measurement principle used can be significantly improved by replacing 
the bench-top Raman setup with a miniaturized or even portable system, by integrating the sample 
clean-up step in the platform and by opting for a pressure driven pumping system. 
Supplementary Materials: The following are available online at http:/ /www.mdpi.com/1424-8220/17 /8/1704/sl. 
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ARTICLE INFO ABSTRACT 
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Sputum 
Early stage detection of Pseudomonas infections is life-saving, especially in the case of patients with cystic fi-
brosis. Pyocyanin (PYO) is a specific metabolite of the Pseudomonas aeruginosa bacteria, and detection of it 
directly in the spuwm can significantly reduce the diagnosis time of the infection. In the present study, aiming to 
achieve this goal, a simple and cost-effective surface-enhanced Raman spectroscopy (SERS) detection platform 
was proposed. For this, a silicon nanowire (SiNW) matrix, produced by metal-assisted chemical etching of silicon 
substrates was variously modified by noble metal (silver and gold) nanoparticles (NPs) and tested for the de-
tection of the metabolite PYO in the complex matrix of artificial sputum. We found the SERS substrate with Ag 
NPs on the bottom of SiNWs and deposited bimetallic Ag/ Au NPs on the top of them the best suited for the 
sensitive detection of PYO. The investigated plasmonic substrate showed good point-to-point and batch-to-batch 
signal reproducibility and allowed for the detection of PYO in artificial sputum down to 6.25 µM, which is the 
required sensitivity for clinical applications. 
1. Introduction 
Pseudomonns aeruginosa is a common opportunistic pathogen of 
nosocomial infection in patients with impaired immunity connected 
with the management of malignancy, organ transplantation, auto-
immune and inflammatory conditions, as well as being the major pa-
thogen associated with respiratory tract infections in patients with 
cystic fibrosis (CF) [1-4]. Early identification of P. aeruginosa in CF 
patients provides the opportunity for early aggressive antibiotic treat-
ment, as early isolates are generally nonmucoid, antibiotic-susceptible 
and present at low density [5-8]. Mucoid Pseudomonas is very chal-
lenging to treat and eradicate because of its ability to form im-
penetrable biofilms and rapidly develop resistance to antibiotics [9]. P. 
aeruginosa airway infection in CF patients is generally diagnosed by a 
culture of respiratory tract samples, such as spontaneously expectorated 
or induced sputum, oropharyngeal swabs or bronchoalveolar lavage 
(BAL) [7]. It usually takes more than 3 days to obtain accurate results. 
Moreover, there is a risk of inconsistent results due to sample con-
tamination, and P. aeruginosa biofilms formed in CF lungs has decreased 
cultivability under standard conditions. Thus, in recent years, some 
attention has been given to alternative methods of diagnosis, such as 
serology or molecular techniques like polymerase chain reaction (PCR) 
[10---12]. Both methods exhibit high potential for the detection of P. 
aeruginosa; however, PCR methods require expensive reagents and the 
design of target-specific primers, while serological tests often fail to 
detect early colonization in young patients [13,14]. An alternative 
approach is the indirect detection of the P. aeruginosa by identifying the 
virulence factors secreted by the bacteria. One of these virulence factors 
is pyocyanin (PYO), which alters critical cellular processes, thereby 
generating reactive oxygen species and inducing neutrophil apoptosis 
• Corresponding author. Friedrich Schiller University Jena, InstiWte of Physical Chemistry and Abbe Center of Photonics, Helmboltzweg 4, 07745, Jena, Germany. 
** Corresponding author. Lomonosov Moscow State University, Physics Department, 119991, Moscow, Russia. 
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[15]. PYO is exclusively secreted by P. aeruginosa, giving this molecule 
high potential to be used as a diagnostic biomarker. In clinical sputum 
samples, PYO can reach concentrations up to 16.5 µg/ml ( -76 µM) for 
cystic fibrosis patients and up to 27.3 µg/ml ( -130 µM) for patients 
with bronchiectasis [16]. Hunter et al. observed a certain correlation 
between the concentration levels of PYO and its biosynthetic precursor, 
phenazine-1-carboxylic acid, in expectorated cystic fibrosis sputum 
samples and the severity of the disease. Patients with severe lung ob-
struction showed a significant progressive increase in PYO concentra-
tions (46.8 µM) relative to those with normal lung function (7.7 µM) 
[17]. The development of a fully enclosed automatic technique for di-
rect PYO detection in respiratory samples will shorten diagnostic 
turnaround time and reduce the risk of contamination. 
Surface enhanced Raman spectroscopy (SERS) already has been 
proven to be a molecular-specific and highly sensitive analytical tech-
nique suitable for biological applications [18-20]. SERS allows for the 
sensitive identification of the molecular fingerprint of the analyte 
brought in the proximity of plasmonic nanostructures, which enhance 
the Raman signal by several orders of magnitude. Different SERS ap-
proaches have been described for studying P. aeruginosa biofilm for-
mation and intercellular communication on the basis of the PYO signal 
[21 ,22]. In our previous study, we demonstrated direct detection of 
PYO spiked in the saliva of three volunteers using silver colloids as the 
SERS agent. PYO was successfully detected down to the 10 µM con-
centration in two saliva samples and down to 25 µM in the third one 
[23]. Moving to more complex biological environments, such as sputum 
or BAL, still represents a significant challenge, since the intrinsic 
complexity of the matrix may prevent the interaction of the target 
analyte with the metallic surface. In tum, this would hinder analysis by 
SERS, as other molecular species, e.g., proteins or DNA bases inter-
acting with metal would increase the background signal. For instance, 
Wu et al., using an Ag nanorod arrays as the SERS substrate due to the 
dense matrix and volume dilution of processed sputum, could not detect 
PYO directly in clinical sputum samples from CF patients; prior to the 
measurements, PYO had to be extracted from sputum by chloroform 
[24]. That outcome makes the development of SERS substrates, which 
could overcome the limitations brought by complex matrix, of high 
importance. 
Vertically aligned silicon nanowires (SiNWs) are imperative for the 
fabrication of such SERS substrates, because they have very high sur-
face area and surface tailorability. Thus, a high number of metallic 
nanoparticles (NPs) could be packed on them, which would yield a high 
enhancement factor. SiNWs decorated with silver or gold were suc-
cessfully used for ultrasensitive SERS detection of the standard analyte 
Rhodamine 6G [25,26], pesticides such as carbaryl [27], DNA [28] or 
avidin molecules [29]. 
In the current study, we present four different types of SiNWs sub-
strates covered with the gold and/or silver for the direct, label-free 
SERS detection of PYO spiked in artificial sputum. Here, artificial 
sputum was selected since it simulates clinical samples and because its 
exactly known composition offers the possibility to study interaction of 
the matrix components and target analyte with plasmonic nanos-
tructures. To the best of our knowledge, this is the first report proving 
the high potential of SERS for the direct determination of PYO in such a 
complex matrix as sputum. 
2. Materials and methods 
Chemicals and Reagents. Silver nitrate (AgNO3), 48% 
Hydrofluoric acid (HF), Pyocyanin from P. aeruginosa, ;,, 98% (HPLC) in 
powder form, DNA from fish sperm and mucin from porcine stomach 
(type II) were purchased from Sigma Aldrich. Bovine serum albumin 
(BSA) and egg yolk emulsions from VWR Prolabo, potassium chloride 
(KC!) (;,, 99.5% p.a. ACS, ISO) and sodium chloride (NaCl) from Carl 
Roth, diethylenetriaminepentaacetic acid (DTPA) with tris(hydro-
xymethyl)aminomethane hydrochloride (TRIS x HCl pH 8) from 
172 
SiNWs matrix 
LLLW 
Talanta 202 (2019) 171-177 
The disposal of The deposition 
native AgNPs of AgNPs 
The deposition 
of AuN Ps 
WW lllW (1) Ag•Au•SiNWs 
II I I ll------- 1(2tttNt.' >----~• I i i i I __ ~-lJ,w,i 
........ (3)Ag; Au ' SiNWs 
........... 
(4) Ag.,Au•SiNWs 
Scheme I. Schematic representation of the formation of SiNWs based sub-
strates covered with noble metal nanoparticles. (no color print). 
Merck, nitric acid (HNO3), 65% from Chimmed and gold(III) chloride 
(AuC13) from ABCR were also used. 
Fabrication of the SERS substrates. Four SERS substrates based on 
SiNWs matrix were produced, as shown in Scheme 1: (1) Ag*Au*SiNWs, 
for which bimetallic Ag/ Au NPs were deposited on the top of SiNWs 
matrix; (2) Au*SiNWs, for which only Au NPs were deposited on the top 
of SiNWs matrix; (3) Ag;Au'SiNWs, where Ag NPs covered the bottom 
and bimetallic Ag/Au NPs were deposited on the top of SiNWs matrix; 
( 4) Ag,Au*SiNWs, with Ag NPs at the bottom and Au NPs on the top of 
SiNWs matrix. 
The SiNW matrix was prepared by metal-assisted chemical etching 
(MACE) of boron-doped 1-5 Qcm (100) single crystalline silicon (Si) 
wafers using a similar procedure as published in our previous work 
[30]. Prior the MACE procedure, the Si surfaces were rinsed in acetone 
and isopropanol for 2 min to remove organic and inorganic residues, 
and then rinsed in 5% HF aqueous solution for 1 min to remove the 
native oxide. In the first step of MACE, Ag NPs were deposited on the 
surfaces by immersing them in aqueous solution of 0.02 M AgNO3 and 
5 M HF at a volume ratio of 1:1 for 15 s. In the second step, the Si 
surfaces covered with Ag NPs were immersed in the second etching 
solution containing 5 M HF and 30% H2O2 at a volume ratio of 10:1 in a 
Teflon vessel for 30 s. The etching step was performed at room tem-
perature. After the MACE procedure, the typical SiNWs matrix of ver-
tically aligned nanowire array with native Ag NPs at the bottom was 
observed, as shown in Fig. Sl. If it was necessary, native Ag NPs were 
removed by immersing the samples in concentrated (65%) nitric acid 
(HNO3) for 15 min. Finally, the samples were rinsed several times in 
deionized water and dried at room temperature. 
For the formation of Ag, Au, or bimetallic Ag/ Au NPs in SiNWs 
matrix, the matrix was immersed in 0.02 M AgNO3 or in 0.01 M AuC13 
and 5 M HF at a volume ratio of 1:1 for 10-30 s, similar to galvanic 
displacement and autometallography [31]. As a result, on the top of the 
nanowires appeared silver or gold NPS recovered from silver nitrate or 
from gold(III) chloride, respectively. In the case of bimetallic Ag/ Au 
NPs, the silver was recovered first, and then the procedure was repeated 
for the gold. 
SEM analysis. The morphology and composition of the SiNW ma-
trix covered by noble metal (gold and silver) particles was studied by 
scanning electron microscopy (SEM) using a Carl Zeiss ULTRA 55, FE-
SEM microscope. To carry out the SEM analysis, the samples were 
rinsed several times in deionized water and dried at room temperature. 
The surface morphology was investigated by detecting secondary 
electrons. The surface composition was studied by detecting back 
scattered electrons (BSEs). 
Pyocyanin Solution. Since PYO is slightly soluble in water, a stock 
solution of 1 mM PYO was prepared in ethanol by adding the appro-
priate amount of powder. Next, serial dilutions were performed to 
prepare 1000, 500, 100, 50, 10, 5, 1, 0.5 nM PYO. Concentration of 
ethanol was kept 10% in all solutions. 
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Artificial sputum. The artificial sputum was prepared according to 
the protocol used by KloB et al. [31] Briefly, 400 mg of DNA from fish 
sperm and 3 g of mucin from porcine stomach (type II) were each 
suspended in 25 mL of deionized water and solubilized in a rotation 
mixer (12-15 rpm) over the night at 4 °C 1 g of BSA was solubilized in 
lOmL of deionized water. 500mg of NaCl, 225mgofKCl, and 0.6mg of 
DTPA were dissolved in 10 mL of deionized water each. All solutions 
were mixed, and 5 mL of egg yolk emulsion was added. The pH was 
adjusted to 7.0 with 1 M TRIS x HCl at pH 8, and, finally, the solution 
was filled up to 100 mL with deionized water and vortexed. The arti-
ficial sputum was stored at - 20 °C. Before measurements, the sputum 
was thawed at room temperature and vortexed. 900 µL of artificial 
sputum were spiked with 100 µL of 1 mM PYO solution in ethanol to 
achieve 100 µM PYO in the sputum. For reference, the artificial sputum 
was spiked just with ethanol. Next, serial dilutions of artificial sputum 
with 100 µM PYO were performed to prepare the final concentrations of 
100, 75, 50, 25, 12.5 and 6.25 µM of the analyte in the sputum samples, 
keeping the same sputum amount. For the SERS measurements, the 
resulting solutions were diluted 5 times with deionized water. 
SERS measurements. The SERS measurements were performed 
using a commercially available Renishaw inVia Qontor setup equipped 
with a 785 nm laser. During the measurements, a 1200 lines per mm 
grating was used with a spectral resolution of ~ 0.84 cm -1, the same 
objective (Leica 50 x 0.75 NA.) was employed for focusing the laser 
beam on the sample and for collecting the backscattered light. The laser 
power was set to 3 mW on the laser head. For the SERS measurements, 
the substrates were incubated for 30 min in the as-prepared solutions of 
the sputum and then air dried. For the artificial sputum samples, due to 
the surface tension and the evaporation of the sample liquid, the 
'coffee-ring effect' occurred and the target sample was concentrated 
around the edge of the substrate [32]. Therefore, the scanning areas 
were chosen around the edges for artificial sputum solutions (Fig. S2). 
When incubating substrates in aqueous PYO solution, the 'coffee-ring 
effect' was not detected; thus, for the aqueous PYO solutions, scan areas 
were selected randomly within the whole substrate area. For every 
sample, 10 50 x 50 µm areas were scanned using a 5 µm step. This 
resulted in 100 spectra per scan and 1000 spectra per sample. An in-
tegration time of 1 s was used. 
Data Processing. Data processing was performed using an in-house 
developed algorithm in the programming language R [33]. During data 
processing, the spectra were background corrected using the Statistics-
sensitive Nonlinear Iterative Peak-clipping (SNIP) algorithm [34]. To 
estimate the peak area, the Simpson rule was applied. 
3. Results and discussion 
Characterization of the SiNWs decorated with metallic NPs. 
Fig. 1 shows top view and cross-sectional images of the SiNW matrix 
variously modified by noble metal (gold and silver) NPs. During the 
sample preparation process, the nanowires acquire a conical shape. This 
is due to the formation of an oxide SiO2 layer on the surface of the 
nanowires in the process of the reduction of Au NPs from gold chloride 
and its simultaneous etching in hydrofluoric acid. The top view and 
cross-sectional images of SiNWs matrix covered by gold on the top, 
Au*SiNWs, are presented in Fig. 1 (a, b). It is clear that gold forms the 
branched structures consisting of NPs with sizes between 10 and 20 nm 
on top of the nanowires. The presence of Au nanostructures on top of 
SiNW matrix is also confirmed by BSE analysis, as shown in Fig. S3. 
Fig. 1 (c, d) shows SEM images of the SiNW matrix with native silver at 
the bottom and deposited gold on top of the nanowires (Ag*Au*SiNWs). 
Based on SEM, as well as on the BSE images shown in Fig. S4, it can be 
argued that the native Ag NPs that remain after the SiNWs production 
process are approximately 100 nm. The fine-grained gold nanos-
tructures, similar to the structures observed in Fig. 1 (b), are localized 
on the top of SiNWs, as shown in Fig. 1 (d). Fig. 1 (e, f) represents the 
top view and cross-sectional SEM images of SiNWs with bimetallic Ag/ 
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Au NPs on top (Ag*Au*SiNWs). The Ag NPs, formed during the reduc-
tion of silver nitrate, are approximately 50 nm and localized on the top 
of the SiNWs, as shown in Fig. S5. From the SEM and BSE images shown 
in Fig. 1 (e, f) and Fig. S6, it is clear that these Ag NPs are homo-
geneously coated with a fine-grained structure of 10-20 nm Au NPs. 
SEM images of the SiNW matrix with a native layer of Ag NPs at the 
bottom and bimetallic Ag/Au NPs on the top (Ag;Au'SiNWs) are shown 
in Fig. 1 (g, h), and the corresponding BSE images are shown in Fig. S7. 
The morphology of Ag NPs at the bottom and bimetallic Ag/Au NPs on 
top of the SiNW s was similar to the previous cases. 
SERS characterization of SiNWs matrices covered by metal NPs. 
To move toward clinical application, the feasibility of using the in-
vestigated substrates for SERS detection of PYO in artificial sputum was 
explored. Due to the inherent limitations of SERS, direct detection of 
target analytes in complex biological environments still represents a 
significant challenge, mainly because of the competition between ma-
trix components and the target analyte for binding sites on the SERS-
active metallic surface. To find which type of the investigated substrates 
is the most suitable, two substrates of each type were incubated in ar-
tificial sputum with 50 µM PYO and 1000 spectra per substrate were 
measured. This resulted in the dataset of 2000 spectra for every sub-
strate type. 
Here, it is worth to notice that prior to the substrate incubation the 
spiked sputum sample was diluted. The dilution step was introduced in 
order to reduce the matrix effects [35,36] and to optimize the incuba-
tion process, since an increased viscosity of artificial sputum leads to a 
non-homogeneous distribution of the sample on the substrate and the 
formation of a thicker layer of the sample, which results in a lower 
SERS signal. To select the optimal dilution ratio, different dilutions 
were prepared. The achieved SERS spectra are depicted in Fig. SB. It can 
be seen that with an increasing amount of water, all Raman peaks be-
comes more prominent, even if the concentration of all components is 
decreased. The highest SERS signal of the target molecule PYO was 
achieved for the dilution ratio of 1:4, which was implemented for all 
measurements. In parallel, as a negative control, substrates were in-
cubated in sputum without the analyte. Subsequent Raman spectro-
scopy measurements revealed that artificial sputum by itself has intense 
Raman modes at 732, 960 and 1327 cm- 1 (Fig. 2 (a)), which, based on 
previous studies, can be mainly assigned to adenine, which is the one of 
four nucleobases in the nucleic acid of DNA [37]. However, despite 
some background information from the matrix, the Raman modes 
characteristic of PYO at 597, 676, 1353, 1600 and 1615cm-1 are 
clearly visible for the all investigated SERS templates. The molecular 
structure of PYO is presented in the inset of Fig. 2 (a). The Raman band 
at 597 cm- 1 is related to c-c, C-N and C-H out-of-plane bending 
vibrations, the one at 676 cm - 1 is assigned to the ring deformation, and 
the peak at 1353 cm - l corresponds to the combined C-C stretching, 
C-N stretching and C-H in-plane bending. Finally, the double band at 
1600cm- 1 and 1615cm-1 is ascribed to the ring deformation, C-C 
stretching vibration and C-H in-plane bending. 
More detailed assignment of the all Raman modes of PYO can be 
found in the literature [24]. To analyze which SERS substrate allows the 
highest SERS performance, the ring deformation vibrational mode at 
676 cm - l was integrated from the vector normalized spectra and 
plotted for each type of SiNW matrix (Fig. 2 (b)). The relative standard 
deviations (RSDs) for Ag*Au*SiNWs, Ag;Au'SiNWs, Ag*Au*SiNWs and 
Au*SiNWs were 27.7, 22.7, 32.0 and 32.2%, respectively. It is clear that 
the most intense and stable SERS signal was obtained using 
Ag;Au'SiNWs. The Ag*Au*SiNWs substrate had a very similar SERS 
performance, while Ag*Au'SiNWs and Au*SiNWs substrates had al-
ready significantly lower SERS intensity and higher RSD. Thus, it can be 
concluded that keeping the native layer of Ag NPs at the bottom of the 
substrate is improving the SERS signal. Most probably in this case, 
molecules of PYO, which reached the bottom of the substrate, can also 
be enhanced and contribute to the SERS signal. From Fig. 2 (b) it can 
also be observed that creating on the top of SiNWs bimetallic Ag/ Au 
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Fig. 1. SEM images of the SiNW matrix, differently modified by noble metal nanoparticles. Top view (a) and cross-sectional view (b) of Au*SiNWs; top view (c) and 
cross-sectional view (d) of Ag*Au*SiNWs; top view (e) and cross-sectional view (D Ag*Au*SiNWs; top view (g) and cross-section view (h) of Ag;Au•siNWs. (no color 
print). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
NPs gives no significant signal improvement in comparison with just 
deposited Au NPs. However, it improves the RSD. 
Based on those findings, for the further investigations, only 
Ag'.i\u'SiNWs substrates were utilized. This included the determination 
of the point-to-point and batch-to-batch SERS reproducibility of the 
nanostructures, performed by utilizing the same 50 µM PYO in artificial 
sputum. 
The SEM analysis of the Ag'.i\u•siNWs illustrates the morphological 
homogeneity across a large segment of the substrate (see Fig. 1). 
However, slight variations of the nanoparticles size, aggregation state 
and their distribution are still present. To investigate how it influences 
the SERS signal uniformity, SERS spectra were collected from 10 dif-
ferent randomly chosen 50 x 50 µm areas with a 5 µm step. Fig. 3 (a) 
174 
presents the point-to-point SERS reproducibility of the measurements 
within one map. The characteristic Raman mode of PYO at 676cm- 1 
was investigated for 100 individual spectra and plotted as a function of 
the spectrum number. The relative standard deviation (RSD) of the 
SERS intensity was approximately 11.6%, which is shown as the light 
red area. This demonstrates that the investigated chemically produced 
SERS substrate is capable of generating SERS signals with good re-
producibility. 
Fig. 3 (b) depicts the signal variation for different scans within the 
substrate. Each box represents 100 spectra measured within one scan. 
Here already higher deviations can be observed. This possibly can be 
caused by differences in the focus depth changing the measurement 
position as well by inhomogeneous drying of the sputum. The 
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Fig. 2. (a) Mean SERS spectra of 50 µM PYO in artificial sputum measured on 
four different types of SiNWs substrates (2000 spectra per type of SERS sub-
strate) and the mean SERS spectra of artificial sputum. Inset presents the mo-
lecular structure of Pyocyanin. (b) Normalized peak area for the peak at 
676cm- 1 for four different types of SiNW substrates. (no color print). (For 
interpretation of the references to color in this figure legend, the reader is re-
ferred to the Web version of this article.) 
illustrated variations still demonstrate that scanning some areas within 
a substrate is a reliable method for getting an overview of substrate 
SERS activity. 
Additionally, four batches of substrates were prepared to investigate 
the batch-to batch SERS reproducibility. Here, two substrates from each 
batch were investigated by measuring 1000 spectra per substrate using 
50 µM concentration of PYO. Similarly, as for previous analysis, the 
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Fig. 3. (a} Point-to-point SERS reproducibility of 50 µM of PYO in artificial 
sputum obtained from 50 x 50 µm area with a 5 µm step. The red line shows 
the average intensity, and the light red area represents the standard deviation of 
the obtained spectra. (b} The scan-to-scan SERS reproducibility of 10 different 
scans consisting of 100 spectra. (no color print). (For interpretation of the re-
ferences to color in this figure legend, the reader is referred to the Web version 
of this article.} 
peak area for the ring breathing mode at 676 cm_, was calculated and 
plotted for individual batches of substrates (Fig. 4). These investiga-
tions reveal that all batches of Ag;Au'SiNWs are SERS active and have 
similar performance with RSD for the mean for all batches being around 
12%. This indicates the good reliability of the method. 
Finally, the sensitivity of the substrates for the detection of PYO in 
artificial sputum was investigated. Prior to the measurements, different 
clinically relevant concentrations of PYO were spiked into the matrix. 
Fig. 5 (a) represents the mean spectra for the investigated concentra-
tions, as well as the SERS spectrum from the sputum without the ana-
lyte. Despite some background from the matrix, already for 6.25 µM 
PYO, the peaks at 593, 676, 1353, 1600 and 1615 cm- 1 appear, which 
are the signature of PYO. With the increase of the concentration, the 
peaks become even more prominent. For better visualization in Fig. 5 
(b), the integrated peak area of the C-N stretching and C-H in-plane 
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Fig. 4. Batch-to-batch reproducibility obtained by measuring two substrates 
from each batch (2000 spectra per batch) using a 50 µM concentration of PYO 
in artificial sputum. (no color print). 
bending vibrations at 1353cm-1 was plotted against the concentra-
tions of PYO. 
From Fig. 5 (b), it is obvious that the PYO band at 1353 cm- 1 can be 
detected at 6.25 µM, which is the lowest expected concentration of the 
clinically relevant range for patients with cystic fibrosis. It can be 
concluded that the designed substrates are sensitive platforms for the 
SERS detection of biomolecules in complex matrices. In parallel to the 
visual assessment, the calculation of the limit of detection (LOD) was 
performed. Using the definition that the LOD is equal to the blank in-
tensity plus three-times SD (3o confidence level) divided by the slope of 
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the calibration line [38] a LOD of 15 µM was achieved. Although in the 
literature lower LODs for SERS based PYO detection can be found (see 
Table Sl ), this is the first study reporting direct detection in such 
complex matrix as artificial sputum without complex sample prepara-
tion steps. 
To investigate the influence of the complex matrix on the SERS 
performance, different concentrations of PYO in aqueous solution were 
investigated. Fig. S9 shows the PYO signal for different concentrations 
as well as the background signal of the substrate. The characteristic 
bands of PYO can be reliably detected down to 1 nM without any sig-
nificant background contribution from the substrate. Thus, the com-
petition for free binding sites on the metallic surface between the PYO 
and other components of artificial sputum results in a decrease of SERS 
signal by three orders of magnitude. Despite this, the proposed sub-
strates have significant ability to directly detect clinically relevant 
concentrations in artificial sputum. This finding is highly important for 
solving the diagnostic issues of P. aeruginosa infections. 
4. Conclusions 
PYO is a virulence factor uniquely produced by P. aeruginosa. Thus, 
the fast and selective detection of this factor can reveal the presence of 
P. aeruginosa in an organism. The direct detection of PYO in sputum will 
reduce diagnosis time and lead to successful antibiotic treatment. SERS 
is a powerful technique for the identification and potential quantifica-
tion of target analytes. However, its real application is challenging due 
to the multiple interferences from the complex matrix. Thus, suitable 
SERS substrates for such purposes should be designed. In this study, the 
fabrication process of a SiNW matrix differently modified with Ag and 
Au NPs was demonstrated. The process combines SiNW synthesis by the 
metal-assisted chemical etching with or without native Ag NPs and 
subsequent Ag and Au NPs chemical deposition. This fabrication 
method has short processing time, is cost-effective and provides struc-
tural variability with high potential for SERS applications. The 
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investigation of different substrates for PYO detection in artificial 
sputum revealed that keeping native Ag NPs on the bottom of the 
SiNWs is beneficial for the SERS performance. Furthermore, the de-
position of Ag first, followed by that of Au, to achieve bimetallic Ag/ Au 
NPs on top of the SiNWs, gives a more stable signal. Based on those 
findings, the Ag;Au'SiNWs substrate was selected for studying the 
sensitivity in detection of PYO in artificial sputum. Point-to-point and 
batch-to-batch investigations showed good stability of the signal, and 
PYO could be successfully detected in artificial sputum down to 
6.25 µM, which is the lower extreme of the clinically relevant range. 
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Figure S1. SEM images of SiNWs matrix with native silver nanopartcles. (a) top view and (b) cross-section view. 
Figure S2. Microscopic image of the substrate incubated in artificial sputum with during drying formed 'coffee-ring' 
effect. Red squares indicate measurement areas. 
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Figure S4. Top view SEM image of Ag,Au"SiNWs in BSE modus. 
Figure SS. SEM images of SiNW s with native silver nanopartcles at the bottom and silver nanoparticles on the top 
(Ag,Ag'SiNWs): (a) top view and (b) cross-sectional view. 
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Figure S7. SEM images of Ag:Au.SiNWs in BSE modus: (a) top view; (b) cross-sectional view. 
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Figure SS. Mean raw SERS spectra of artificial sputum spiked with PYO and diluted with different amount of water. 
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Table S1. An overview of the reported SERS studies on PYO detection. 
Substrate Matrix 
Lowest detected 
Linear range (µM) Reference 
concentration 
Water 0.5 µM 0.5 - 15 
Ag colloids [23] 
Spiked saliva lOµM -
Water 23.8nM 0.0238 -47.6 
Ag nanorrod array Spiked culture media 23.8nM 0.0238 -47.6 
substrates Spiked clinical sputum 
[24] 
samples (PYO extraction 47.6nM 0.0476 -4.76 
by chloroform) 
Macroporous poly-N-
isopropylacrylamide 
(pNIP AM) hydrogels 10-10 M 0.01 -0.1 
loaded with Au 
nanorods 
(Au@pNIPAM) 
Me so structured Aqueous samples 
Au@TiO2 substrates obtained from 
bearing a mesoporous chloroform extracted 10---<>M 0.01 -0.1 
[21] 
TiO2 thin film over a P. aeruginosa culture 
submonolayer of Au supematants 
nanospheres; 
Mesoporous silica-
coated micropattemed 
supercrystal arrays of 10-14 M 0.001- 0.1 
Aunanorods 
(Au@SiO2) 
Au nanoparticle Water 0.476 nM 0.00476- 47.6 
assemblies with [22] 
controlled nanogap LB media 4.76nM 0.00476 - 476 
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Surface-enhanced Raman spectroscopy and 
microfluidic platforms: challenges, solutions 
and potential applications 
I. J. Jahn/·b 0. Zukovskaja/ X.-S. Zheng,b K. Weber/·b.c T. W. Bocklitz/·b 
D. Cialla-May"·b and J. Popp*a,b,c 
The exhaustive body of literature published in the last four years on the development and application of 
systems based on surface-enhanced Raman spectroscopy (SERS) combined with microfluidic devices 
demonstrates that this research field is a current hot topic. This synergy, also referred to as lab-on-a-chip 
SERS (LoC-SERS) or nano/micro-optofluidics SERS, has opened the door for new opportunities where 
both techniques can profit. On the one hand, SERS measurements are considerably improved because 
the processes previously performed on a large scale in the laboratory and prone to human error can 
now be carried out in nanoliter volumes in an automatic and reproducible manner; on the other hand, 
microfluidic platforms need detection methods able to sense in small volumes and therefore, SERS is 
ideal for this task. The present review not only aims to provide the reader an overview of the recent 
developments and advancements in this field, but it also addresses the key aspects of fundamental SERS 
theory that influence the interpretation of SERS spectra, as well as the challenges brought about by the 
experimental conditions and chemometric data analysis. 
Introduction 
a Friedrich Schiller Universit:y Jena, Institute of Physical Chemistry and Abbe Center 
ofPhotonics, Helmholtzweg4, 07745Jena, Germany. 
There is a need for (bio )analytical methods in the field of life 
sciences to help improve the quality of life and to answer fun-
damental research questions about biological processes, and 
consequently, new platforms are continually sought and being 
developed. Among these methods, techniques based on chrom-
atographic separation are the most widely used. They are 
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applied in the clinical diagnosis of disease and disorders,1-• 
biopharmaceutical data screening,5- 7 water and environmental 
applications, 8- 10 food, 11- 15 pharmaceutics, 16- 19 and forensic 
testing.20- 23 Although chromatography-based platforms are 
considered to be the reference analytical methods, they require 
a large initial capital investment and, later, high service costs. 
There is also a lack of standardization; therefore, results from 
different laboratories are not comparable. 24 Furthermore, they 
are sophisticated methods requiring qualified staff and are not 
suitable for on-site detection. Optical detection platforms, on 
the contrary, have been extensively miniaturized25- 30 in the 
last years and their potential for a multitude of applications 
has been demonstrated.31- 37 
Vibrational spectroscopies, infrared (IR) and Raman spec-
troscopy, are, in particular, well known for giving molecular 
specific information by taking advantage of the vibrational 
modes of molecules. Water, one of the main constituents of 
biological and environmental samples, has high absorption in 
the IR range, whereas its scattering cross-section is very low. 
Thus, for the analysis of aqueous samples, Raman spec-
troscopy is preferred instead of IR absorption spectroscopy. 
The Raman effect is based on the inelastic scattering of 
photons. Thus, it is a very weak process and consequently the 
detection of analyte molecules present at very low concen-
tration is limited. One of the approaches to enhance the inher-
ently weak Raman signal is to bring the target molecules into 
the proximity of metallic nanostructures. Thus, surface-
enhanced Raman spectroscopy (SERS) combines the molecular 
specific information with the signal-enhancing power of plas-
monic structures. The SERS effect was first observed in 1974 
by Fleischmann while he was recording the Raman spectrum 
of pyridine adsorbed on a roughened silver electrode. 38 Forty 
years later, 15% of the overall Raman publications are still 
related to this topic. Over the years, SERS has advanced from 
X.-S. Zheng 
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being a technique mainly used to characterize molecule-metal 
interactions39- 41 and to detect dye molecules in pure water•2-•• 
to being applied in the quantification of biomolecules in clini-
cal and environmental samples as well as to the detection of 
biomarkers of various diseases.45- 53 Nevertheless, compared 
with the reference analytical methods, SERS is considered to 
still be in its childhood when it comes to the available com-
mercial platforms. 
The main challenge to obtain reliable SERS measurements 
is represented by the quality of the plasmonic substrates. For 
analytical applications, the preparation of these structures has 
to be straightforward, reproducible, and cost effective, while at 
the same time the provided signal enhancement has to be 
homogenous. Silver and gold are the most commonly used 
metals for fabricating SERS-active substrates. They can be syn-
thesized in numerous ways, such as bottom-up methods for 
obtaining metal colloids or core-shell nanoparticles, self-
organization or template-assisted methods, and top-down 
processes. 54- 57 From the measurement principle point of view, 
two strategies are commonly employed when recoding SERS 
spectra. In the first case, metallic colloidal solutions are mixed 
with the target analytes and with a so-called activation or 
aggregation agent and the measurements are performed in a 
cuvette. In the second case, analyte-containing solutions are 
drop-casted or incubated on the surface of solid (1D, 2D, or 
3D) substrates and then the mapping measurements are 
carried out. 
Both measurement approaches have their particular dis-
advantages. It was proven by Schliicker et al. 58 and is illustrated 
herein in Fig. 1, that single spherical metallic nanoparticles 
offer a signal enhancement of at most two orders of magni-
tude and that the aggregation of the nanoparticles is required 
for an optimal SERS signal. The creation of hot-spots can be 
achieved via the addition of an active (i.e., KC!) or a passive 
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Fig. 1 Finite element method simulation of the incident electric field 
amplitude IEI distribution on a 80 nm Ag sphere upon 633 (left) and 514 
(right) nm excitation showing a maximum field enhancement of 2.34 
and 2.47. respectively. This corresponds to a SERS enhancement factor 
of ~30 (in the IEl4 approximation) (Zhang et al.58 published by the PCCP 
Owner Societies). 
(i.e., KN03) electrolyte, by the presence of the analyte itself, or 
by the addition of polymers or long chain ions. 59 The aggre-
gated metallic nanoparticles yield great signal enhancements, 
but the SERS spectrum of the molecule to be detected 
becomes dependent on the time elapsed between the induc-
tion of the aggregation and the measurement. 60·61 Furthermore, 
the order of addition and the mixing ratio of the nanoparticles, 
the analyte solution, and the aggregation agent have a crucial 
influence on the SERS signal.62 In the second case, when solid 
substrates are employed for signal enhancement, the drop-
casting procedure creates a heterogeneous layer of analyte mole-
cules on the surface due to the coffee-ring effect, yielding SERS 
signals with low reproducibility. Furthermore, when the sub-
strates are incubated into the sample, the incubation time will 
strongly influence the final SERS results. 
Limitations brought about by the hard-to-control colloid 
aggregation and the need to ensure heterogeneous analyte 
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layers on solid substrates can be overcome by injecting or inte-
grating the SERS-active substrate in a microfluidic platform. 
The combination of SERS with microfluidics, also referred to 
as lab-on-a-chip SERS (LoC-SERS) or nano/micro-optofluidic 
SERS, opened new opportunities for system miniaturization 
and integration, 51•63-71 bringing the advantages of both tech-
niques. On the one hand, SERS measurements are consider-
ably improved because processes previously done on a large 
scale in the laboratory and that were prone to human error can 
now be carried out in nanoliter volumes in an automatic and 
reproducible manner. On the other hand, microfluidic plat-
forms need detection methods able to sense in small volumes 
and therefore, SERS is ideal for this task. 
The reported LoC-SERS platforms can be sorted into two 
distinct categories: flow through or continuous flow platforms72- 114 
and segmented or droplet-based platforms.60•115-126 The main 
body of literature is focused on the first type of microfluidic 
systems. Here, colloidal nanoparticles prepared via the chemi-
cal reduction of salts can be injected at the same, or at an 
additional inlet as the sample,72- 81 while stationary substrates 
prepared via i. e. top-down processes can be integrated in the 
channel system, 84-103 or the synthesis can be carried out 
in situ.10•-11• Compared with conventional SERS measure-
ments on open platforms, liquid evaporation is avoided and 
the deposition of molecules along the perimeter of the liquid 
droplet due to the capillary flow at a pinned contact line is 
overcome. Furthermore, the diffusion of the analyte toward the 
substrate can be improved via electrokinetic concentration, 86 
magnetic trapping, 80 hydrodynamic focusing, 87 or dielectro-
phoresis.102 However, regardless of the chosen way to apply 
the SERS-active substrate, the sample permanently wets the 
channel walls of the microfluidic platform. This will lead, in 
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most cases, to the so-called memory effect, where the mole-
cules of the sample get enriched over time on the surface of 
the channels. This will result, for example, in an overestima-
tion of the detection limits, especially when stationary sub-
strates are used for signal enhancement. Consequently, Meier 
et al. 127 reported an approach to regenerate on-chip SERS sub-
strates by applying a high electrical potential ( 100 V) leading to 
analyte desorption. However, one has to make sure that the 
nanostructure of the SERS-active substrates is not affected 
during this process. 
The segmented flow, and especially droplet-based LoC-SERS 
platforms, 115- 122,124- 126•128 completely inhibit the cross-
contamination by assuring that no or very low cross-talk exists 
between the liquid compartments. This is achieved by dispen-
sing the sample and colloidal nanoparticles into individual 
droplets surrounded by an immiscible liquid phase. The 
droplets can be trapped, sorted, mixed, or split, based on 
the specific experimental requirements.65 '129 Commonly, the 
employed nanoparticles are previously synthesized and then 
injected into the chip, although in situ nanoparticle synthesis 
has also been reported. 125' 126 This offers a great advantage 
because the challenges represented by the batch-to-batch 
reproducibility and colloidal solution aging effect can be 
avoided. Furthermore, each droplet can be considered as a 
micro-cuvette or a micro-reactor. The colloids are mixed with 
the analyte in a reproducible way and, by mounting the chip 
on the microscope stage and fixing the focus point, the aggre-
gation time can be easily controlled. Nevertheless, these plat-
forms are limited to the detection of analyte molecules with 
good water solubility, as most often the segmented flow is 
achieved by forming aqueous droplets in the continuous flow 
of oil. 
Although the feasibility of most of the reported LoC-SERS 
platforms has been tested only with analyte molecules with a 
high scattering cross-section, such as rhodamine 6G, the ulti-
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mate goal should be their application in life sciences or other 
fields. Considerable efforts have been undertaken in the last 
years in pathogen identification, 80•92' 116'130 the quantitative 
measurement of low weight molecular species,79 •88•103,110,131 
and in the biomarker detection of various diseases.77•122•132•133 
As most of these applications are based on databases, cali-
bration data, or are multi-parameter problems, chemometric 
approaches have to be applied for correct and complete result 
interpretation. This is also necessary because the amount of 
recorded data is extensive and their analysis cannot be carried 
out manually with conventional software. 
In the last two years, two reviews, one by Zhou and Kim71 
and a second one by Huang et al. 70 have been published 
regarding microfluidic approaches combined with SERS as a 
detection method. These reviews provide an excellent overview 
of the fabrication methods of the nanostructures integrated 
in such platforms and address the influence of certain 
morphologies on the function of the device. The authors approach 
the topic from the perspective of technology and address the 
questions: what can be achieved? what can be fabricated? 
However, in practice, for the final aim of commercializing 
LoC-SERS platforms, one needs to be directed toward overcom-
ing the challenges associated with specific applications and 
solutions. Therefore, in the present review, besides offering an 
overview of the recently published studies on microfluidic plat-
form development, SERS-active substrate fabrication, and the 
application of LoC-SERS systems, aspects of fundamental 
SERS theory influencing the interpretation of SERS spectra, 
challenges brought by experimental conditions and chemo-
metric data analysis will also be addressed. 
Surface-enhanced Raman 
spectroscopy: fundamental 
considerations 
The SERS spectrum of a molecule is strongly influenced by: (1) 
the SERS-active substrate, ( 2) the emission wavelength of the 
excitation laser, and (3) the molecule-metal interaction 
(Scheme 1). The present section does not aim to give a 
thorough description of the fundamental theory of SERS, but 
it will focus on specific theoretical aspects that affect the 
appearance of the SERS spectrum. 
Surface-enhanced spectroscopies, such as surface-enhanced 
fluorescence (SEF), surface-enhanced infrared spectroscopy 
(SEIRA), or SERS, are governed by the plasmon, defined by Le 
Ru and Etchegoin as: "a quantum quasi-particle representing 
the elementary excitations, or modes, of the charge density 
oscillations in a plasma".134 If the frequency of an incident 
electromagnetic wave matches the oscillation frequency of the 
plasmon modes of a metallic particle, the particle will act as a 
dipole antenna and will emit light. As a consequence, a local 
field enhancement, referred to as the dipolar localized surface 
plasmon polariton (LSPP), is induced. Additionally, under 
appropriate experimental conditions, Kretschmann or Otto 
configuration, at the interface between a dielectric and a 
Analyst, 2017, 142, 1022-1047 I 1025 
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Scheme 1 Surface-enhanced Raman spectroscopy: the parameters that play a major role in the appearance of the SERS spectra. 
metallic layer, propagating surface plasmon polaritons (PSPPs) 
can be created.134 The increased local electric field caused by 
the dipolar LSPP or PSPP is the source of the Raman signal 
enhancement and the basis of the electromagnetic mechanism 
of SERS. In the case of a spherical particle, in the electrostatic 
approximation, the plasmon resonance condition is fulfilled 
when the dielectric function of the material out of which the 
particle is made of meets the relationship: e(J) = -2em (where 
em is the dielectric constant of the surrounding medium).135 
This condition is met, partially, only in the case of metallic 
materials, where Re(e(J)) < 0, because of the nonzero imaginary 
part, Im(e(J)). In the visible spectral range, silver and gold 
SERS-active substrates are widely used. Even though gold has a 
considerably higher chemical stability under atmospheric con-
ditions, silver is preferred when the aim is a high signal 
enhancement. The difference between the strength of the 
LSPP of the two metals is due to their slightly different optical 
properties. In the case of silver, the contribution of inter-band 
electronic transitions to the dielectric function in the visible 
spectral range is constant and real. In the case of gold, the 
natural oscillations of the free electron plasma are strongly 
affected by the presence of the inter-band transitions at wave-
lengths bellow 600 nm, and thus, Im(e(J)) is significant in this 
spectral range.135 
As foreseen from the plasmon resonance condition, 
optimal signal enhancements can be achieved only for specific 
wavelengths of the excitation laser. Generally, the position of 
the LSPP resonance can be easily tailored via the fabrication 
protocols. As a result, numerous synthesis approaches yielding 
a high diversity of metallic structures have been reported. 
Nonetheless, the Lee and Meisel136 (cited 2935 times) and 
Leopold and Lendl137 (cited 552 times) protocols are the most 
commonly employed ones for carrying out SERS studies. The 
1026 I Analyst. 2017. 142, 1022-1047 
reported extinction spectra of these colloids exhibit one main 
band, centered at around 410 nm. Based on this, one would 
expect that by applying a laser with an emission wavelength at 
410 nm, one would obtain a very strong SERS spectrum. 
Nevertheless, the connection between the extinction spectrum 
and the magnitude of the electromagnetic SERS enhance-
ments is, generally, indirect. In Fig. 2, the extinction coeffi-
cient, defined as the ratio of the extinction over the geometri-
cal cross-section, and the enhancement factor of a single 
sphere and dimers with a 10 and 2 nm gap separation are 
depicted.138 According to calculations performed with general-
ized Mie theory, the overall extinction coefficient is compar-
able for the three considered cases, while the maximum 
Fig. 2 Extinction (on a linear scale) coefficient and enhancement factor 
(on a log-scale) for a single sphere (d = 50 nm) and for dimers with 10 
and 2 nm gap separation, respectively (reproduced from Le Ru et al. 138 
with permission from the PCCP Owner Societies). 
This journal is © The Royal Society of Chemistry 2017 
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enhancement, on the contrary, changes by several orders of 
magnitude. Thus, single particle LSP resonances present the 
same extinction magnitude as dimers, despite their no or very 
low SERS signal enhancement.138 The extinction band located 
at 410 nm in the UV-Vis spectrum of the colloids prepared via 
the two mentioned particles is due to the dipolar LSPP reson-
ances of the single spherical particles. In practice, the red-
shifted, respective to the position of the plasmon resonance, 
emission wavelength of the excitation laser is used for colloidal 
particles. In the case of solid substrates, if the analyte mole-
cule or the medium used as a solvent does not affect the mor-
phology or optical properties of the nanostructures, one can 
expect that the position of the plasmon resonance derived 
from the optical measurements or theoretical calculations 
would give more accurate information about the magnitude of 
the electromagnetic enhancement.139 This is because of the 
fixed geometry and position of the hotspots. However, when 
performing theoretical calculations, the measurement con-
ditions, especially the dielectric properties of the surrounding 
medium, have to be considered for accurate results. 
The electromagnetic enhancement is present also in the 
absence of an adsorbed molecule140 and although it brings 
interesting fundamental knowledge, the applicability of SERS 
can be assessed only in the presence of an analyte. The inter-
action of molecules with the plasmonic nanostructures can 
lead to SERS spectra showing spectral features significantly 
different from the ones observed in the reference Raman 
spectra. These changes may be caused by the gradient field 
effect, the specific orientation of the molecule on the surface, 
and the quenching of fluorescence. 
Generally, Raman bands are observed for those vibrational 
modes of the molecule that present a change in their dipole 
electric polarizability during vibration. However, if the size of 
the molecule is comparable with the spatial distribution of the 
LSPP local electric field gradient, excitation of the multi-pole 
transitions becomes significant.141 As a result, forbidden 
vibrational modes are present in the recoded SERS spectrum 
and they have to be considered for a correct interpretation of 
the results. 
A second parameter influencing the SERS spectrum is the 
orientation of the molecules on the metallic surface, referred 
to as 'surface selection rules'.142 If the polarizability of the 
local electric field is perpendicular to the metallic surface, 
Raman modes of the adsorbed molecule with a strong polariz-
ability tensor component normal to the surface are selectively 
enhanced as compared with the Raman modes with strong 
parallel polarizability tensor components. By following these 
rules, many publications report the orientation of the mole-
cules on the metallic surface. However, these statements are 
valid only if the local field polarization is predominantly per-
pendicular to the surface at positions with the highest 
enhancements and if the molecule have several Raman modes 
with very different symmetries.143 A consequence of the selec-
tive enhancement of specific Raman modes is that, at different 
concentrations, new bands can appear or some can vanish in 
the SERS spectrum. This happens especially in the case of 
This journal is © The Royal Society of Chernistry 2017 
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molecules with multiple functional groups with high affinity 
toward the metallic surface. This, combined with the steric 
hindrance, can lead to reorientation of the molecule on the 
metallic surface, and hence to new spectral features. 
Lastly, when the energy of the excitation laser matches a 
dipolar electronic transition within the interrogated free mole-
cule, the fluorescence emission most often covers the weak 
Raman spectrum. Nevertheless, if the molecule is in the proxi-
mity of metallic surfaces, new channels for the absorption of 
the fluorescence emission are provided and fluorescence 
quenching occurs. This phenomenon is especially prominent 
for molecule-metal distances of a few nanometers.135 In this 
case, one might refer to surface-enhanced resonance Raman 
spectroscopy (SERRS), where, besides the electromagnetic 
enhancement provided by the SERS-active substrates, also the 
resonant excitation of the molecule contributes to the overall 
signal. One should also take into consideration, that when 
measuring under resonant Raman conditions, the vibrational 
modes with the greatest Franck-Condon overlap integrals will 
be the ones most visible. 
The electromagnetic enhancement mechanism was proved 
to account for signal enhancements of up to 1011 •144 However, 
factors of 1014-1015 have been reported in the literature. The 
additional signal gain was attributed to the chemical enhance-
ment mechanism. Three different processes have been 
suggested to contribute to this: (1) chemical interaction of the 
nanoparticle and the molecule in the electronic ground state; 
( 2) resonant excitation of the charge-transfer process between 
the molecule and the nanoparticle; and (3) the resonance 
Raman enhancement of the chemically bound molecule. In 
the first case, the molecule is not covalently bound to the 
surface of the nanoparticle. However, the presence of the 
metal perturbs the electronic structure of the analyte, inducing 
a slight change in its electronic distribution. In the second 
case, it was shown, depending on the relative energies of the 
Fermi level of the nanoparticle, the highest occupied mole-
cular orbital, and the lowest unoccupied molecular orbital of 
the molecule, charge transfer from the molecule to metal or 
from the metal to molecule can occur. Lastly, an effect similar 
to SERRS can occur, but here the energy of the incident radi-
ation does not induce an electronic transition in the free mole-
cule, but instead it resonantly excites the molecule with a 
modified electronic structure due to the interaction with the 
metallic surface. Overall, due to the chemical interaction of 
the molecule with the metallic surface, the position of the 
SERS bands can be shifted respective to their original position 
in the reference Raman spectrum. This is particularly strong 
for the vibrations of functional groups in the proximity of the 
metallic surface. 
Microfluidic platforms for SERS 
Continuous flow platforms 
Colloidal nanoparticles. The approach of utilizing continu-
ously flowing streams of completely miscible liquid phases 
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was the first route toward scaling down reaction volumes and 
increasing the throughput of measurements. SERS-active sub-
strates in the form of colloidal nanoparticles synthesized via 
chemical reduction are the most accessible metallic nano-
structures. In the last four years, the focus of the reported 
studies combining colloidal nanoparticles with continuous 
flow microfluidics72- 81 has been directed toward the trapping 
of nanoparticles and enrichment of the analyte at the detec-
tion area,75•76•78•80 the on-demand formation of nanoparticle 
aggregates,72•74•77•109 and on the enhancement of the collection 
efficiency of the SERS signal. 73•95 
The interaction of analyte molecules with the colloidal 
nanoparticles inside a conventional microfluidic channel is 
governed by the slow diffusion forces. This leads to high signal 
variations and thus to low reproducibility. The concentration 
of analyte-nanoparticle conjugates in the detection volume 
can be achieved via passive or active processes. White and co-
workers used a passive concentration strategy by employing a 
3D nanofluidic network with packed nanoporous silica micro-
spheres. 75•76•78 The platform evolved from a single microchan-
nel chip, where the analyte and colloidal nanoparticles were 
mixed off-chip and were injected via the same port to a multi-
port injector with meander channels and an integrated com-
petitive displacement unit for DNA sequence detection 
(Fig. 3(a)). The microfluidic chip requires no nanofabrication 
processes, while delivery of the excitation laser and the collec-
tion of the SERS signal are achieved via optical fibers. 
Although this approach overcomes the limitations of open 
channel microfluidics, where the nanoparticles are typically 
poorly concentrated in the detection volume, the trapping of 
the analyte-nanoparticle conjugates is irreversible and the 
device is thus for single use only. An alternative approach for 
trapping analyte-nanoparticle conjugates was demonstrated 
by Gao and coworkers by using an active concentration strat-
egy.80 They implemented an automatic competitive immuno-
assay into a solenoid-embedded dual channel microfluidic 
device containing a sensing and a control channel (see 
Fig. 3b). The authors took advantage of antibody-antigen 
binding reactions and magnetic separation. After the competi-
tive reaction between the free antigen and antigen-conjugated 
gold nanoparticles for binding sites on the surface of anti-
body-conjugated magnetic beads, the magnetic immuno-
complexes were trapped by yoke-type solenoids, and the result-
ing SERS spectra were recorded. The integration of a control 
channel considerably increased the reliability of the device by 
minimizing the influence of most of the experimental 
variables. 
The formation of hotspots via the aggregation of colloids is 
essential for sensitive SERS detection. The passive or active 
trapping of nanoparticles is one way to achieve this. In the 
search for improved measurement conditions, scientists orien-
tated their attention toward the reversible and on-demand con-
centration and formation of nanoparticle aggregates. In this 
way, new hotspots can be created for each measurement and 
the chip can be used for multiple analysis. Following this goal, 
Zhou et al. 77 fabricated a poly( dimethylsiloxane) (PDMS) 
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Fig. 3 (a) Microfluidic SERS microsystem with integrated competitive 
displacement for DNA sequence detection. Silica microspheres functio-
nalized with DNA probe-reporter pairs are packed against a frit. When 
the target sequence is introduced at the inlet. Raman-labeled reporter 
oligos are displaced. As they flow along the channel, they are mixed with 
metal nanoclusters and trapped in the microfluidic SERRS detection 
region. (Reprinted with permission from Yazdi et a/.78 Copyright 2012 
American Chemical Society.) (b) Schematic illustration of the solenoid-
embedded dual channel microfluidic sensor for SERS-based competitive 
immunoassay, optical images of the solenoid chip filled with four 
different colors of inks, photograph of the capture area for the magnetic 
immunocomplexes (reprinted from R. Gao, J. Ko, K. Cha, J. H. Jeon, 
G. Rhie, J. Choi, A. J. deMello, J. Choo, Fast and sensitive detection of 
an anthrax biomarker using SERS-based solenoid microfluidic sensor, 
Biosens. Bioelectron., 72, 230-236,8° Copyright 2015, with permission 
from Elsevier). 
microfluidic chip with a pneumatic valve and nanopost arrays 
at the bottom of the microchannel. The trapping and releasing 
of gold nanoparticles is shown in Fig. 4(a). The opening and 
closing of the valve is controlled via the applied pressure. By 
optimizing the amount of pressure, the thin elastomeric mem-
brane deforms and contacts the nanoposts at the bottom of 
the channel. The diameter of the used gold nanoparticles was 
250 nm and they were larger than the height of the deformed 
PDMS relief structures. In this way, the particles can be 
trapped while the solvent can still flow through. In order to get 
a reliable SERS spectrum, 10-15 minutes were needed for com-
plete formation of the aggregates. After the measurement was 
performed, the pressure could be released and the aggregates 
were flushed away. Nevertheless, nanoparticles with small dia-
meters cannot be efficiently trapped and high-throughput 
measurements are hindered by the slow formation of aggre-
gates. An alternative strategy for aggregates formation was 
reported by Hwang et al. 72 They used an optoelectrofluidic 
This journal is © The Royal Society of Chemistry 2017 
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Fig. 4 (a) Schematics of the trapping and releasing of gold nano-
particles using a modified pneumatic microvalve for SERS detection 
(Springer, J. Zhou, K. Ren, Y. Zhao, W. Dai, H. Wu, Convenient formation 
of nanoparticle aggregates on microfluidic chips for highly sensitive 
SERS detection of biomolecules, Anal. Bioanal. Chem., 2011, 402, 
1601-1609, 77 Copyright Springer-Verlag 2011). (b) Reversible, on-
demand formation of nanoparticle aggregates by using an opto-
electronic platform (reproduced from Hwang et al. 72 with permission 
from The Royal Society of Chemistry). 
platform consisting of three layers: a photoconductive layer on 
a transparent electrode, a liquid chamber, and a ground elec-
trode (Fig. 4(b )). When electromagnetic radiation is shone on 
the photoconductive layer, current flows through the illumi-
nated area and creates a nonuniform electric field in the 
liquid chamber. As a result, metal nanoparticles can be 
efficiently concentrated and SERS-active sites can form in a 
reliable and stable manner. The recorded SERS signals 
become saturated into a steady state after about 2 min. The 
authors also demonstrated dynamic control of the SERS-active 
sites by adjusting the position of the laser spot during the 
voltage application. The presented platform required no 
fluidic components or complicated fabrication processes, and 
the on-demand formation of colloidal aggregates at a specific 
place could be easily achieved. In contrast with this method, 
the electrokinetic concentration of gold nanoparticles reported 
by Kim et al. 84 required a more complicated fabrication proto-
col of the microfluidic chip, and the aggregates could be 
formed only at the predesigned positions. 
Stationary SERS-active substrates. The sophisticated engin-
eering of materials and their integration in microfluidic plat-
forms is a hot topic in nanoscience. As a result, many metallic 
nanostructures with elaborate morphologies have been 
reported. Gold layers roughened via UV laser pulse 
irradiation, 85 silver nanodot arrays obtained via the use of a 
through-hole ultrathin anodic aluminum oxide template,88 
nanopillar forests realized by an oxygen-plasma-stripping-of-
the-photoresist technique,89 nanoporous gold disks,91 plasmo-
nic nanodomes,93 metal-elastomer nanostructures,97 Ag-
coated TiO2 nanotubes,98 plasmonic nanopillar arrays,1°0 and 
silver-covered electron beam lithography patterned quartz sub-
strates101 are just some of the SERS-active substrates 
implemented within continuous flow cells. Soft lithography on 
PDMS is the most often applied fabrication procedure for 
obtaining these microfluidic platforms. 
Among the designed SERS-active substrates, 3D plasmonic 
structures offer a considerably large surface area for the adsorp-
This journal is © The Royal Society of Chemistry 2017 
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tion of analyte molecules. Mao and coworkers89 fabricated a 
SERS sensor consisting of a PDMS microchannel cap and a 
nanopillar forest based upon a SERS-active substrate (see 
Fig. s(a)). The nanopillar forest was obtained via a new 
oxygen-plasma-stripping procedure and consisted of Si pillars 
covered by a thin layer (so nm) of sputtered Ag. The perform-
ance of the embedded substrates was compared with the 
results obtained by the traditional drop-casting of an analyte 
solution onto the open metallic surface. The reproducibility of 
the measurements was improved considerably by the flow cell 
method, and had a relative error of only 13%. However, the 
overall signal intensity was four times decreased compared 
with the open surface, because the SERS spectra were recorded 
through the PDMS cover. Unfortunately, the authors did not 
indicate the required time to achieve a steady and stable SERS 
signal of the target molecule. Furthermore, this platform, as 
many others reported, seals the SERS-active substrate in an 
irreversible way in the PDMS channel. Therefore, either an 
effective cleaning procedure has to be applied before reusing 
the microfluidic chip or they have to be considered as disposa-
ble devices. An alternative to these platforms was reported by 
Patze et al. 101 They embedded silver substrates prepared by 
(a) 
(b) 
8 ··· 
Fig. 5 (a) Microfluidic SERS sensor based on nanopillar forests realized 
by a technique involving oxygen-plasma stripping of the photoresist: 
schematic structure, the entire chip with the inlet and outlet depicted, 
photo of the chip, and SEM images of the nanopillar forest. (Reprinted 
from Mao et al. 89 Copyright 2013. With permission from Wiley-VCH 
Verlag GmbH & Co. KGaA, Weinheim.) (b) Microfluidic cartridge setup 
applied for SERS experiments: the microfluidic cartridge (a), the 
implemented SERS substrate (b). the silicon channel (cl. and the glass 
cover (d) are shown with an offset for better visibility; photographical 
image of the entire cartridge and SEM image of the silver-covered elec-
tron beam lithography patterned quartz substrates (reprinted from 
S. Patze, U. Huebner, F. Liebold, K. Weber, D. Cialla-May, J. Popp, SERS 
as an analytical tool in environmental science: The detection of sulfa-
methoxazole in the nanomolar range by applying a microfluidic car-
tridge setup, Anal. Chim. Acta, 949, 1-7 (ref. 101) Copyright 2016 with 
permission from Elsevier). 
Analyst, 2017, 142, 1022-1047 I 1029 
7 PUBLICATIONS 
126 
Critical Review 
electron beam lithography into a microfluidic cartridge. On 
top of the plasmonic structures, a silicone cover with a micro-
fluidic channel was positioned and covered by an optical glass 
window (see Fig. S(b)). The system was closed with screws, 
allowing the easy replacement of the SERS-active substrate. 
The system offered many possibilities as it could be used for a 
large variety of stationary SERS-active substrates. 
Although the two above-described platforms have different 
designs, they share the same limitation as most continuous 
flow devices. Namely, the transport of analyte molecules 
toward the surface of the metallic surface relies on diffusion, 
which is especially slow in parabolic velocity flow profiles with 
zero velocity at the channel walls. Hydrodynamic focusing, 87•94 
electrokinetic concentration, 86 or chemical functionalization 
of the metallic surface91 '92'145 are some of the solutions to 
overcome this challenge. The incorporation of hydrodynamic 
focusing into a microfluidic device with embedded fluidic 
tubing and a SERS-active electrode was reported by Bailey 
et al. 94 On this platform, both SERS and electrochemical 
measurements could be carried out. The sample was injected 
via a capillary embedded into the chip and via an additional 
inlet. Due to the perpendicular flow of the two streams, a 
sheath-flow profile was created, where the analyte molecules 
were confined near the SERS-active substrate. An alternative 
way to increase the amount of the target analyte on the met-
allic surface is by applying an electrokinetic concentration. In 
this way, pathogens could be concentrated by combining the 
discriminating capability of short-range dielectrophoresis with 
the long-range transporting capability of DC-biased AC 
electroosmosis. 86 
As in the case of the platforms employing colloidal nano-
particles, immunoassay-like platforms have also been fabri-
cated with stationary SERS-active substrates. 83•92•145 Due to the 
very strong binding reaction between antibodies and antigens, 
the capturing of the target molecules can be significantly 
enhanced. Lee and coworkers83 combined the immunoassay 
concept with a fully automated gold array-embedded gradient 
microfluidic chip. A schematic illustration of the device is 
shown in Fig. 6. The top layer consists of a PDMS panel for 
uniform distribution of the antibody-conjugated hollow gold 
nanospheres, followed by a middle PDMS gradient panel for 
l 
POMS panel for 
the uniform 
distribution of 
antibody-
conjugated HGNs 
gold array-embedded 
panel for the glass substrate for the 
generation of various immobilization of 
concentrations of a sandwich 
cancer marker 
_j 
photograph of an 
integrated gold 
array embedded 
gradient chip 
photograph of the 
channel filled with 
differenl ink 
solutions 
Fig. 6 Schematic of a gold-array-embedded gradient chip consisting of 
three layers and its photographs (reproduced from Lee et al. 83 with per-
mission from The Royal Society of Chemistry). 
1030 I Analyst, 2017, 142, 1022-1047 
View Article Online 
Analyst 
the generation of various concentrations of the biomarker, and 
a bottom panel featuring a gold-embedded glass substrate for 
immobilization of the sandwich immunocomplexes. The 
tedious manual dilution process involving repetitive pipetting 
and inaccurate dilutions is eliminated in this way. Another 
interesting approach was reported by Wu and coworkers.145 
They realized a concept of a SERS-assisted 3D barcode, where 
different SERS probes labeled with different Raman reporters 
allow quantitative multiplex detection. The platform, therefore, 
has multiple channels and allows the simultaneous detection 
of m x k kinds of antigens in n kinds of samples when k kinds 
of Raman reporters are used. 
In situ synthesized SERS-active substrates. The platforms 
described up to now in the present review implement SERS-
active substrates that were prepared via off-chip methods. This 
requires additional lab equipment and skilled personnel and 
increases the overall time of the analysis. However, the in situ 
synthesis of plasmonic nanostructures opens a new avenue for 
system integration, miniaturization, and on-site applications. 
Leem et al. 131 applied the polyol method to synthesize 
silver-patterned surfaces in a microfluidic chip (Fig. 7(a)). In 
the chemical reaction, ethylene glycol acts as a solvent as well 
as the reducing agent for silver. As silver ions are reduced to 
silver atoms, the concentration of silver atoms in the precursor 
solution increases and silver nuclei start to form and grow into 
nanoparticles. In order to enhance the crystalline structure of 
the nanoparticles, polyvinylpyrrolidone (PVP) and copper(n) 
chloride are added to a precursor containing silver nitrate. 
A thin layer of nanoparticles forms on the walls of the micro-
fluidic platform, consisting of a PDMS channel on the Si wafer 
substrate. After fabrication, the substrate is washed with 
ethanol in order to remove the PVP from the surface. For the 
measurements, the silver-patterned-PDMS channel was after-
wards attached to a glass substrate. 
Parisi and coworkers106•110 published two subsequent 
studies where they made use of the galvanic replacement reac-
tion for the in situ synthesis of rough metallic structures. In 
their approach, after the in situ electrodeposition of Cu-core/ 
C-sheath nanowalls, a facile in-channel silver galvanic replace-
ment reaction method took place at room temperature. For 
this, the electrodes had to be integrated into the microfluidic 
channel. These electrodes were prepatterned on a Si substrate 
using photolithography and lift-off techniques. The PDMS 
microfluidic channel was plasma-bonded to the Si substrate. 
The as-prepared platform offered high sensitivity due to the 
large available surface of the silver-nanoparticle-decorated 
nanowalls for analyte absorption and a large number of nano-
cavities, which could confine the surface plasmons in very 
small volumes. 
Zhao et al. 114 used the PDMS-PDMS-glass "sandwich" 
microfluidic device illustrated in Fig. 7(b) for the in situ syn-
thesis of composite Ag film@nano Au structures. For this, 
first, silver ammonia solution and glucose were filled into the 
channel in order to create a silver mirror. This was followed by 
the addition of poly(dimethyldiallylammonium chloride) and 
self-assembly of the Au nanoparticles. Finally, a chemical-
This journal is © The Royal Society of Chemistry 2017 
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Fig. 7 (a) Schematic of the microfluidic patterning system. the SEM 
image of the Ag thin film, and photographs of the Ag-patterned PDMS 
and Si wafer. (Reproduced from Leem et a/.131 with permission from 
The Royal Society of Chemistry.) (b) Components of the "sandwich" 
microfluidic chip and a cross-section of the microfluidic channel. 
(Reproduced from Zhao et a/. 114 with permission from The Royal Society 
of Chemistry.) (cl Scheme for the laser fabrication of silver microflowers 
inside a microfluidic channel (reproduced from Xu et a/.104 with per-
mission from The Royal Society of Chemistry). 
plating solution flowed over the nanostructure. Although the 
authors claim the in situ synthesis of the SERS-active substrate, 
gold colloids synthesized a priori were used in order to obtain 
the final nanostructures. 
These three approaches and some others107•112 published 
during the last four years have yet to deal with the challenge of 
cross-contamination and single-measurement design. A solu-
tion for this was published by Bjerneld et al. 146 and it involved 
the photochemical reduction of silver nitrate. More exactly, 
upon illumination with laser radiation, a chemical reaction 
between silver nitrate and citric acid is induced and colloidal 
silver, acetone-1,3-dicarboxylate, and carbon dioxide is 
This journal is © The Royal Society of Chemistry 2017 
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formed. El-Zahry and coworkers105'113 applied this synthesis 
principle for the in situ preparation of silver substrates. This 
was combined with a measurement protocol, where the 
memory effects did not play any role anymore in the SERS 
detection. Namely, in the procedure, a sequential injection 
analysis was used and the flow cell was moved by a few 
micrometers after each SERS detection. The formation of 3D 
Ag@ZnO nanostructures at any predefined position inside the 
microfluidic channels was also achieved by using a weak-
focused, continuous-wave laser beam on the surface of a gold 
film serving as the bottom of the chip.108 Due to light absorp-
tion of the Au film, the solution was locally heated up and 
then, by applying a precursor, 3D Ag@ZnO structures were 
formed. Light-matter interaction was also used by Xu et al. 104 
to create silver microflower arrays in situ (see Fig. 7(c)). The 
authors used femtosecond-laser-induced photoreduction on 
the bed of a glass microchannel, and they attributed the for-
mation of the structures to multi-photon-absorption-induced 
photoreduction. Nevertheless, the whole microflower array was 
created at once and then sealed in a PDMS template. 
Therefore, the advantage offered by the creation of a new 
hotspot after each SERS measurement is cancelled out. 
Segmented flow platforms 
In continuous flow platforms, cross-contamination and a weak 
analyte-plasmonic-substrate interaction are the main chal-
lenges. As described above, multiple strategies have been 
applied during the last few years to try to overcome these limit-
ations. In parallel with this work, microfluidic platforms with 
segmented flow were also developed.60•115- 124 Here, segments 
can be formed by separating the liquid of interest by an immis-
cible fluid phase or by gas bubbles. 129 Although the liquid con-
taining the sample wets the channel walls, cross-contami-
nation is less relevant, as liquid exchange between the seg-
ments might happen only due to the thin wetting layer on the 
channel walls. Furthermore, by functionalizing the surface of 
the channels with a hydrophobic layer,147 the aqueous seg-
ments do not wet the channel walls and precipitation of the 
substances is thus avoided. The challenge of cross-contami-
nation is completely overcome only if the molecules or ions in 
the liquid sample cannot diffuse between segments. 
Droplet-based microfluidic chips are the most popular seg-
mented flow microfluidic platforms. Here, mixing is consider-
ably enhanced by the convective flow inside the droplets.129 
Operational units, such as the droplet generator, splitting, 
fusion and mixing, solution dosing, phase separation, and dis-
tance control can be easily integrated. 65 Many of these units 
do not require an external trigger and they act thanks to the 
interplay of the interface generated forces with the hydro-
dynamic forces. As the SERS-active substrates, colloidal nano-
particles are applied. 
Batch-synthesized SERS-active substrates. Citrate-116- 118•121 
and hydroxylamine hydrochloride60•123' 124-reduced silver col-
loidal nanoparticles are commonly encountered in the field of 
droplet-based microfluidic platforms. In the first case, the 
authors followed the protocol published by Lee and Meisel136 
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in 1982, which consisted of the chemical reaction between 
silver nitrate and sodium citrate at the boiling temperature of 
water. The reaction took up to one hour, and thus, other proto-
cols have been considered in order to reduce this time. An 
almost instantaneous reduction of silver nitrate by hydroxyl-
amine hydrochloride in the presence of sodium hydroxide can 
be carried out at room temperature. The preparation proto-
col137 was published in 2003 and in the literature, the resultant 
products are referred to as 'Leopold-Lend! nanoparticles'. The 
same microfluidic platform was combined by Popp 
et al. so,11?,11s,121,123,12• with both types of colloidal nano-
particles for various applications. The glass-based platform is 
depicted in Fig. 8(a). Glass has a low Raman scattering cross-
section, and, as compared with PDMS, no signals interfere 
with the fingerprint of the molecules of interest. The success-
ful generation of droplets in the continuous phase of oil was 
assured by a T-junction and in the hydrophobic channel walls 
due to the silanization procedure. Through a dosing unit, 
additional aqueous solutions could be injected into the 
already-existing droplets. The efficient mixing of substances 
was assured via the two meandering channels, while a long 
measurement loop allowed fine tuning of the measurement 
position. Generally, the analyte solutions and the solvents are 
pumped through ports 1-3, while the silver nanoparticles and 
their activation agent are injected via ports 4 and 5. In this 
way, the in-droplet concentration of the analytes could be 
easily and automatically adjusted and the addition of the 
SERS-active substrate can then be done in a reproducible 
manner. Lu and coworkers116 employed a PDMS microfluidic 
chip very similar to the one depicted in Fig. 8(a), demonstrat-
ing the versatility of the microfluidic platform. Gold-core 
silver-shell nanocomposite particles were also employed in 
droplet-based microfluidics due to their proven SERS-signal-
enhancement properties. For the synthesis of the gold core, 
Chung and co-workers115 used the citrate reduction protocol 
followed by the addition of a DNA probe and encapsulation in 
a 4 nm thin silver layer. A pentagon-shaped microfluidic 
channel was designed to control the droplet size, as depicted 
in Fig. 8(b ). After droplet formation, the samples in each com-
partment were mixed during the transport through the 
winding channels, and a long measuring loop is implemented. 
Wu et al. 120 prepared gold nanorods, as cores, using a pre-
viously developed seed-mediated growth method.148 After a 
purification step, the cores were coated with silver. For this, 
L-ascorbic acid, hexadecyltrimethylammonium bromide, and 
silver nitrate were used. The as-prepared nanoparticles, the 
carrier oil, and the sample were injected at three different 
inlets of the microfluidic platform (Fig. 8( c )), which had a 
single, long, meandering channel. 
Recently, Gao and coworkers122 reported an approach for a 
wash-free magnetic immunoassay combined with droplet 
microfluidics. The starting point for this platform was based 
on the microfluidic device depicted in Fig. 3(b ). There, the 
same authors used yoke-type solenoids for separation of the 
magnetic immunocomplexes from the solution. Nevertheless, 
the removal of unbound reagents was challenging and compli-
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Fig. 8 (a) LoC-SERS system made out of glass: ports 1-5 are used for 
the injection of an aqueous solution containing the sample, the SERS-
active substrates, and their aggregation agent. (Reprinted with per-
mission from Hidi et al.123 Copyright 2016 American Chemical Society.) 
(b) Microdroplet channel layout for the SERS detection of mercury(11) 
ions. Photograph of the channel filled with different colors of ink (blue 
and red), injected through the two inlets for the formation of aqueous 
droplets. (Reproduced from Chung et al.115 with permission from The 
Royal Society of Chemistry.) (cl Schematic of a droplet-based microflui-
dic device (reprinted from L. Wu, Z. Wang, S. Zang, Y. Cui, Rapid and 
reproducible analysis of thiocyanate in real human serum and saliva 
using a droplet SERS-microfluidic chip, Biosens. Bioelectron., 62, 
13-18.12° Copyright 2014 with permission from Elsevier with the per-
mission of Elsevier). 
cated-to-fabricate solenoids were required. In their recent 
study, the same authors designed and implemented a droplet-
based microfluidic system embedded with a rectangular mag-
netic bar. The platform, depicted in Fig. 9, has four distinct 
operational units: microdroplet generator, immunocomplex 
and supernatant separator, isolation of magnetic immuno-
complex droplets, and collection of unbound SERS nanotag 
droplets for SERS detection. The microdroplet generator had 
the same pentagon design as the platform in Fig. 8(b). The key 
parameters of this platform were the last two operational 
units. Namely, after the separation of the magnetic beads by 
the magnetic bar, the initial droplet was split into two smaller 
This journal is © The Royal Society of Chemistry 2017 
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Fig. 9 Wash-free magnetic immunoassay combined with droplet-based microfluidics having five compartments (i-v) (reproduced from 
Gao et a/.122 with permission from The Royal Society of Chemistry). 
droplets due to the presence of the y-shaped channels. The 
large droplets contained unbound SERS nanotags, while the 
smaller ones contained the magnetic immunocomplexes. 
Therefore, washing steps for removal of any unbound targets 
were not required. 
In situ synthesized SERS-active substrates. As already men-
tioned, the in situ synthesis of SERS-active substrates provides 
numerous advantages. Nonetheless, during the last four years, 
only two publications, to the best of our knowledge, have 
reported the synthesis of SERS-active colloids in droplet-based 
microfluidic platforms. This low number may be for many 
reasons. First, due to the formation of gaseous reaction pro-
ducts in most of the existing synthesis protocols, the stability 
of the droplets can be affected. Second, the slow reduction 
reaction of metal salts requires long microfluidic channels in 
order to assure the completeness of the reaction. The 
Leopold-Lend! nanoparticles are formed instantaneously and 
at room temperature. Gao et al. 125 took advantage of this fast 
reaction and synthesized these nanoparticles in a droplet-
based microfluidic platform, as illustrated in Fig. 10. For this, 
they used a PDMS chip with two compartments. The first one 
had multiple winding channels in order to assure a good 
mixing of the reactants used for the colloidal synthesis and a 
long diffusion channel for the fast growth of silver nucleation. 
The second compartment had a T-junction, where the analyte-
containing solutions were pumped into the droplets contain-
ing silver colloids. Although this is a promising approach, this 
synthesis protocol cannot be used in the case of the microflui-
dic chip shown in Fig. B(a) because the sodium hydroxide used 
for assuring an alkaline pH during the synthesis will react 
with the silane layer deposited on the surface of the micro-
channel. To overcome this, Dugandzic et al. 126 used instead a 
chemical reaction between silver nitrate and hydrazine hydrate 
in ammonium hydroxide solution and trisodium citrate as a 
protective agent. 
This journal is © The Royal Society of Chemistry 2017 
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Fig. 10 Schematic of a droplet-based microfluidic platform used for 
the in situ synthesis of silver nanoparticles and the detection of a 
diaquat dibromide (reproduced from Gao et a/.125 with permission from 
The Royal Society of Chemistry). 
Both described strategies show the superiority of the in situ 
synthesized colloidal solution over the batch protocols. 
Namely, each droplet contains a freshly prepared batch of col-
loids synthesized in an automatic and reproducible way. Also, 
colloid formation and SERS measurements can be performed 
on the same platform. And finally, the aging of the colloids no 
longer plays a role anymore. 
Powerful application schemes in 
biophotonics 
As discussed above, the combination of SERS as an optical 
detection method with nano/microfluidics offers the possi-
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bility to tackle the challenges of conventional SERS measure-
ments without compromising the sensitivity and specificity of 
the technique. This synergy opened the door for new appli-
cations, such as the immunoassay-based reliable SERS detec-
tion of biomarkers. The present section aims to offer an over-
view of the current hot topics of applications addressed by 
SERS and microfluidics. 
Environmental and food monitoring 
Even micromolar concentrations of pollutants in food or water 
can bring potential public health risks, so it is highly impor-
tant to control any presence of naturally occurring or inten-
tionally added chemical hazards in the environment. During 
the last few years, many studies have demonstrated that SERS 
combined with microfluidics is a powerful analytical tool for 
this purpose.96,149-152 
Chung et al. 115 realized the SERS-based trace analysis of 
Hg(n) ions in water down to 10 pM concentration using Cy3-
labeled aptamer-modified Au/Ag core-shell nanoparticles in 
the microdroplet channel (Fig. s(b)). Namely, in the presence 
of Hg(n) ions, aptamer DNAs formed stable T-Hg(n)-T 
mediated hairpin structures, displacing the Raman reporter 
Cy3 from the surface of the nanoparticles and causing a 
decrease in the SERS signal (Fig. 11(a)). Similarly, an indirect 
strategy was used for the detection of As(m) ions by mixing 
them in a zigzag microfluidic chip with glutathione (GSH)/ 
4-mercaptopyridine ( 4-MPY)-functionalized silver colloids 
(Fig. 11(b )). The binding of As(m) ions with GSH led to the 
aggregation of Ag colloids, and a SERS signal of 4-MPY could 
be recorded. Such sensors exhibited selectivity to the As(m) 
ions with an estimated limit of detection (WD) of 0.67 ppb.153 
Some toxic chemicals are widely used in agricultural areas 
and can contaminate waterways. Zhou et al. 154 reported the 
SERS-based trace analysis of the fungicide methyl parathion in 
lake water samples using a capillary with incorporated electri-
cal heating constantan wire covered with vertically aligned 
ZnO nanotapers decorated with Ag nanoparticles (Fig. 11(c)). 
For SERS measurements, the capillary was filled with a 
mixture of a thermoresponsive microgel, Au-nanorod colloids, 
and an analyte solution, and then heated up. The heating 
process induced the shrinkage of the microgels, which caused 
the immobilization of the analyte and the reduction of the 
gaps between the plasmonic nanostructures. As a result, 
highly dense hotspots were formed and strong SERS signals 
were recorded. 
An alternative strategy for creating hotspots was presented 
by Yazdi and White and was described in the previous section 
(Fig. 3(a)).75 The passive trapping of Ag nanoparticles with 
adsorbed analyte molecules into the SERS detection volume in 
the measurement system allowed the detection of the organo-
phosphate insecticide malathion down to a concentration of 
12 ppb. Thereafter, the system was improved by implementing 
a passive micromixer for mixing the analyte and colloids on-
chip. With the new design, detection of the fungicide thiram, 
with an estimated WD of 50 ppt, and of the food contaminant 
melamine, with an WD of 63 ppb, were reported.76 For on-
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Fig. 11 (al In the presence of Hg(11) ions, aptamer DNAs form stable 
T -Hg(11)-T mediated hairpin structures and move the Raman reporter 
Cy3 far away from the nanoparticles, resulting in a decrease in the SERS 
signal (two right). (Reproduced from Chung et al. 115 with permission 
from The Royal Society of Chemistry.) (b) Schematic diagram of the 
microfluidic chip used for analyzing As(111) and the mixing of As(111) ions 
with GSH/4-MPY-functionalized AgNPs. (Reproduced from Qi et a/.79 
with permission from The Royal Society of Chemistry.) (cl Schematic 
of a battery-controlled SERS-based fluidic system (reproduced from 
Zhou et a/.112 with permission from Nature Publishing Group). 
field analysis, the authors simplified the system by using a 
portable Raman spectrometer and a simple pipette instead of 
a bulky pump for sample loading. The authors successfully 
performed the multi-detection of 5 ppm methyl parathion, 
0.1 ppb malachite green, and 5 ppb thiram.155 Thiram down to 
1 x 10-8 M concentration was also detected by Wang et al. 156 in 
a microfluidic channel, using a SERS optrode fabricated in situ 
by light-controlled polymerization and silver deposition. Gao 
et al. 125 used SERS to identify the herbicide diaquat dibromide 
monohydrate in microdroplets (see Fig. 10) with in situ 
This journal is © The Royal Society of Chemistry 2017 
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synthesized Ag colloids, reaching concentration levels below 
5nM. 
Parisi et al. 110 presented the direct fabrication of Ag-nano-
particles-based SERS substrates in a microchannel followed by 
the detection of the pesticide Carbofuran and the herbicide 
Alachor, with determined WDs as low as 5 ppb for both 
targets. Patze et al. 101 developed a microfluidic cartridge setup 
using structured quartz wafers covered with a 40 nm layer of 
silver as the SERS substrate (see Fig. 5(b)). A real-world appli-
cation of such a system was proven by its successful detection 
of the antibiotic sulfamethoxazole, as a drinking water pollu-
tant, in spiked tap, river and lake waters in the nanomolar 
range.101 
Many toxins threaten health and the life of humans and 
animals throughout the various food supply chains. One of 
them, ochratoxin A (OTA), was detected utilizing a microfluidic 
chip with a Au nanostructure in situ functionalized with an 
OTA-binding aptametric sequence. The injection of OTA to the 
microfluidic channel resulted in a change in the structural 
conformation of the aptamer sequence, which was possible to 
monitor with SERS. Unfortunately, only a single solution 
with a concentration of 2.5 µM was tested during the study.157 
The animal food additive clenbuterol was also detected by 
a SERS-based paper microfluidic platform with an WD of 
0.1 pg mL - 1 .158 
Detection of biomolecules 
The ability to isolate, detect, and quantify certain bio-
molecules, such as DNA or proteins, from biological matrices 
opens up plenty of opportunities in clinical and diagnostic 
medical science. Optofluidic SERS sensors, benefiting from 
ultrasensitive, repeatable, and label-free detection, have been 
successfully applied in this area. 85•108 
Zhou et al. 77 developed a SERS-based microfluidic platform 
with a pneumatic valve and nanorod arrays at the bottom of 
the microchannel for Au nanoparticle aggregation and the cre-
ation of SERS hotspots (see Fig. 4(a)). The potential of this 
ZnO 
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device was shown not only by detecting a typical protein, 
namely bovine serum albumin (BSA), down to the picomolar 
level, but also by distinguishing cytochrome C from BSA in a 
mixture of these two proteins. Wang and coworkers159 
obtained SERS spectra from the nerve agent simulant MP at a 
concentration as low as 10-8 M, using capillaries coated with 
3D-clustered nanostructures decorated with Ag nanoparticles 
(Fig. 12(a)), which also exhibited good recycling performance. 
Leem et al. 131 developed a simple and low-cost microfluidic 
pattering system for the fabrication of Ag thin films in a micro-
fluidic channel and then utilized them as an adenosine-
sensing SERS probe (Fig. 7(a)) that worked down to the 
500 nM concentration level. 
The aggregation of amyloid beta peptide (A~), a biomarker 
for Alzheimer's disease, was studied using micro/nanofluidic 
junctions and a gold-nanoparticles-based SERS-active sub-
strate. The A~ aggregates were injected into the chip and, due 
to their large size, they were trapped at the micro/nanojunction 
and then examined with SERS (Fig. 12(b)). The authors proved 
their initial hypothesis that A~ aggregation and its resulting 
structural characteristics are dependent on the initial A~ con-
centration and on the time.133 Neugebauer et al.160 used a 
combination of droplet microfluidics (see Fig. 8(a)) and SERRS 
to successfully detect hemin at a 55 µM concentration in a 
binary mixture with cytochrome C, DNA, and glutathione. 
The detection of specific DNA/RNA sequences is a major 
challenge in the fields of molecular biology and diagnosis, in 
which probing of a particular disease is based on nucleic acid 
identification. Prado et al. 161 reported the selective SERS detec-
tion of label-free purine and pyrimidine bases at low concen-
trations in continuous and in segmented flow microfluidic 
devices with silver colloids. Both platforms exhibited homo-
geneous mixing with silver colloids, but the microdroplet 
system inhibited the formation of large clusters that might 
clog the channel. 
Zhao et al. 100 presented a fast method for the detection 
of natural sources double-strand DNA. This was done by 
(b) 
Fig. 12 (a) Schematic of the preparation of 3D-clustered nanostructures for bovine serum albumin detection (reprinted with permission from Wang 
et al. 159 Copyright 2016 American Chemical Society). (b) Schematic description of a SERS-active nanofluid device (Springer, I. Choi, Y. S. Huh, 
D. Erickson, Ultrasensitive, label-free probing of the conformational characteristics of amyloid beta aggregates with a SERS-active nanofluidic 
device, Microfluid. Nanofluid., 2011, 12.133 Copyright 2011 with permission of Springer). 
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embedding a Ag/Si nanopillar array in a microfluidic chip for 
SERS monitoring. Because of the wide-range enhancing field 
and sufficient interpillar space, DNA molecules can easily 
enter the enhancing sites and yield reproducible signals upon 
excitation. 
Saha et al. 162 adapted SERS in a simple paper-based micro-
fluidic system. Using silver-coated gold nanoparticles, functio-
nalized with a Raman reporter molecule, namely 4-mercapto-
pyridine, and glucose or biotin, they could detect the proteins 
concanavalin (Con) A and streptavidin. The presence of these 
proteins, due to the high affinity to glucose or biotin, induces 
the aggregation of nanoparticles, and the SERS signal of 
4-mercaptopyridine could be detected. The authors reported 
the detection sensitivity for Con A as 1 x 10-15 M and for strep-
tavidin as 1 x 10-14 M. It was found that the SERS signal inten-
sity reached a maximum value within 3-4 min, independent of 
the protein concentration. 
Drug and narcotics detection 
The capability of LoC-SERS platforms to detect low molecular 
weight substances at low concentrations has also found use in 
drug monitoring and narcotics detection.163 
Underlining the importance of therapeutic drug monitor-
ing, Hidi et al. 60•117•123 assessed the potential and limitation of 
LoC-SERS platforms to detect drugs using silver colloids as 
SERS agents and a segmented flow microfluidic chip 
(Fig. 8(a)). The authors successfully detected methotrexate in 
the target therapeutic concentration range in distilled water. 
Thereafter, moving closer to real-world applications, the detec-
tion of the antibiotic levofloxacin was realized in complex 
matrices, such as artificial and human urine. Prior to the 
measurements, the urine samples were filtrated and diluted in 
order to reduce the matrix effects and to optimize the SERS 
signal. The system showed it held great promise in point-of-
care applications, even with a portable Raman setup.60 The 
authors also proved that such a technique is suitable for quan-
titative measurements and, combined with the standard 
addition method, it is able to predict unknown concentrations 
of an antibiotic in clinical samples. For example, for the detec-
tion of nitroxoline in spiked human urine, the achieved WD 
was 3 µM and the limit of quantification (WQ) was 6.5 µM. 
Furthermore, by applying chemometric approaches, the mole-
cule was successfully quantified in simulated clinical samples 
with an unknown nitroxoline concentration.123 
El-Zahry et al. 113 simultaneously detected aspirin and 
vitamin C in their pharmaceutical dosage forms and in spiked 
urine samples using a microfluidic chip with an in situ-
produced SERS silver substrate. SERS detection was combined 
with sequential injection analysis, offering possibilities for 
automation of the analytical procedures. The authors found 
that a slower flow leads to an increased SERS signal. The detec-
tion limits were 32 and 3 ng ml-1 for aspirin and vitamin C, 
respectively. Bailey et al. 94 combined SERS and electrochemical 
detection in a sheath-flow microfluidic channel, and detected 
riboflavin with a detection limit near 1 nM. The fast-moving 
sheath flow limits the analyte diffusion within the region close 
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to the SERS-active surface and stimulates the interactions 
between the analyte and substrate for a more sensitive SERS 
detection. 
Yiikse1 et al. 103 demonstrated that SERS combined with 
microfluidics could be applied for narcotics monitoring. The 
authors realized the detection of the main component of 
cannabis, i.e., tetrahydrocannabinol (THC), by the use of a 
SERS-based capillary platform created by in situ microwave-
synthesized Ag nanoparticles. Such a system benefited from a 
simple and fast production of capillaries, which took only 
around 3 min. After loading the analyte, SERS measurements 
along the capillary exhibited good reproducibility and THC 
was detected down to a concentration of 1 nM. Another drug 
of abuse, methamphetamine, was determined down to 10 nM 
concentration in saliva using a microfluidic flow-focusing 
device, which allowed the analyte to be first adsorbed on the 
surface of the silver colloids before introducing the aggrega-
tion agent (Fig. 13(a)). In this way, the analyte was present in 
the created hotspots and not just surrounding them as it 
would be if the analyte were to be added to already-aggregated 
nanoparticles.164 
Wu et al. 120 successfully detected a small molecule, namely 
thiocyanate (SCN-), in complex matrices, such as human 
serum and saliva, by implementing a droplet SERS-microflui-
dic device using Au@Ag nanorods (Fig. 8(c)). The rapid detec-
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Fig. 13 (a) Flow-focusing device used for controlled Ag colloids aggre-
gation. (Reprinted with permission from Andreou et al. 164 Copyright 
2013 American Chemical Society.) (b) Schematic of the sensor architec-
ture and concentration-dependent SERS spectra of dopamine (repro-
duced from Li et al.165 with permission from SPI E). 
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tion of SCN- in human saliva was also achieved and the result 
could be used to distinguish between smokers and 
nonsmokers. 
Li et al. 165 employed nanoporous gold disks in a micro-
channel to increase the total usable area of a nanostructured 
surface, thus providing more adsorption sites for biomolecules 
(Fig. 13(b )). The efficiency of such a microfluidic SERS sensor 
was demonstrated by detecting dopamine in the nanomolar 
range and urea in artificial urine with an WD 0.67 mM. 
Another urine component, namely creatinine, was measured 
in artificial urine down to 0.9 mg dL -l using nanostructured 
capillary tubes with an inverse opal photonic crystal decorated 
with gold nanoparticles.111 
Cell and bacteria detection 
The combination of SERS and a microfluidic system provides 
an efficient platform for the sensitive, rapid, low-cost, and 
automatic separation, online detection, and identification of 
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cells and bacteria without the risk of contamination of the 
sample as well as the operator.130 
Chrimes et al. 166 developed a microfluidic system integrat-
ing dielectrophoresis (DEP) and SERS for the trapping and 
real-time investigation of the cell functions of isolated and 
grouped yeast cell clusters, as shown in Fig. 14(a). Yeast cells 
were coated with silver nanoparticles first to enable highly sen-
sitive SERS analysis. Then, DEP was applied to immobilize a 
desired number of cells into the condition of being in intimate 
contact (grouped) or at a spacing greater than 10 µm from 
each other (isolated) in the microfluidic environment to 
observe the effect of such conditions on the live cells' chemical 
secretions. Principal component analysis (PCA) was used to 
visualize and examine hidden patterns in the SERS signals 
obtained from the two types of cells, and the significant sys-
tematic difference was found in the PCA score plot. The pres-
ence of chemicals and proteins around isolated cells before 
the budding process was found by analyzing the results 
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Fig. 14 (a) Schematic of silver bonding to the yeast cell-wall, followed by exposure to the light source. and the consequent generation of SERS 
signals (left). Results from the SERS of live versus dead yeast cells and grouped versus isolated yeast cells (middle and right) (reprinted from 
A. F. Chrimes, K. Khoshmanesh. S.-Y. Tang, B. R. Wood. P. R. Stoddart. S. S. E. Collins. A. Mitchell, K. Kalantar-zadeh, In situ SERS probing of nano-
silver-coated individual yeast cells. Biosens. Bioe/ectron .. 49. 536-541.166 Copyright 2013. with permission from Elsevier.) (b) Schematic of the 
microfluidic device with a sample preparation module mounted to the microscope stage (left). Mean spectra of the three batches for every myco-
bacterial species (middle). PCA-LDA model trained to separate the six species for data visualization (right). (Reprinted with permission from Muhlig 
et al.124 Copyright 2016 American Chemical Society.) 
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compared with grouped cells. This microfluidic SERS-DEP 
system enabled the in situ monitoring of cell secretion. A SERS 
substrate composed of 3D Ag@ZnO nanostructures was also 
integrated into a single-cell trapping microfluidic device by Xie 
et al. 108 for the SERS fingerprint detection of a single living 
HeLa cell surface, and multiple peaks from proteins, carbo-
hydrates, and lipids were detectable. 
The long-range concentration and rapid (<5 min) identifi-
cation of rare pathogens from human blood were realized by 
Cheng et al. 86 by using SERS and a microfluidic platform with 
a hybrid electrokinetic mechanism for the isolation and 
concentration of bacteria. By capturing low concentrations of 
bacteria from a sample containing very dense blood cells, the 
approach showed high promise for the determination of blood 
infections. Besides this study, the fast online SERS detection 
of a single bacterium with high specificity and sensitivity was 
also realized by Lin et al. 167 They combined specific antibody-
conjugated SERS tags with a microfluidic DEP device. 
Recently, a closed system for sample preparation and analysis 
based on LoC-SERS was developed by Miihlig et al. 124 and suc-
cessfully applied to the identification of six species of 
Mycobacterium tuberculosis complex (MTC) and nontubercu-
lous mycobacteria (NTM), as shown in Fig. 14(b). First, the 
bacteria were disrupted by using a bead-beating module and 
then they were directly injected into the LoC device after a 
washing step in the closed system, which ensured the operator 
safety as well as higher stability and reproducibility of the 
measurement conditions. Then, the AgNPs were also injected 
into the system to generate the SERS signals. The vibrational 
signals of the cell-wall component mycolic acid specific for 
each species dominated the SERS spectra and were thus used 
for the identification of the mycobacteria. The identification of 
the six species was realized with high accuracy and reliability 
by introducing chemometric methods. 
The synergy between SERS and microfluidics appears to be 
useful also for the detection of most common foodborne 
pathogenic bacteria. Applying chemometric analysis to SERS 
data, Mungroo et al. 81 could effectively discriminate between 
eight different pathogen species: E. coli, S. typhimirium, 
S. enteritis, Pseudomonas aeruginosa, L. monocytogenes, 
L. innocua, MRSA 35, and MRSA 86. To simulate a more realistic 
industry scenario, the authors also studied polymicrobial cul-
tures, but could reach only 64.5% accuracy in differentiation 
between individual bacterial species and 72.6% for detecting 
Gram-negative versus Gram-positive bacteria. 
Immunoassays and biomarker detection for diagnosis 
Microfluidic SERS immunoassays and biomarker detection 
dramatically improve the sensitivity and selectivity, and reduce 
the reaction volume as well as the time-cost of the assay and 
detection, which could simplify the diagnostic process and 
promote their further practical applications in the field of 
early diagnosis_ 1a2,168,169 
A robust and sensitive SERS-microfluidic bioassay plat-
form was developed by Wang et al. 92 for the simultaneous 
detection of two pathogen antigens, as shown in Fig. 15(a). 
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Fig. 15 (a) Image of the 3-channel microfluidic device containing gold 
patterns (left) and schematic illustration of the SERS biosensor platform 
with NYscFv for duplex antigen detection (right) (reproduced from Wang 
et a/_92 with permission from American Chemical Society). (b) Design of 
the microfluidic sensor and the principle of the sandwich immunoassay 
(reproduced from Zou et a/. 17° Copyright 2015. With permission from 
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim). 
The nanoyeast single-chain variable fragments (NYscFv), with 
the advantages of cost-effective production, stability in solu-
tion, and target-specificity, were developed as alternative 
affinity reagents. Highly purified, silica-coated Au nano-
particles with a self-assembled monolayer of Raman repor-
ters were introduced to generate maximum Raman signals 
and to minimize the coadsorption of other molecules. The 
use of a microfluidic device with multiple channels enables 
the rapid detection of multiple targets simultaneously. 
Finally, the highly sensitive detection of the individual 
Entamoeba histolytica antigen EHI_115350 (WD = 1 pg mL - 1) 
and EHI_182030 (WD = 10 pg mL - 1) with high specificity 
has been achieved by using this platform. Gao and co-
workers80 developed a fully automated SERS-based solenoid-
embedded microfluidic device with magnetic immuno-
coplexes for the quantitative and sensitive detection of the 
anthrax biomarker in solution, as shown in Fig. 3(a). In their 
further work, 122 the rapid and sensitive detection of prostate-
specific antigen (PSA) cancer markers in serum was also rea-
lized by using a SERS-based microdroplet sensor for a wash-
free magnetic immunoassay, as shown in Fig. 9. The WD 
was estimated to be below 0.1 ng mL -l for the PSA cancer 
This journal is © The Royal Society of Chemistry 2017 
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marker, which is much lower than the clinical cut-off value 
for the diagnosis of prostate cancer. 
Zou and coworkers170 developed a microfluidic sensing 
platform based on the sandwich immunoassay to detect the 
carcinoembryonic antigen (CEA), which serves as a reference 
for the diagnosis and prognosis of various malignant carci-
noma in whole raw blood samples, as shown in Fig. 15(b). The 
sensing platform comprised a microfluidic chip, magnetic 
immunosensors, and SERS probes, which enabled analysis of 
the whole blood sample without sample pretreatment. All the 
immunoassay steps could be completed in the microchannel 
network for high-throughput analysis. The WD for CEA in 
blood samples was as low as 10-12 M by using this method. 
Perozziello and coworkers171•172 established a SERS-microflui-
dic platform composed of a microfluidic filtering device and a 
super hydrophobic surface integrating SERS sensors for the 
filtering, concentration, and analysis of specific peptides derived 
from the breast-cancer-related (BRCA1) protein, a vital tumor-
suppressor molecule in the development of breast cancers. 
A concentration of the peptide down to 1 ng µL -l could be 
detected, demonstrating the efficacy of the microfluidic device 
to purify the complex biological sample. Distinguishing can-
cerous prostate cells from normal cells was also realized by 
Pallaoro et al. 173 by combining microfluidics with SERS for the 
identification of individual cells incubated with SERS biotags 
continuously flowing in a microfluidics channel. This work 
provided a way for one-step cell labeling and continuous cell 
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analysis for tumor cell identification at the single-cell level 
with a disposable device. Aimed at practical application, a 
paper-membrane-based SERS-microfluidic platform was also 
developed to separate glucose from a blood matrix and to 
detect the glucose level by using a nitrocellulose membrane as 
the substrate paper, a wax-printing method to construct the 
microfluidic channel, and gold nanorods with Raman labels 
as the SERS probes.174 This paper-based microfluidic SERS 
device offered a cost-effective method to simplify the diagnos-
tic process for diabetes mellitus. 
Multiplex detection 
SERS-based multiplex detection has a number of superior 
advantages, such as (1) facile labeling, (2) stable signal, (3) 
narrow peak width and high spectral resolution, (4) allowing 
simultaneous labeling of multiple reporters, and (5) multiple 
signals with a single wavelength excitation. When combined 
with the merits of microfluidics, it permits the capabilities to 
perform rapid, low-volume, and high-throughput multiplex 
detection with high sensitivity and reproducibility. 88•175•176 
Choi et al. 82 developed a programmable SERS-based micro-
network gradient platform to simultaneously and quantitat-
ively detect two breast cancer-related DNA oligomer mixtures, 
as shown in Fig. 16(a). The microfluidic network was designed 
by using an electric-hydraulic analogy to generate on-demand 
concentration gradients and to automatically produce different 
concentration gradients by continuously mixing Cy3-labeled 
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Fig. 16 (a) Three-layer integrated micro-network gradient channel and photograph of the channel filled with different colors of ink injected 
through the three inlets (top). SERS signal coming from the DNA oligomers adsorbed on the silver nanoparticle aggregates in the microfluidic 
channel and confocal SERS spectra of different molar ratios of the duplex DNA oligomer mixtures (below). (Reproduced from Choi et al.82 with per-
mission from The Royal Society of Chemistry.) (b) Simultaneous detection of human lgG, mouse lgG, and rabbit lgG. Schematic illustration of the 
multiplex immunoassay using one channel containing three antibodies (top). Components in each sample (middle). The results of the multiplex 
immunoassays are represented in 3D barcode (below) (reproduced from Wu et al.145 Copyright 2015. With permission from Wiley-VCH Verlag GmbH 
& Co. KGaA. Weinheim). 
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oligomers (BRAC1-Wild). AgNPs were used to measure the 
SERS signals for different ratios of the duplex DNA oligomer 
mixtures under flowing conditions, and a good linear response 
was achieved. The detection time (less than 10 min) was 
reduced dramatically compared with the traditional PCR tech-
nique. The multiplex detection of DNA sequences was also 
demonstrated by Yazdi and coworkers78 through a SERS-based 
competitive displacement assay in an integrated microsystem, 
as shown in Fig. 3(a). The WD was as low as 100 pM for the 
target DNA sequence. Nguyen et al. 177 designed a SERS-micro-
fluidic system for a multiplex immunoassay to detect four bio-
markers of breast cancer from mimicked-patient serum. Gold 
nanostars conjugated with intact antibodies (IgG) and frag-
ments of antigen binding (Fab) were used to determine the 
SERS signals. 
The Fab-immunosenor demonstrated a 2.4-times higher 
signal than that of the IgG-immunosensor. The microfluidic 
device with four reaction chambers was designed for the detec-
tion of the four approved biomarkers. This improved SERS-
microfluidic platform has been successfully used for the multi-
plex detection of a panel of breast cancer biomarkers, includ-
ing cancer antigen (CA125), HER2, epididymis protein (HE4), 
and Eotaxin-1 from patient-mimicked serum samples. Wu 
et al. 145 developed a SERS-assisted 3D barcode microfluidic 
chip for a simultaneous, high-throughput, and multiplex 
immunoassay, as shown in Fig. 16(b). A microfluidic patterned 
antibody barcode substrate was designed for the spatial separ-
ation of multiple proteins in different samples. Au@Ag nano-
rods with different Raman labels served as SERS tags to gene-
rate spectroscopic information. The 3D barcode joins 2D 
spatial encoding with Raman spectroscopic encoding to store 
all the information for multiplex detection, including the 
sample sequence number, the presence of different proteins, 
and the concentration of the corresponding proteins in each 
sample. The one-step multiplex detection of human IgG, 
mouse IgG, and rabbit IgG within 30 min could be achieved 
with an ultrasensitivity down to 10 fg mL - 1 • 
In situ monitoring of biological processes and chemical 
reactions 
SERS-microfluidic systems have also found important appli-
cations in the in situ monitoring of chemical reactions and 
processes. This is possibly due to the unique advantage they 
offer whereby complex reactions can be easily carried out in 
different microchannels, which act as microreactors allowing 
reactant injection as well as procedure monitoring and the 
sensitive detection of reaction products with SERS.104 
Qi et al. 91 developed a SERS-based label-free approach for 
the in situ monitoring of the individual DNA hybridization by 
immobilizing molecular sentinel (MS) on nanoporous gold 
(NPG) disks inside microfluidics, as shown in Fig. 17(a). The 
microfluidic environment allowed agile fluid manipulation 
with a small volume. MS involves the complementary sequen-
cing of a target ssDNA into a hairpin probe, which has a thiol 
group at the 5' end for robust binding and cyanine 3 (Cy3) at 
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Fig. 17 (a) Schematic of MS sensing mechanism in microfluidics (left). 
In situ hybridization monitoring using SERS line-spectra (right). 
(Reproduced from Qi et al. 91 with permission from The Royal Society of 
Chemistry.) (b) The microfluidic reactor chip used for label-free SERS 
monitoring of the reduction of 4-NTP on Au-Pt-Au bifunctional NPs in 
aqueous borohydride solution (left). Kinetic SERS monitoring of the 
catalytic reactions at different pH values and comparison of the reaction 
kinetics by using freshly prepared and aged sodium borohydride solu-
tions at pH 13.7 (reproduced from Xie et a/. 178 Copyright 2016. With per-
mission from Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim). 
the 3' end for SERS detection. The strong SERS signal of Cy3 
decreases during the hybridization process when the hairpin 
structure is open. By using this approach, the onset of hybridi-
zation events within 10 min after introducing 20 pM target 
ssDNA molecules could be detected with the sensitivity down 
to the single-molecule limit. The in situ monitoring of the 
enzymatic breakdown of organophosphate (OP) was carried 
out by Liberman et al. 109 by forming SERS-active AgNP clusters 
to enhance the Raman signals of the thiolated breakdown pro-
ducts inside a microfluidic device. Recently, Xie and co-
workers178 investigated the platinum-catalyzed reduction of 
4-nitrothiophenol (4-NTP) to 4-aminothiophenol (4-ATP) by 
using label-free SERS monitoring in a microfluidic reactor, as 
shown in Fig. 17(b). Bifunctional Au-Pt-Au hybrid NPs were 
used as metal catalysts and SERS-active substrates. A microflui-
dic reactor chip with 30 alternatingly combined channels was 
used for completely mixing, eliminating unwanted photo-
catalytic side reactions, and providing the necessary time 
resolution for kinetic monitoring. A strong pH-dependent cata-
lytic reduction of 4-NTP in aqueous solution of sodium boro-
hydride was revealed based on kinetic analysis. This work 
demonstrated the potential of the microfluidics-based kinetic 
SERS monitoring of heterogeneous catalysis in colloidal 
suspension. 
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Chemometric methods 
This section gives an overview and a short explanation of the 
chemometric methods applied in the LoC-SERS papers 
reviewed in the previous sections. Chemometrics is generally 
utilized to translate the SERS spectra into meaningful infor-
mation, normally either concentration estimates or diagnostic 
values. In order to take advantage of the unique potential of 
SERS for chemical analytics or diagnostic purposes, methods 
that allow 'control' of the SERS enhancement have to be deve-
loped. The reason for this is that an uncontrolled enhance-
ment leads to unreliable varying information. Control can be 
achieved by either controlling all the experimental parameters, 
as demonstrated in the experimental sections above, or exercis-
ing control within the data analysis pipeline. In the second 
route, the robustness of the prediction is enhanced within the 
chemometric data pipeline used to analyse the SERS spectra. 
Both experimental and computational control methods try to 
reduce variations of the signal that do not arise from the 
analyte of interest. The results of both approaches are reliable 
and robust SERS spectra and/or extracted information (either 
concentration estimates or diagnostic values). 
The computational approach will be described in the fol-
lowing pages. To the best of the author's knowledge, general 
investigations on the chemometric workflow for SERS spectra 
are not reported, therefore the usual data pipeline used for 
Raman spectra with minor modifications is employed. 179 
This Raman spectroscopic data pipeline is composed of a 
spectral pre-processing and construction of the analysis 
models. These models are, ultimately, evaluated with vali-
dation schemes, e.g., cross-validation or bootstrapping, to cal-
culate the model characteristics. These characteristics may be 
the root-mean square error of prediction (RMSEP) for 
regression models or accuracies in the case of classification 
models. These characteristics are calculated to estimate the 
generalization performance of the models, e.g., which error 
may result when predicting unknown SERS spectra with the 
evaluated models. The chemometrical models applied are 
standard chemometrical models, such as factor, classifi-
cation, and regression techniques, which are widely 
described in textbooks.180 The evaluation procedures and the 
calculated characteristics do not differ from the ones used in 
classical Raman spectroscopic analysis. Beside these simi-
larities in the data pipeline of classical Raman spectroscopic 
analysis and SERS analysis, the pre-processing features a few 
differences. In the following, we give an overview of the 
analytical models used, the evaluation procedures,181 and the 
pre-processing routines.182 
Preprocessing of LoC-SERS spectra 
The preprocessing routines used for the pretreatment of 
LoC-SERS spectra are slightly changed in comparison to the 
preprocessing routines used for Raman spectra. This change 
results from the fact that most of the microfluidic platforms 
allow the use of internal/external standards or certain spectra 
that can be used as such. The usual preprocessing for Raman 
This journal is © The Royal Society of Chemistry 2017 
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spectra consists of a spike correction, a wavenumber cali-
bration, 183 intensity calibration, a baseline correction,101•124•164 
a smoothing, and a normalization.179'182 For Raman spectra, 
this data pipeline is intensively investigated and optimized. 
For example, Guo et al. 184 developed a marker that can be used 
to estimate the baseline correction quality and therefore can 
combine different background correction algorithms for the 
same dataset.184 In this study, 184 a sensitive nonlinear iterative 
peak (SNIP) clipping, an asymmetric least squares baseline fit 
(ALS), and a modified polynomial fitting (Modpoly) were com-
bined. These algorithms are widely used for the analysis of 
Raman and SERS spectra (see references of the study184). All 
these methods try to separate a slowly varying background 
from fast changing Raman bands. While ALS and Modpoly fit 
a low order polynomial, the SNIP algorithm uses the Low 
Statistic Digital Filter, then the Peak Clipping Loop and the 
inverse filter to determine a background estimation. For the 
normalization, often the vector norm or the area norm of a 
certain band or of the whole spectrum are utilized. While the 
area norm is the sum of all intensities, the vector norm is the 
squared root of the sum of all the squared intensities. Often 
LoC-SERS devices allow measuring either an internal stan-
dard147 or spectra of a different channel within the device or 
the spectra of some separation medium,183 which can then be 
used as the standard spectra. With the help of these additional 
spectra wavenumber or intensity, changes183 can be corrected. 
This is visualized in Fig. 18, where a marker band of the separ-
ation medium (oil) is used to perform additionally a wavenum-
ber calibration. Other researchers often try to correct for 
colloid properties118·147 by means of new calibration concepts. 
These calibration procedures aim to standardize the SERS 
spectra in such a way that a robust and reliable analysis of 
these spectra is possible. The utilized analytical models will be 
described in the next section. 
Statistical models and their quality measures 
The statistical models used to analyze every kind of data, 
including LoC-SERS spectra, depend on the spectroscopic task 
to be solved. In principle, regression models and classification 
algorithms are used depending on if a continuous or a discrete 
variable should be extracted from the data. 180 Such a conti-
nuous variable is most often the concentration of an analyte of 
interest. In this case, regression algorithms, like partial least 
squares regression (PLS)185 or principal component regression 
(PCR), can be applied. The basis is always to optimize the cor-
relation of the spectra and the analyte concentration. All of 
these methods construct a predictive linear model for the 
given analyte based on a training dataset and their perform-
ance is then evaluated using evaluation procedures, like the 
cross-validation procedure.181 Based on these evaluation pro-
cedures, the generalization performance of the model is esti-
mated and quantified. As a quantitative marker for the per-
formance, the average relative prediction error (ARPE)151 or the 
root-mean squared error (RMSE)180 can be utilized. The ARPE 
can be interpreted as the mean relative error, while the RMSE 
results in an absolute quantification of the average error. 
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Fig. 18 (a) Segmented flow applied within a microfluidic device with a 
fixed measurement position and continuous movement of the droplets 
during detection; baseline-corrected Raman spectrum of mineral oil 
measured at t1 (measured outside a droplet) and a baseline-corrected 
SERS spectrum of an analyte detected at t2 (measured inside a droplet). 
(b) Plot of the peak position of a fitted oil band at 1445 cm-1 before and 
after wavenumber calibration. (Reprinted with permission from Marz 
et a/.183 Copyright 2011 American Chemical Society.) 
Sometimes a 'P' for prediction or 'CV' for cross-validation is 
appended to the abbreviation to emphasize how this value was 
derived. 
Beside the presented regression techniques, other tech-
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(MCR-ALS), which is used due to its flexibility to incorporate 
constraints123•186- 188 into the data pipeline. 
If, in contrast, a discrete variable should be extracted, 
classification algorithms are utilized. Most common for the 
analysis of LoC-SERS data is a combination of principal com-
ponent analysis (PCA) and linear discriminant analysis 
(LDA).81•124•160 These two methods are over 100 years old, but 
their advantage is their robustness. This robustness results 
from the fact that the LDA constructs a linear classification 
model after a PCA has been utilized to reduce the dimension-
ality. Again, these models are evaluated based on evaluation 
procedures, like cross-validation. 181 From this evaluation or 
from the application to an independent dataset, quantitative 
markers for the model performance are extracted. This can be 
the accuracy, which is the overall working of the classification 
model, or the sensitivity of an important group.189 As we have 
already mentioned, the applied statistical models are standard 
models, which are also applied in classical Raman spec-
troscopy. Nevertheless, there are a few studies that have tried 
to standardize LoC-SERS specific characteristics, which will be 
described at the end of this section. 
Computational ways to deal with Loe-SERS-specific 
characteristics 
There are two ways to deal with variations within LoC-SERS 
measurements: one is based on ( extended) multiplicative 
signal correction (EMSC/MSC)190•191 and the other one is 
based on the standard addition method (SAM).192 The first 
way was investigated by Xia and coworkers.151 They combined 
the 'optical path-length estimation and correction' (OPLEC) 
and a MSC to a method called 'multiplicative effects model for 
SERS (MEMsERS)'. They showed that their model was superior 
to PLS in terms of RMSEP and ARPE. Another approach is the 
combination of LoC-SERS and SAM, where a known concen-
tration of the analyte of interest is added to the test sample 
and via recalculation the unknown concentration of the test 
sample can be determined.192 In principle, this method cor-
rects for matrix effects, which is thus a great advantage.121•123 
The SAM procedure for the determination of the unknown 
concentration of Congo red in the presence of methyl red in 
an aqueous solution by applying microfluidic SERS is illus-
trated in Fig. 19. Namely, by keeping a constant flowrate for 
the sample and adjusting the flowrates of water and the stan-
dard solution while keeping a constant total droplet volume 
(Fig. 19(a)), the unknown concentration of the target molecule 
could be determined. After a dimension reduction, where the 
SERS spectra were converted (Fig. 19(b )) to a 1D score 
(Fig. 19(c)), the unknown concentration of Congo red in the 
binary solution was accurately estimated. 
niques exist that can be used as regression tools. Two of these Future perspectives and conclusions 
techniques are the classical least squares,173•175 where known 
SERS spectra are fitted as the sum of the constituents spectra The body of literature focusing on the development of 
and the fitting coefficients are used as concertation estimates, LoC-SERS platforms is exhaustive, as demonstrated in the pre-
and the multivariate curve resolution alternating least squares vious sections of this review. Much effort has been done to 
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Fig. 19 (a) LoC-SERS-SAM gradient flow: the flow rate of water (gray 
dashed line) and the sum of the flow rates of an unknown sample and of 
an added standard are illustrated (green solid line). The colored areas 
illustrate the corresponding fraction of the analyte concentrations of the 
unknown sample (pink) and the standard (blue). (b) SERS spectrum of 
methyl red (black dotted line) used as an interfering molecule for the 
determination of the unknown concentration of Congo red (green line) 
in a binary matrix. The following spectra belong to the stepwise 
additions of the standard. (c) The gray points represent the prediction 
from the PCR. Also, the mean and standard deviation of the scale pro-
jection are shown. (Springer, E. Kammer, K. Olschewski, S. Stockel, 
P. Rosch, K. Weber, D. Cialla-May, T. Bocklitz, J. Popp, Quantitative SERS 
studies by combining LoC-SERS with the standard addition method, 
Anal. Bioanal. Chem., 2015, 407, 8925-8929.121 Copyright Springer-
Verlag Berlin Heidelberg 2015. With permission of Springer.) 
improve the reliability and feasibility of these systems. Namely, 
LoC-SERS systems with on-demand and reversible formation 
of nanoparticle aggregates, with efficient analyte trapping in 
the detection area, with integrated competitive assay designs, 
and with in situ synthesis of SERS-active substrates have been 
reported over the last four years. Nevertheless, in a market-
place where numerous devices are well established, the 
implementation of new technologies is challenging. In order 
to overcome this, the research activities should be directed 
toward developing field-ready hardware and test kits with mul-
tiplexing capabilities, but without compromising their speci-
ficity and sensitivity. 
LoC-SERS-integrated systems have a high potential for on-
field, low-cost applications. The footprint and the costs of 
these platforms can be considerably reduced thanks to the 
continuous development of miniaturized, fiber-based Raman 
setups. Furthermore, moving away from low-scale, clean-room 
fabrication toward large-scale or in situ, right before measure-
ment, synthesis of reliable SERS-active substrates will also 
promote a wide range of applications of these systems. 
This journal is © The Royal Society of Chemistry 2017 
View Article Online 
Critical Review 
Although in the research laboratory setting the reusability of 
microfluidic chips is of high interest for reducing costs, single-
use, disposable and finger-nail sized chips with integrated 
operational units are desirable for large-scale applications. 
Furthermore, bulky syringe pumps have to be replaced with 
small units or ideally, by self-acting capillary forces. 
In the last two sections of the present review, we showed 
that LoC-SERS systems combined with chemometric 
approaches have a high potential for a multitude of appli-
cations. Among these, multiplex detection is of high interest, 
as i.e., for medical diagnosis, a whole panel of biomarkers has 
to be detected in order to confirm the presence of a disease. 
Microfluidic SERS in combination with competitive immuno-
assay designs can offer 3D barcode information with high sen-
sitivity. Furthermore, considerable advances have been done 
in pathogen, drug, and pollutant detection in clinically and 
environmentally relevant matrices. Therefore, the latest studies 
have transited from ideal, easy-to-handle solvents to real-world 
situations. Nevertheless, the reliable quantification of sub-
stances by means of SERS is still challenging to realize. The 
quality of SERS-active substrates, the high chemical variability 
of clinical and environmental samples, and the fact that SERS 
is by definition a surface-sensitive technique are some of the 
factors contributing to these challenges. 
In conclusion, although there is still much work to be done 
on the field of LoC-SERS platforms before the technique can 
be commercialized and implemented in practice, we are opti-
mistic that the individual contribution of each research group 
focused on this topic will lead to a powerful bioanalytical tool 
of the future. 
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